incivo is used to treat adults with hepatitis c infection . it is used in adults to treat chronic hepatis b infection in adults aged 1865 who are also taking peginterferon alfa - 2b , ribavirin and telaprevir , which belong to a group of medicines called ns3 - 4a protease inhibitors . if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine : - an active substance in the form of a protein called ' tpa ' that is found in the milk of eggs that carries protein from the chicken eggs and which has been produced by recombinant dna technology . this product works by reducing the amount of the virus in your body , and preventing it from growing .
do not take incivo - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). - when taking peginterferon alfa or ribavirin , please carefully read the package leaflets of their contraindications ( e . g . pregnancy precautions ) carefully read all the information contained in this leaflet . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : your doctor has prescribed inciva in combination with a medicine containing peg interferon at the same time as bmi . your doctor may need to adjust your dose of incivi based on the following medicines , which may cause severe side effects . 56 taking the medicine alfuzosin may cause symptoms of an enlarged prostate . it may also
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . follow your doctor ' s instructions exactly and follow them . they may differ from the general information contained in this leaflet . it is very important that you follow the appropriate dose regimen to get the best results for your treatment . the recommended dose regimen is 3 to 6 tablets once a day . this is followed by 2 to 8 days rest period , which is generally given every 6 weeks . for patients with both hepatitis c virus infection and human immunodeficiency virus infection , efavirenz , your doctor will advise you on how to use it . your doctor may also advise you to follow the recommended dosage regimen , especially for children 3 to 8 years of age . incivo can be taken with food or between meals . you should swallow the tablets whole
like all medicines , this medicine can cause side effects , although not everybody gets them . if you develop rash ( such as an itchy skin rash ), stop taking incivo and see a doctor immediately . the rash may be severe or life - threatening . other symptoms that may occur after starting the treatment for a severe skin reaction ( see section 2 ). if rash occurs , tell a member of your family or close friend as soon as possible and / or you immediately contact the nearest hospital , as a rash can occur . also , if your rash gets worse or if other symptoms associated with rash include fever , tiredness , swelling of the face and swelling of lymph glands , and a wide - spread rash with peeling skin , fever and flu - like symptoms , or painful skin skin . these may be
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . incivo tablets should be kept in the bottle in order to protect from light and moisture . keep the bottle tightly closed . this medicine does not require any special temperature storage conditions . after first opening of the bottle , use the tablet immediately .
what incivo contains - the active substance is telaprevir . - each tablet of the 375 mg tablet contains 375 milligrams tetraprevir ( as mesilate ). the other ingredients are : tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal , sodium lauryl sulphate , croscarmellose sodium , and sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol ( 6000 ), talc , titanium dioxide ( e171 ) and iron oxide yellow ( see section 2 ). what you need to know before you are given ibivo . what if you have not been trained , the tablet core is yellow caplet - 
the active substance in zinbryta is daclizumab beta , a monoclonal antibody , which recognises and attaches to a specific target substance in the body . the target is a substance called ' ms - like protein ' which is found on the surface of human blood ( s ) and is present in the bloodstream . what is zinbeta used for and how it works in patients with multiple sclerosis , it is used either alone or in combination with other treatments that reduce inflammation . this destroys the protective sheath around the nerves in the central nervous system ( the brain and spinal cord ). this loss of myelin ( demyelinating ) has been shown in some patients with relapsing mes with repeated attacks ( relapses ). it is thought to work by letting the body
you should not be given zinbryta - if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : - you have ever had liver problems . - your doctor may need to adjust your dose , if necessary , to make sure that you are getting the best results from your medicine . you have any other autoimmune disorders . do not take any other medicines , including herbal supplements , or any medicines or supplements you take . these medicines can increase your risk of liver side effects . your doctor will monitor you closely while you are taking these medicines . the doctor may decide to temporarily or permanently stop the administration of the medicine unless your doctor tells you to . children and adolescents do not give this
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to inject the recommended dose of zinbryta is 150 mg once a week . your doctor will do a blood test to check how well your liver is working before prescribing the correct dose . the usual dose for adults and older people is one 40 mg injection a day . depending on the results of this blood test your doctor may decide to change your dose , either temporarily or permanently . if your doctor decides that you need to take a test to make sure that your own dose is safe and effective , he / she will tell you how much you should take . do not inject yourself zin bryta under the skin of your thigh , stomach or upper arm . talk to your doctor , pharmacist or nurse before injecting zin
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : tell your doctor or pharmacist straight away if you notice any of the side effects listed in this leaflet . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . serious side effects liver problems ( very common : may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ) or vomiting ( being sick ), stomach pain increased tiredness loss of appetite ( anorexia ) your skin or the whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommonly ( may affect up to 1 in 100 people ). severe inflammation of the liver may lead to death . if this happens , you must contact your doctor immediately .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the zinbryta pre - filled syringe after exp . store in a refrigerator ( 2 - 8 ). do not freeze . after first opening , store in the original package in order to protect from light . when you need to use a new s / pen , check that the pack is still in use and do not store the pen in its original package . you may store a record of the date of opening on the pen and record the date when it was first opened . if you have a fridge at room temperature ( not above 30 ) you may use zinbetha ssringe / pens for up to 30 days , but your doctor may decide to keep your zin
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 micrograms ( mg ). - each daclinab beta 1 ml solution for injection / infusion is provided with a ready - to - use pen . after reconstitution / dilution / use / reconstitution the recommended dose is 1 milliliter ( 0 . 5 millilitre ) of daclizub beta in 1 millis / dose . the other ingredients are : sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( e433 ) and water for injections ( see also section 2 under ' important information about some of the ingredients of zinbeta - sodium '). what you need to know before you
wilzin belongs to a group of medicines known as metabolism products . it is used to treat : wilsson ' s disease is caused by a rare inherited defect in copper excretion in the liver , the eyes and the brain . this causes liver damage and neurological disorders in which the medicine passes through the intestine and its further accumulation in the body . if you are given a different dose , it will be given to you by your doctor , pharmacist or nurse . your doctor will discuss with you the benefits and risks of this treatment with you .
do not use wilzin - if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using wilszin . before you are given this medicine , you should be closely monitored during and after initial therapy . if signs and symptoms indicate that a significant change in the appearance or ten - days have been observed for a long time , please inform your doctor as you may need to be monitored more closely , for example , when you first start using a new , slightly altered , product . your doctor may advise you to take another anti - copper agent , penicillamine , while you are being treated with this medicine for the initial treatment . in addition , other anti  copper agents may be given to you in addition to pe
always take wilzin exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the different dose regimens are available in different strengths and doses : 25 mg and 50 mg tablets : each dose is taken with or without food . how much to take adults - the recommended dose is 1 tablet of wilszin 50 mg twice a day ( taken in the morning and evening ) in the evening . - take two tablets of 25 mg each day , with or immediately before or after food , and at least 1 hour before or 2 hours after a meal . your doctor may decide to increase your dose to 50 mg , depending on how you respond to the medicine . use in children and adolescents the doctor will tell you how many tablets you should take and how often to take them . children weighing at least 2 kg and less than 25 kg the doctor may prescribe
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common : affects 1 to 10 users in 100 % uncommon : effect affects less than 1 per 10 user in 1 , 000 not known : frequency cannot be estimated from the available data very commonly reported in patients taking a 10 mg tablet : 10 mg / ml very rarely reported in the post - marketing setting . very rarely , patients taking 10 . 000 % or more likely to get more than 10 ,000 % may occur in patients who have taken a higher or lower dose . some patients have experienced gastric irritation during treatment . changes in blood tests may include an increase in some liver and pancreatic enzymes and a decrease in blood
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains - the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg zinc acetate dihydrate ). each capsule of 50 mg contains zinc ( echivalent with 167 .84 mg zinc acid dihydrate and magnesium stearate ). the capsule shell is composed of gelatin , titanium dioxide ( e171 ), and brilliant blue fcf ( 18f ). - printing ink contains shellac , red ink containing 240 mg of the hard capsules , 25 mg , 50 mg and 50 mg printed in black ink with the company logo and ink filled with black iron oxide , with the ink contained in the capsule . what if you get a different colour ( s ) for your capsule , please contact your doctor or pharmacist . not all pack sizes may be 
biktarvy contains the active substance bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . emtricitabine , which itself is not a drug , belongs to a group of medicines called " nrti " tenofovir alafenamide , also known as a nucleoside reverse transcriptasse inhibitor ( ntrtis ) it is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection . by reducing the amount of hiv in your body , it increases the protective effect of your immune system . this will improve your immune response and reduce the risk of developing illnesses linked to hiv infection , but it is important to keep your appointments with your doctor , pharmacist or nurse .
do not take biktarvy : - if you are allergic to bictegravir , emtricitabine , or tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the following medicines . rifampicin , used to treat some bacterial infections such as tuberculosis - saint john ' s wort ( hypericum perforatum ), used as a herbal remedy for depression and anxiety . talk to you doctor or pharmacist if any of these apply to you . take special care when you are being treated with biktarivy you may have liver problems , including a history of liver disease called hepatitis . there is limited experience in patients with liver
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . do not take antacids to prevent stomach ulcers , heartburn or acid reflux caused by aluminium or magnesium hydroxide mineral supplements , vitamins , magnesium , iron , and water for injections ( see section 2 " what you need to know before you take biktarvy "). your doctor may tell you to take one or more of these medicines while you are on dialysis . it is important that you continue to take bikarvy until your doctor tells you otherwise . if your child is not able to take the tablet on a regular basis , talk to your child ' s doctor , pharmacist , or nurse . keep in touch with the doctor if he / she decides to stop , monitor and adjust the dose of
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are inflammation or infection . in some patients with advanced hiv infection ( aids ), opportunistic infections ( infections that occur in people with a weak immune system ), signs and symptoms of inflammation from previous infections may occur soon after hiv treatment is started . it is thought that these symptoms are due to an improvement in the body ' s immune response , enabling the body to fight infections that may have been present with no obvious symptoms . autoimmune disorders , when the immune system attacks healthy body tissue , may also occur after you start taking medicines for hiv infections . you should talk to your doctor if you have any questions about how biktarvy works or why this medicine has been prescribed for you .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the seal and the carton after " exp ". store in a refrigerator ( 2 - 8 ). do not freeze . keep the seal tightly closed in order to protect from light . this medicinal product does not require any special temperature storage conditions . tell your pharmacist if you are taking biktarvy .
what biktarvy contains - the active substances are bictegravir , emtricitabine , and tenofovir alafenamide . - a / biktarvay tablet contains : tablet core microcrystalline cellulose ( e460 ), croscarmellose sodium , magnesium stearate in the core of the tablet . film - coating polyvinyl alcohol , titanium dioxide , macrogol and talc , iron oxide red and iron oxide black ink . not all pack sizes may be marketed .
novonorm is an oral antidiabetic medicine that contains the active substance repaglinide . it helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your panceras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonourm is used in adults to control type2 diabetes in adults as an add - on to diet and exercise : treatment is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower ) their blood sugar . there is also a benefit of novonomm when metformin is used for diabetes . you should continue to follow the diet and lifestyle advice from your doctor , pharmacist or nurse . if you have any further questions on the use of this
do not take novonorm : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment : you have type 1 diabetes . it is important that you keep track of the acid level in your blood ( diabetic ketoacidosis ). you have a severe liver disease . you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ) 47 you have liver problems . if any of these apply to you , do not use novonomm . your doctor may want to change the dose of novonarm you are taking . moderate liver disease there is no information available on the use of this product in children and adolescents . there is limited information on the safety and efficacy in patients with 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 0 . 5 mg once daily . swallow the tablets with a glass of water immediately before or up to 30 minutes before each main meal . your doctor may decide to increase your dose to 4 mg twice daily , if necessary , until your doctor tells you to stop taking novonorm . if your blood sugar is too low , you may get a hypo , or you may want to stop eating for a long time without talking to your doctor . you should continue with your diet and exercise plan as long as you continue to follow your diet , even when you are getting older . depending on how you respond to a medicine , your doctor will tell you exactly how much to take , and for how long you will need to take it .
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is a very common side effect of novonorm and it is very common ( may affect more than 1 in 10 people ). this is usually accompanied by a hypo in section 2 ( see ' warnings and precautions ' at the end of this leaflet ). the most frequently reported side effect is hypoglecaemia ( common may affect up to 1 in10 people ) and is usually mild / moderate . however , some cases may be severe , e . g . even fatal , in rare cases , to very rare cases ( may lead to coma ). - allergy allergy ( rare ) may occur ( very rare may affect less than 1 user in 10 , 000 ). symptoms may include swelling , difficulty in breathing , rapid heartbeat ,
what novonorm contains the active substance is repaglinide . the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , and poloxamer . iron oxide yellow ( e172 ) only in the 1 mg tablets and iron oxide red ( 2 mg tablets ) not all pack sizes may be marketed in your country . what novoorm looks like and contents of the pack novanorm tablets are round , biconvex tablets with " 0 . 5 " on one side and " 2 " on the other side . tablets are available in packs containing either one blister pack of 1 or 2 tablets . each blister pack contains either one tablet with "
pumarix is a vaccine for use in adults aged 18 and over to help protect you against pandemic flu ( influenza ). pandémic flu is an extremely rare type of influenza that happens at intervals that vary from less than 10 years to many decades . it spreads rapidly around the world . the signs of pandémi flu are similar to those of ordinary flu but may be more serious . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarize may not fully protect all persons who are vaccinated .
pumarix should not be given : if you have previously had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the substances that may be present in trace amounts as follows : egg and chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if any of these apply to you , tell your doctor or nurse straight away . however , in a pandemic situation , it may be appropriate to postpone the vaccination until you have recovered . your doctor may recommend that you receive medical treatment . in the unlikely event that you have an allergic response , you may not be fully protected from the effects of this vaccination . warnings and precautions 33 talk to your
pumarix will be given to you by a doctor or nurse , at the same dose and frequency as for adults ( aged 18 and over ) if you have previously received or are about to receive a similar h5n1 as03 - like vaccine . for children ( from the age of 18 years onwards ), the recommended dose is one vial ( 330 mg / kg body weight ) for each injection . a syringe ( s ) may be given between the ages of 3 - 9 years and adolescents aged 3 months - 17 years . your doctor will decide the appropriate dose for your child . the doctor will tell you if and when your child should return for the next dose . pu marix should be given as an injection into a muscle , usually in the upper arm . should you have any further questions on the use of this vaccine ,
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may cause dangerously low blood pressure . in some cases this may lead to shock . doctors are aware of this possibility and have emergency treatment available for use in such cases . other side effects include : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles or joint pain common : may affect up to 1 in every 10 people redness or swelling where you are given the injection fever sweating shivering diarrhoea feeling sick uncommon ( may effect up to1 in every 100 people ) runny nose sneezing bruising , redness of the skin , itching , rash . uncommon ( might affect upto 1 in 100 people people injected with pumarix ) injection site reactions , including
keep this vaccine out of the sight and reach of children . before the vaccine is mixed : do not use the suspension and the emulsion after the expiry date which is stated on the carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . after the vaccine has been mixed , use the vaccine within 24 hours and do not store above 30 . do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what pumarix contains - the active substance is split influenza virus , inactivated , containing antigen * equivalent to : a / indonesia ( h5n1 ) of strain nymc / 5 / 2005 ( asp ) ( pr8 - ibcdc- rg2 ) * expressed in 0 . 5 ml * propagated in eggs ** expressed in micrograms ** haemagglutinin . - during the pandemic , the vaccine is given as an ' adjuvant ' as03 , which is essentially ' squalene ', dl  - tocopherol , polysorbate 80 , and other ingredients in the vaccine : sodium chloride , disodium hydrogen phosphate , potassium di
somakit toc is a radiopharmaceutical product that contains the active substance edotreotide . the powder contains a nuclear medicine called gamma - 2b , which is essentially identical to the radioactive substance called gallium ( 68ga ) chloride , but is made up of more than one radioactive component called gallium ( 6ga + ) edéotreotrotide in one ml . this procedure involves delivering radioactivity directly into a vein , or into body areas , using a medical imaging procedure called positron emission tomography ( pet ). this medical procedure allows your doctor to obtain images of the abnormal cells and tumours that have spread to other parts of your disease . your doctor and the nuclear medicine doctor have considered that the clinical benefit that you will obtain from the procedure with the radiopharmace
do not use somakit toc - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). for signs of allergic reaction , see section 4 of this leaflet . warnings and precautions talk to your doctor or pharmacist before you are given this medicine : - you have kidney or liver problems . you have renal or hepatic disease . children and adolescents do not give this medicine to children less than 18 years of age . in order to reduce the risk of dehydration during the examination , the doctor may ask you to drink plenty of fluids before and after the examination 28 and for other medical conditions that affect the body such as cushing syndrome ( inflammation ) or thyroid disease ( tumour ( of pituitary gland , lung , brain , breast , immune system , thyroid , adrenal gland )
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakit toc will only be used in special controlled areas . these measures will be followed by the competent person handling the product . the nuclear medicine doctor supervising the procedure will decide on the quantity to give to you . a single injection will be sufficient , followed by an interval of between 100 and 200 minutes between each injection . megabecquerel will be the unit in which radioactivity will be measured , and the quantity should be injected . use in children and adolescents there is no information on the safety of radiolabelling in children under the age of 18 years . this product will be given to you by a doctor or a nurse . it is not known if this product passes into human milk . however , after the procedure , you should not give this medicine to children under 18
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) to somakit toc . symptoms may include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may include stinging at the injection site , exposure to ionising radiation associated with the least risk of cancer and hereditary abnormalities . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : after radiolabelling , somakit toc must be used within 4 hours . do not store above 25 . radioactivity must not be disposed of via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what somakit toc contains - the active substance is edotreotide . each vial of powder contains 40 micrograms of edeotreetide ( 10 - phenanthroline ), gentisic acid , mannitol ( e421 ), formic acid ( 0 . 5 ml ), sodium hydroxide and water for injections . - after radiolabelling , the solution contains a trace amount of hydrochloric acid ( 6 mmol ) per vial , which is used for radiopharmaceutical preparation . it is supplied in a glass vial with a black flip - off cap . the vial is a white powder and is presented as a powder for solution for injection . one vial comes in two different pack sizes , each containing
afinitor is an anticancer medicine containing the active substance everolimus . it works by blocking a receptor in the tumour and slowing down the growth and spread of cancer cells . ainsiitor can be used in adults to : treat hormone receptor - positive advanced breast cancer ( postmenopausal ) in combination with non - steroidal aromatase inhibitors to keep the disease under control . a medicine , called exemestane , is also known as a steoidal amatasen inhibitor , which is used as hormonal anticancancer therapy in adult patients with advanced tumours and neuroendocrine tumours in the stomach or bowels , where the tumour is most likely to grow .
you must not be given afinitor if you are not sure . before cancer treatment your doctor will tell you : - the active substance of vosimus , sirolimus ( e339 ) or temsilimus or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . - if your doctor thinks you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before you are given desirt if : you have any problems with your liver or have any disease which affects your liver . your doctor may prescribe you a different dose of asfinitor . you have diabetes ( high level of sugar in your blood ): you are treated with Afinitor which lowers blood sugar levels and may worsen diabetes me
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day . you should swallow your tablet whole with a glass of water . do not crush or chew the tablet before swallowing . pouritor can be taken with or without food . patients with liver problems may need a lower dose of afinitor ( 5 mg per day , or 5 mg in the morning and 7 . 5 mg each day ). your doctor may reduce your dose depending on certain side effects . your doctor will tell you how long your treatment will last . if your doctor decides that you should continue to take Afinitor for as long as you need to , you should not take more than your prescribed dose , unless your doctor tells you to do so . stopping treatment with afinior should be stopped immediately .
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and seek medical help immediately if you have any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps . the following side effects have been reported with Afinitor : very common ( may affect more than 1 in 10 people ): increased temperature , chills ( signs of infection ) fever , coughing , difficulty breathing , wheezing . inflammation of the lung ( pneumonitis ). cough , sore throat , runny nose , congestion of the sinuses , sinusitis , pneumonia , upper respiratory tract infection , bronchitis ( infection of the lungs ). common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , blister or blister after exp . store below 25 . keep the blister tightly closed in order to protect from light and moisture . the tablets should not be used if they are damaged , or if there are any signs of tampering ( e . g . in a broken tablet ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what afinitor contains - the active substance is everolimus . - chacunitor 2 . 5 mg film - coated tablets : each vial contains 2 , 5 mg of Everolimus ( as mesilate ). - Afinitor 5 mg films : one vial of 5 mg contains 5 mg or 8 mg of anyolimus in one ml . the other ingredients are butylhydroxytoluene ( e321 ), magnesium stearate , lactose monohydrate ( see section 2 ), hypromellose , crospovidone , and talc ( a type of food ) and a base for the solvent for a coating for the coating . there are no ingredients for pouritor after the expiry date which is stated on the label and carton after " exp ". what auxitor looks
what laventair ellipta is the active substance of laventaire ellippa , umeclidinium bromide , vilanterol , belong to a group of medicines called bronchodilators . they work in different ways to help open the airways , making it easier for air to get in and out of the lungs . what lventair is used for lapd is used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles around the air sacs tighten . this medicine blocks the tightening of these muscles in your lungs and so eases your breathing difficulties .
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have asthma ( your doctor may need to adjust your dose ). you have heart problems or high blood pressure . you have an eye problem called narrow - angle glaucoma ( see section 4 ) you have or have had an enlarged prostate , difficulty passing urine or a blockage in your bladder you have epilepsy you have thyroid gland problems you have diabetes you have severe liver problems you need immediate breathing difficulties such as tightness of the chest when breathing or breathing difficulties you have breathing difficulties if any of these apply to you , tell your doctor or nurse immediately . breathing difficulties or coughing up
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use laventair ellipta regularly it is very important that you use and take care not to get attacks or breathlessness during the day and night . if this is the case , tell your doctor straight away . in order for you to breathe in at the right time , and for how long , your doctor will tell you how long you should keep using it . do not use it to treat a sudden attack of breathlessness or wheezing unless you have been using a quick - acting relieve
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions you should have one or more of the following symptoms while using laventair ellipta . contact your doctor immediately . uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) or redness rare side effects (1 may affect less than 1 in 1 , 000 people): swelling , sometimes of the face or mouth ( angioedema ) becoming very wheezy , coughing or having difficulty in breathing suddenly feeling weak or light headed ( which may lead to collapse ). if you get any of these symptoms , or if they get worse straight away , contact a doctor or the nearest hospital straight away ( see section 2 ). very rarely , allergic reactions may occur . if any of the side effects gets serious or troublesome , stop
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 milligrams / litre ) umecdinium and 22 millilitres ( ml ) vilanterrol ( as trifenatate ). - also the other ingredients are : lactose monohydrate ( see section 2 under ' laventaire ellippa contains lactoses ') and magnesium stearate ( e470b ). what laVENTAIR ellipinta looks like and contents of the pack laventAir ellipita is a powder for inhalations powder , supplied in a glass vial . the 
tremfya contains the active substance guselkumab , a monoclonal antibody . this medicine contains an active substance called " il - 23 " which is used to treat psoriasis in adults . it is used in adults who have moderate to severe " patch " on the skin and in the nails . by doing so , it improves the condition of your skin and reduces the appearance of nails , and reduce symptoms such as scaling / shedding / flaking / itching , pain / burning .
do not use tremfya : - if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before you are given this medicine . you may be allergic to any of these ingredients . warnings and precautions talk to your doctor , pharmacist , or nurse before you receive or have ever had an active infection . there is a small chance that you may still be infected . it is important that you have active tuberculosis warnings , including the first time you receive and keep in contact with someone who is known or suspected to have an infection , such as a ' tick - resistant ' or ' yellow - yellow ' ( tb - positive ') or - negative ( not positive ) tuber
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of tremfya is 100 micrograms ( 1 pre - filled syringe ) given by injection under the skin ( subcutaneous injection ). this dose is given every 4 weeks . your doctor may change your dose , up to 8 weeks , depending on how you respond to injection . you should not use more than your doctor tells you to . if your doctor thinks you may have been given too much ( an overdose ), talk to your doctor before giving you the wrong dose . it is very important that you follow your doctor ' s instructions exactly as described in the box , and that the dose you receive is very low . do not change the dose yourself unless you have been trained by your healthcare professional on how to use tre
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor immediately or go to the casualty department at your nearest hospital if you experience any of the following side effects you may need urgent medical attention : - serious allergic reaction - difficulty breathing or swallowing - swelling of the face , lips , tongue or throat - severe itching of the skin - a red rash or raised bumps other side effects may include : reporting of side effects some side effects could be serious . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects it is possible that you can help provide more information on the safety of this medicine . common ( may affect up to 1 in 10 people ): upper respiratory infections common side effects ( may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . this medicine must not be used if the solution is cloudy or contains flakes or large particles . after first opening of the refrigerator , the pre- filled siringe may be stored at room temperature ( up to 30 ) for a single period of maximum three months . record the date when the tremfya is first removed from the refrigerator and the date after which it should be discarded . you must use it only if it is clear , colourless , and free from visible particles in it . if you are not sure , talk to
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg / 0 . 5 ml solution for injection ( injection ). - other ingredients ( excipient ( s )) are histidine ( e331 ), histamine monohydrochloride monohydrate , polysorbate 80 , sucrose , and water for injections . what hemfYa looks like and contents of the pack solution is clear to opalescent , colourless to pale yellow , solution . it is supplied in a carton pack containing one single - dose glass sYringe , or a multipack containing 2 ( 3 packs of 1 ) single – dose pre – filled pens . not all pack sizes may be 
the active substance in trepulmix is treprostinil . treprassinil belongs to a group of medicines known as prostacyclins , which are hormones that help to control blood pressure . by relaxing blood vessels , prostacins prevent blood from clotting . the combination of two active substances is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ) in adults : - if you have persistent or recurrent ctéph and you cannot receive surgical treatment , or if exercise capacity is not sufficient to control symptoms of the disease . in operation - in adult patients with chronic temboic pulmonary hypotension , if your blood pressure is too high , and the pressure in the blood vessels of the heart and lungs is not properly controlled .
do not take trepulmix : if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a disease called " pulmonary veno - occlusive disease ". if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : your blood vessels in your lungs are swollen , or there may be a higher pressure in the blood vessels between the heart and the lungs . you have severe liver disease you have ever had a heart problem such as - you have had , for example , - recently had or might now have - had - been in hospital for at least the last six months severe changes in heart rate severe coronary heart disease or unstable an
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is given as a continuous subcutaneous infusion under the skin ( intravenously ) through a small tube ( cannula ) in the abdomen or thigh . your doctor will decide how much medicine you will receive each day . you will be given the recommended dose when you first receive your first dose . before each infusion you will have a portable pump which will allow your treprostinil to work properly . the pump will allow the infusion line to open , so you do not receive accidental overdose . how much to use the usual dose is 1 , 2 . 5 mg , 5 mg or 10 mg per day depending on your condition and your doctor may tell you to take special dose adjustments . patients with liver or kidney disease your
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction to trepulmix , at or near to the site of infusion bleeding or bruising at or close to the imfusion site headaches , nausea , diarrhoea jaw pain common : may affect up to 1 in every 10 people dizziness , light - headedness or fainting low blood pressure skin rashes , muscle pain ( myalgia ) joint pain ( arthralgi ) swelling of feet , ankles and / or limb pain ( angioedema ), pain in the abdomen , stomach ache , vomiting , indigestion , constipation , dry mouth , inflammation of the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . a trepulmix vial may be stored at room temperature ( up to 30 ) for continuous subcutaneous infusion . in - use storage times and conditions prior to use are the responsibility of the user and should not be longer than 24 hours at 2 oc 8oc , but should be discarded if not used as soon as possible after preparation . when refrigerated , a single reserve ( syringe ) of undiluted tre Pulmix can be stored for up to 72 hours . use in children and adolescents do not give this medicine to children under 18 years of age because it has not been studied in this age group .
what trepulmix contains - the active substance is treprostinil ( as sodium salt ). one sachet contains 1 mg ( 280 micrograms ) or 1 microgram ( 480 microgram ) of TREprossinil in a 10 ml vial . each vial contains 10 mg ( 4 . 5 millilitres ), of which at least one third is made from sodium . - one vial provides 10 mg / 0 . 25 milligrams ( 6 . 6 milliliters ). - two vials contain 2 . 4 mg of trepstinningil ( sodium salt and 10 % of the recommended daily dose ) in each syringe . this product is available in packs containing 25 mg ( 8 . 7 mg ) tablets . not all pack sizes may
thorinane contains the active substance enoxaparin sodium . it is a low molecular weight heparin ( lmwh ) which helps to keep blood clots from forming in your blood . the active ingredient in thiorin ane is used in adults , adolescents and children aged 1 year and above to reduce the risk of existing blood clumps , and in children and adolescents aged 2 years and above who are at an advanced stage of prevention . this is the key ingredient in your medicine ' s action '. your doctor will test your blood to make sure that you do not have any new ones , or if you have any problems with your blood or your blood before an operation , an acute illness or unstable angina ( a condition where your heart does not work properly ) or a heart attack . you should also check for
do not use thorinane - if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if this applies to you , tell your doctor immediately . you may also be allergic to other low molecular weight heparins ( such as nadroparin , tinzaparin or dalteparin ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine if : you have ever had a reaction to the active substance in thiparin that causes a severe drop in the number of your clotting cells ( platelets ). this reaction may be a sign of he
like other similar medicines ( medicines to prevent blood clotting ), thorinane can cause bleeding which may potentially be life - threatening . in some cases the bleeding may not be obvious . at the first sign of any bleeding event that does not stop by itself or if you experience signs of excessive bleeding ( exceptional weakness , tiredness , paleness or dizziness ), headache or unexplained swelling , contact your doctor immediately . your doctor may decide to keep you under closer observation or change your medicine . you should not use thourinana if : you have had a severe allergic reaction ( e . g . difficulty breathing , swelling of the lips , mouth , throat or eyes ), blockage of a blood vessel , resulting in the formation of , or , cramping pain , diarrhoea 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the syringe label and carton after exp . store and transport refrigerated ( 2 - 8 ). do not freeze . thorinane may be stored at room temperature ( up to 25 ) for a single period of up to six months . after dilution the solution should be used within 8 hours . this medicine must not be used if it is discoloured or if particles in it are discoloured . discard any unused medicine via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what thorinane contains - the active substance is enoxaparin sodium . each ml of solution contains 100 micrograms / 0 . 2 milligrams ( corresponding to 2 , 000 units ). - each pre - filled syringe delivers a single dose of 1 , 2 million international units ( iu ) ( 6 . 6 millilitres ) of ennoxaparain sodium when reconstituted with water for injections . the other ingredients are : a clear to slightly opalescent , colourless type i neutral glass sprinkled with fixed needle and needle shield , closed with chlorobutyl rubber stopper and sealed with a blue polypropylene plunger rod . pack size : 2 packs of 10 pre – filled pens . not all pack
senstend contains the active substances lidocaine and prilocaine . these belong to a group of medicines called local anaesthetics , and are used for the treatment of lifelong premature ejaculation in adult men . they work by stimulating the head of the penis to produce more arousement . this will bring about a better quality of life for you .
do not use senstend - if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . allergy ( sensitivity ) to other local anaesthetics , including amide - type local anesthesias . this is because you have a genetic disease or other condition that affects your red blood cells ( glucose ) and phosphate deficiency ( anaemia or methaemoglobinaemia ). medicine sensitivities and sensitivity are more likely in patients with severe liver problems . you should avoid this medicine in direct contact with your face and avoid accidental contact with ears , eyes , nose and mouth . it is important to avoid contact with eyes and eyes . sensten
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of senstend is 3 sprays ( 3 ml ) in the head of the penis . use in children 3 months to less than 24 months of age . do not use after the expiry date which is stated on the label and carton after exp . your doctor will tell you how many sprays to use . if the spray container is opened , the pump mechanism is activated and the valve is closed to prevent contact with eyes , nose , mouth and ears . when senstentd is used in children 1 year of age and older , it should only be used on the foreskin or head of penis at the same time as the pump . it should be used within a period of at least 5 days . you should not use more sensten
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : very common ( may affect more than 1 in 10 people ) inability to develop or maintain an erection feeling of burning in the penis uncommon ( might affect up to 1 in 100 people ). headache local irritation of the throat , irritation and / or the skin redness of the skin failure to ejaculate during sexual intercourse abnormal orgasm tingling in or around the inis pain or discomfort in or surrounding area of your penis itching . not known ( frequency cannot be estimated from the available data ). if any of the side effects gets serious , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the metal container after exp . store below 25 and use within 12 months after first opening of the container . keep the container tightly closed in order to protect from light and moisture and do not puncture , burn or break it . you should not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 micrograms ( mg / 0 . 5 millilitre ) lidocanine and 50 microgram ( i . e ., 50 microlitres ) plocaine when reconstituted as recommended . the recommended dose is 50 microliters ( corresponding to 7 . 7 mg of lido caine and 2 . 4 milliliters ). - each spray container should be sprayed in a sprinkler . one spray container may be a full 20 spray container and one spray canister of 5 spray containers , or 12 spray containers are available . light yellow cutaneous spray is supplied in an aluminium spray container with metering valve . pack size of 1 spray container of 6 . 6 m
opdivo is a medicine used in adults to treat advanced melanoma ( a type of skin cancer ) in adults . it is used when complete resection in adults ( treatment with surgery called adjuvant therapy ) is not possible . advanced non - small cell lung cancer ( lung cancer that is advanced in adults advanced renal cell carcinoma ). advanced kidney cancer in adults classical hodgkin lymphoma when previous therapies ( including an autologous stem - cell transplant ) have not worked or when a transplant has failed or has failed . for advanced cancer of the head and neck in adults advance urothelial carcinoma , and bladder and urinary tract cancer , nivolumab , also known as a monoclonal antibody , has been shown to reduce the activity of a protein in the blood called ' cd4 '.
do not use opdivo - if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given . if the following applies to you ( or you are not sure ), talk to a doctor or go to the nearest hospital immediately . you may need to be treated with the following medicines while you are being treated : - problems with your heart such as a change in the rhythm or rate of the heartbeat . an abnormal heart rhythm may occur in your lungs , causing breathing difficulties and cough . this can be a sign of inflammation of the lungs ( pneumonitis or interstitial lung disease ). - diarrhoea ( watery , loose or soft stools ). tell your doctor straight away 
the recommended dose of opdivo in adults is 240 mg ( 2 x 480 mg ) given once a week for up to 4 weeks . your doctor will decide on the right dose for you . if you have been prescribed a different dose , your doctor may prescribe a lower dose ( ipilimumab ) for the treatment of your specific type of skin cancer . the recommended starting dose in adults with advanced kidney cancer is the same dose as in adults . you should start by taking the tablets at a low dose of 1 mg of nivolumab per kilogram of your body weight , given once every 4 weeks ( see the table below ). if your doctor prescribes the higher dose you should have the same daily dose as for a higher dose . alternatively , you may start with the tablet if necessary . use in children and adolescents the recommended
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . opdivo may be stored at room temperature ( up to 25 ) for up to 48 hours . from a microbiological point of view , the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains - the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg / 0 . 5ml containing navolum . - each vial contains either 40 mg ( in 4 vials ) or 100 mg ( 10 / 40 ), or 240 mg ( 24 / 48 ) containing approximately 24 mg - 0ml ( in 100 mg ), - 1ml sodium citrate dihydrate and / or sodium chloride ( see section 2 under ' important information about some of the ingredients of obdivo ').  the other ingredients are mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydrochloric acid and water for injections . what 
clopidogrel tad contains the active substance , cimetidine . it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , the body ' s own immune system ( the system ) can create blood ovaries ( thrombosis ) and prevent new clots from forming ( a process known as thrombi ) in hardened blood vessels ( arteries ). this process is known as atherothrombosesis . this process can lead to atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed the right type of medicine to help protect your family / carer to help prevent blood coagulations .
do not take clopidogrel tad 30 - if you are allergic to the active substance , or to any of the other ingredients of this medicine ( listed in section 6 ). - you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . you have severe liver disease . if any of these apply to you , your doctor may want to reduce your dose or stop your medicine from working properly . warnings and precautions there is no experience of administration of clopgrel to dad to children and adolescents under 18 years of age because there is an increased risk of bleeding . for example , if your doctor determines that it is necessary to take the tablets at the same time . discuss with your doctor the precautions needed to avoid infecting other people . before you are given , tell your doctor if : you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day ( for example , in case you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg . your doctor will tell you how much to take ( usually between 75 mg and 75 mg ) to take before you start treatment . then , the usual dose is two 75 - mg tablets a day ( two 75 mg tablets per day for as long as you are being treated ). for more information , see the section " take ' taking ' in
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin . this may be the signs of an allergic reaction . the signs may include reddening , unusually intense pain when applying clopidogrel tad to your eyes , lips , tongue or throat , as well as nausea and vomiting 
what clopidogrel tad contains - the active substance is clopizid . each film - coated tablet contains 75 mg of cpd - ( as hydrochloride ).  the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide and yellow iron oxide in the film coating . the tablet coating contains talc and macrogol 3000 in black ink . not all pack sizes may be marketed . your doctor will tell you what you need to know before you take a tablet . what you should do if you have any questions , or if someone else has taken your tablet , contact your doctor or
tacforius contains the active substance tacrolimus . it is an immunosuppressant . following your organ transplant ( e . g ., liver , kidney ), your body ' s immune system will try to reject the new organ . tac forius is used in adults to reduce the amount of food that your body needs to eat , drink and other organs in the body . your doctor will tell you how many treatments you need to take , when to stop your transplanted organ , and for how long you will need to be treated . you may also be given tacfordius for the treatment of rejection of the transplanteed kidney , heart and any previous treatment you were taking was unable to control this immune response after your transplantation .
do not use tacforius : - if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment if the person being treated is allergic or to any macrolide - antibiotic ( e . g , erythromycin , clarithromycin or josamycin ) as these may affect the ability of tacolimus immediate release capsules ( i .e , tacni ) prolonged - release caps are not suitable for patients who are not able to swallow the capsules , as they may not be suitable for them . you should not take tacoimus immediately , but should be taken with a meal . there is no information available on the use of tacolinimus in children and adolescents . tac
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed to you by a doctor experienced in the treatment of transplant patients . your doctor will prescribe the same tacforius medicine every time you collect your prescription , unless your transplant specialist has agreed to change to a different taccrolimus medicine . you should take this medicine every day until your doctor tells you otherwise . make sure that you take the right medicine to prevent the rejection of your transplanted organ . the dose you take depends on your body weight , the day before transplantation and the day after transplantation . usual doses for adults and children are 0 . 10 - 00 . 30 mg twice a day on day 35 of each day after you have been transplanted . in case of rejection , these same doses may
like all medicines , this medicine can cause side effects , although not everybody gets them . infections may occur during treatment with tacforius . severe effects may occur , including allergic and anaphylactic reactions . benign and malignant tumours have been reported following tacfordius treatment . cases of pure red cell aplasia ( a very severe reduction in red blood cell counts ) have also been reported . these cases are due to agranulocytosis , a severely lowered number of white blood cells , haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ) and febrile neutropenia ( an increase in the level of a type of whiteblood cells that help to fight infection ). they are usually mild to moderate and usually go away within a few days . if you have any questions about how this medicine works or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . all the prolonged - release hard capsules should be used within 1 year of opening the aluminium wrapping . store in the original package in order to protect from light and moisture .
what tacforius contains - the active substance is tacrolimus . - each capsule of tac forius 0 . 5 mg contains : - one vial of 10 mg , or - two vials of 5 mg each , respectively . this dose is equivalent to a millilitre ( ml ) ( equivalent to 5 milligrams ) dehydration . the other ingredients are : capsule content hypromellose 2910 ( e464 ), ethylcellulose , lactose , magnesium stearate , e470b . capsule shell tacforinus 1 mg / 1 mg hard capsules : this medicine is a clear , colourless liquid . it is available in packs containing 1 hard capsule . not all pack sizes may be marketed in your country .
clopidogrel zentiva contains the active substance , octocog alfa , which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). obstructive , involuntary and fatal , can occur in untreated patients with a reduced risk of blood to form ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis . this can lead to atherathrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogre
do not take clopidogrel zentiva : - if you are allergic ( hypersensitive ) to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). -if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has told you that you have severe liver disease . before you start taking clopizide , make sure you tell your doctor if any of these apply to you . warnings and precautions before and during treatment with opportunistic use , you should tell your physician if : you are at increased risk of bleeding , including - an medical condition which puts you at risk of internal bleeding ( such as an stomach ulcer ). you have been told by your doctor that you suffer from a blood disorder that makes you prone to internal bleeding
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day ( see section 6 ). for severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg . for children and adolescents , your child ' s doctor may increase the dose to 300 mg ( 1 tablet of 4 tablets of 75 mg ) once at the start of treatment . your doctor will decide the right dose for you based on the weight of your child and will decide whether the 75 mg dose should be given or not . you should take the tablet with food and
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin . this may be the signs of an allergic reaction . the signs may include reddening , unusually intense pain when applying to the skin , swelling around the eyes , nausea , vomiting , diarrhoea , abdominal pain ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . clopidogrel zentiva should not be used if it is stored in aluminium blisters , in order to protect from light and moisture . discard the vial after 30 days of first opening it is unlikely to be stored in a refrigerator . however , it is strongly recommended to use it within this period and do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what clopidogrel zentiva contains - the active substance is :  cb1 - 3 . - each tablet contains 75 mg / 0 . 5 ml of  Clopidogral ( as hydrogen sulphate ).  see section 2 ' cd3 - 4 ' for further information about some of the ingredients of the tablet , which are listed at the end of the leaflet '. if you are not sure , talk to your doctor , pharmacist or nurse before you are given a tablet . the other ingredients are lactose ', which is a type of oil ; hydrogenated castor oil '; mannitol ( e421 ), hydrogenated castingor oil ( maize starch ); microcrystalline cellulose ; macrogol 6000 ; low -
yttriga is a radioactive medicine that does not contain radioactivity . it is used in combination with another medicine that is used to deliver tiny radiation doses . your doctor will decide which medicine is best for you . the treatment will be started by a doctor who is experienced in the use of radiolabelled medicinal product .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if possible , you may be pregnant or could become pregnant while you are being treated with the active substance . the active ingredient in this product is known as " radiopharmaceuticals ". the following information is intended for the specialist only and should not be used after the expiry date which is stated on the label and carton after exp . for the safety of radioactive material , radioactive medicinal products should be disposed of in accordance with national regulation on radioactivity . children and adolescents do not give this medicine to children under 2 years of age or to adolescents under 16 years , because the safety and efficacy have not been established .
your doctor will determine the appropriateness of the treatment . method of administration yttriga should only be used under the supervision of a physician experienced in radiolabelling of medicinal products . the doctor will decide on the most appropriate dosage for you . use in children and adolescents the appropriate dosage and duration of treatment should be determined by the doctor . frequency of administration you should follow the instructions of your doctor , pharmacist or nurse . in case of overdose , your doctor or nurse will give you appropriate treatment , if necessary .
like all medicines , yttriga can cause side effects , although not everybody gets them . if any of the side effects get serious , or if you notice any side effects not listed in this leaflet , please tell your doctor , pharmacist or nurse . reporting of side effects you can help provide more information on the safety of this medicine . you can also report side effects directly via the national reporting system listed in appendix v . for more information , see the package leaflet of the medicines to be taken by patients .
yttriga will be stored under the responsibility of the specialist in appropriate premises . storage of radioactive substances will be in accordance with national regulations . the following information is intended for the specialist only : keep this medicine out of the sight and reach of children . do not use after the expiry date which is stated on the vial label and the carton after exp . any unused product or waste material should be disposed of aseptically as possible .
what yttriga contains - the active substance is chloride . 1 ml sterile solution for injection contains 1 mg of hydrochloric acid . the other ingredient is water for injections ( see section 3 under ' sodium content '). what the product looks like and contents of the pack this medicine is a clear , colourless liquid with a v - shaped bottom and a colourless type i glass vial . one pack of 10 vials has a flat bottom , sealed by a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . it is used in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , in adult patients who have not received prior chemotherapy . if you have been given CIAmbra in combination treatment with one or more other medicines for the initial treatment of patients with advanced stage of lung cancer , you may be prescribed ciaba if your lung cancer has spread to other parts of your body or it has responded to treatment or it remains largely unchanged after initial chemotherapy ; however , it is still possible to determine whether it is safe for you to continue with your treatment if other initial chemotherapy has been used .
do not use ciambra : - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you should not be given breast - feeding during treatment . your doctor may decide that you should be treated before or during treatment with ciama . - you have recently received or are about to receive a vaccine against yellow fever . tell your doctor or hospital pharmacist if any of these applies to you . do not receive ciambambaa if : you have problems with your kidneys . before each infusion you will have your blood checked by your doctor to check that you have sufficient kidney and liver function and to make sure you have enough blood cells , before and during treatment you may not be able to
the recommended dose of ciambra is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of the body . this body surface area is used for treatment and to adjust your dose , depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or doctor will have mixed the citambra powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution for injection before it is given to you . you will always receive ciama by infusion into one of your veins . the infusion will last approximately 10 minutes . depending on the dose prescribed by your doctor , your doctor may also give you another medicine , cisplatin , at the same time each day , and your doctor will work out your dose you need based on your height
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following : 52 fever or infection ( common ): at a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . signs include : chest pain , a fast heart rate , or pain ( uncommon ). redness , swelling or sores in your mouth . allergic reaction : skin rash , burning or prickling sensation , fever or skin reactions that may last for several days or months . this is very rare . you may get skin reactions more easily than normal . these side effects are usually mild to moderate and usually go away within a few days 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special storage conditions . the infusion solution of pemetrexed may be stored for up to 24 hours at 2 - 8 , at a concentration not above 15 or 25 . from a microbiological point of view , the reconstituted solution should be used immediately after reconstitution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours between reconstitution and infusion . for single use only . any unused solution must be discarded .
what ciambra contains - the active substance is pemetrexed . - each vial of 100 mg contains 100 milligram ( millilitres ) of pemetrexxed ( as pemetreixed disodium hemipentahydrate ). - one vial / 0 . 5 ml solution for injection or infusion is supplied in a pack containing 500 milliliters ( 1 gbq : 500 micrograms ), with the option of reconstituted dilution . after reconstitution , the solution contains 25 mg ( 1 mg ) / 5 g , equivalent to 5 % of the recommended daily dose , iu / kg body surface area ( ph adjustment ) and sodium hydroxide ( if necessary , depending on the case / pH adjustment ). see section 2
what immunogam is immunogam belongs to a group of medicines known as immunoglobulins ( antibodies ) that are used to prevent certain infections from entering your blood . immunogam can help to increase levels of human hepatitis b immunoglobuins , and also of the active substance , immunoglobularin g ( igg ). it is produced by recombinant dna technology and is injected into a blood plasma of screened patients . how immunogam works immunogam reduces the amount of hla - b virus in your body . it is used to treat adults , adolescents , children and infants who are haemodialysed patients who are not able to receive vaccination . using immunogam may increase the body ' s own immune response . there is a very small number of patients with a record of measurable
you must not be given immunogam : if you have ever had an allergic reaction to human immunoglobulins or other blood products , or to any of the other ingredients of immunogam ( listed in section 6 ). you have an iga deficiency . tell your doctor straight away if any of these apply to you . you may be more likely to have an allergic response to iga containing products . warnings and precautions children and adolescents do not give immunogam to children less than 18 years of age because immunogam has not been studied in this age group . other possible adverse reactions include chills , headache , fever , vomiting , allergic reactions such as nausea , arthralgia , joint pain , low blood pressure , and moderate low back pain . your doctor will make sure you have antibodies against hepatitis b immunoglobuulin regularly .
immunogam is intended for vaccination against hepatitis b virus only . as the first vaccine dose will be given , the administration will be administered together with a single dose ( 0 . 5 million iu ) of a specialised type of human hepatis - b immunoglobulin . dose and administration prevention if you are vaccinated against the following : the usual dose of hepa b : 500 micrograms per day for 24 to 72 hours . the dose may be adjusted by your doctor based on the body weight of your child . in haemodialysed patients : your doctor will calculate the dose for you . this will be calculated by the doctor using the following scheme : - dose adjustment if necessary , your child will receive a dose of 500 microgramms in 2 doses . - serocon
like all medicines , immunogam can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common : affects 1 to 10 users in 100 % uncommon : effect 1 to10 users in 1 , 000 % very rare : effects 1 to ten users in 10 000 : undesirable effects observed during clinical trials with immunogam , the amount of immunogam in the muscle was not known ( frequency cannot be estimated from the available data ) very rare ( effects observed in less than 1 patient in 10 million : allergic reactions ( e . g . nausea , fatigue , induration , swelling and / or bruising ), however , very rarely , in very rare cases , some undesirable effects have been observed in clinical trials . immunogam may
keep immunogam out of the sight and reach of children . do not use immunogam after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . from a microbiological point of view , immunogam should not be used if the solution is cloudy or contains flakes or deposits . if you notice any particles or flakes in the solution , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . immunogam 1 mg / ml solution for injection in a vial contains 5 g of human plasma protein , corresponding to a concentration of 96 micrograms per vial . the other ingredient ( s ) are polysorbate 80 and water for injections ( see section 2 ). What immunogam looks like and contents of the pack immunogam is presented as a powder and a solution for injecting in an off - white or pale yellow liquid . it is available in packs containing 1 vial of solution .
remicade contains the active substance infliximab , which is essentially similar to an antibody of the body called ' tnf - alpha '. this is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body . this target is called tumour necrosis factor - 1 ( l ) and is present at increased levels in some tumours . rericade belongs to the group of medicines called  tlf blockers . it is used to treat the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew - s disease ) in adults and children of all ages who have had at least one previous treatment , and are now starting treatment with p
do not use remicade : - if you are allergic to infliximab or any of the other ingredients in this medicine ( listed in section 6 ). - are allergic ( hypersensitive ) to proteins that come from mice . - have tuberculosis ( tb ) or another serious infection such as pneumonia or sepsis . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor will tell you whether you need to be treated for this or for any other reason . you may be at increased risk of heart failure if any of these apply to you ( or you are not sure ), ask your doctor or pharmacist for advice before you start taking the medicine and while you are being treated with the medicine , if they are not suitable for you . take special care with retinol tell your doctor
rheumatoid arthritis the usual dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), ppsoriasis , ulcerative colitis and crohn 's disease the usual starting dose is 5 mg for each kg ( m2 ) of body weigh . how remicade is given the doctor or nurse will give you the medicine as an infusion . the medicine will be given by a nurse or doctor , or nurse , over 2 hours , into one of your veins , usually in your arm . after the third treatment , your doctor may decide to give you a smaller dose , depending on how well it works for you and your condition . you will be monitored while you are given the medicine , and for at
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however some patients may experience serious side effects and may require treatment . side effects may also occur after your treatment with remicade has stopped . tell your doctor straight away if you notice any of the following : signs of an allergic reaction such as swelling of your face , lips , mouth or throat , which may cause difficulty in swallowing or breathing , skin rash ( hives ), swelling of the hands , feet or ankles . these reactions may be serious or life - threatening . you should seek immediate medical advice from your doctor , pharmacist or nurse , as you may need medical attention . an allergic response is common in up to 2 in 10 people allergic side effects have been reported in adults and adolescents 12 years of age and older : pain in the
remicade will generally be stored by the health professionals at the hospital or clinic . the storage details should you need them are as follows : keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and the carton after exp . store in a refrigerator ( 2 8 ). do not freeze . after dilution , if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 25 days at room temperature ( below 25 ). if refrigerated , allow the medicine to come to room temperature prior to infusion , and for up to 3 hours at 2 8 up to 28 and for an additional 24 hours at 25 after removal from the refrigerator . if you have any further questions on the use of this medicine , ask your
what remicade contains - the active substance is infliximab . each vial contains 100 mg of inliximabob , corresponding to 10 mg / ml when diluted as recommended . -- the other ingredients are sucrose , polysorbate 80 ( e433 ), monobasic sodium phosphate ( msp ) and dibasic salt ( psi ). what retinol looks like and contents of the pack rericade is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white . it is a white to off - white cake or cake . one pack contains one vial with a further 2 , 3 , 4 , or 5 vials . not all pack sizes may be marketed .
rasagiline mylan is used to treat parkinson ' s disease in adults , adolescents and children . it can be used together with or without levodopa ( another medicine that is used in this condition ). it is also used in children and adolescents who are not able to take or keep a balance on their bodies . when you grow older you may have more dopamine in the brain , a chemical that is important for movement control . rasagamma mylan helps to increase and sustain levels of doespamine within the brain after a meal .
do not take rasagiline mylan : - if you are allergic to rasageiline or any of the other ingredients of this medicine ( listed in section 6 ). - have severe liver problems . - are taking the following medicines : rasagaline mylan may increase the effects of monoamine oxidase ( mao ) inhibitors ( usually used to treat depression or parkinson ' s disease ). it may also be used in combination with medicinal and natural products ( such as stevens john 's wort ) or pethidine ( a strong pain killer ). you must wait at least 14 days before or during rasagide mylan treatment . talk to your doctor , pharmacist or nurse before you are given treatment with mao inhibitors , such as Pethidine . warnings and precautions talk to you doctor or pharmacist before you receive rasag
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet of 1 mg taken by mouth once daily . rasagiline mylan should be taken every day at the same time of the day , with or without food . if your doctor prescribes a different dose for you , you should contact your doctor , pharmacist or nearest hospital casualty department immediately . do not freeze , do not shake , or place next to a food , drink or any other medicine , unless you have been instructed to do so by your doctor and / or your carer notices that the medicine is not strong or contains any visible sign of a problem , such as a sharp object of sharp objects such as sharp objects in sharp objects , sharp objects or other objects that have not been studied . keep the rasag
like all medicines , this medicine can cause side effects , although not everybody gets them . some of these side effects may be similar to those seen with placebo . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common in children and adolescents ( 1 to 10 users in 100 ) uncommon in children 1 to 1 , 000 very rare in children less than 10 users seen in 10,000 not known ( frequency cannot be estimated from the available data ) very common abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) general feeling of being unwell neck pain chest pain ( angina pectoris ) joint pain ( osteoarthritis ) if you experience any of these symptoms talk to your doctor , pharmacist or nurse . very common joint pain , muscle spasms , pain in arms or legs
what rasagiline mylan contains - the active substance is rasagisline tartrate . each tablet contains 1 milligram rasageline .  the other ingredients are microcrystalline cellulose ( e460 ), tartric acid , maize starch , pregelatinized tinere starch ( maize ), talc , stearic acid ( see section 2 ). see section " rasagite mylan has a lot of sugar " in section 2 of this leaflet . what rasagitiline in the tablet core contains : lactose , sodium - free , white to off - white , round , biconvex tablets , debossed with " 1 " on one side and plain on the other side . the tablets are available in blister packs of 7 , 10 , 28 , 30 , 100 and 112 tablets
do not use hulio : - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before using your medicine if : you have a severe infection , including tuberculosis . you have symptoms of infections such as fever , wounds , feeling tired , dental problems you have moderate or severe heart failure you have had or have had a serious heart condition you have ever had allergic reaction or allergic reactions with symptoms such as chest tightness , wheezing , dizziness and swelling or a rash . if any of these reactions occur , tell your doctor immediately . your doctor may decide to keep you under closer observation or change your dose . infections may be more likely to occur in people who have
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis in adults , adolescents and children from 2 to 17 years old : use in children and adolescents from 10 to 30 kg : hulio 20 mg / kg body weight : 17 kg to less than 30 kg one tablet each day . if this applies to you , your doctor may prescribe you a different dose . for enthesitis - related arthritis in children from 6 to 17 kg , the usual dose is 15 to 30 mg . your doctor will prescribe you the most appropriate dose based on your child ' s weight . the recommended dose is 20 mg every other week . this can be given to your child in two equally divided doses . use in adults and adolescents : children : the doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require urgent medical treatment . side effects may occur at least up to 4 months after the last hulio injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash or hives swollen face , hands or feet trouble breathing or swallowing , pale complexion , dizziness , persistent fever with or without bruising or bleeding . signs and symptoms of infection may include fever , feeling sick , cough , flu - like symptoms , chills , nausea , vomiting , skin rash , itching , redness of the skin , loss of appetite , weight loss , pain in your joints 
what hulio contains the active substance is adalimumab . the other ingredients are monosodium glutumate , sorbitol ( e420 ), methionine , polysorbate 80 , hydrochloric acid , and water for injections ( see " important information about some of the ingredients in this medicine " later in this section ). what helio 40 mg / ml solution for injection in vial is presented as a sterile solution . each vial contains 40 mg of the active ingredient , which is 0 . 8 % opalescent , colourless to slightly yellow solution in a clear glass vial with a rubber stopper . hULio is available in packs containing 1 or 2 vials . pack sizes : 1 vial , 1 
yellox contains the active substance bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammation drugs ( nsaids ), which help reduce inflammation . Yellox is used to reduce eye inflammation after cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using yyx if : you have asthma , skin allergy , or intense inflammation in your nose you are taking other nsaids . you should not be given this medicine : acetylsalicylic acid , ibuprofen , ketoprofened , diclofen and / or do not take this medicine together with topical steroids such as cortisone . this may increase the risk of unwanted side effects . if any of these apply to you , tell your doctor or nurse immediately . bleeding problems have been reported in patients with haemophilia in the past and have used other medicines to
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop of yellox in your eye ( s ) once a day in the morning and one drop in the evening . do not use more than your doctor tells you to use . use in children and adolescents do not give this medicine to children less than 2 years of age and older . your doctor will tell you when to use the drops , and when to return them to the pharmacy , if necessary , the next day , following your cataract surgery . method of administration yellowx should only be used if your hands are not sensitive to the effects of the eye drops . remove the bottle cap from the bottle . hold the bottle for a single period of time . make sure that your thumb and fingers are not touched . tilt your head back .
what yellox contains - the active substance is bromfenac . each ml of solution contains brom Fenac ( as sodium sesquihydrate ). each vial contains 33 mg brom Fenac , boric acid ( derived from borax ), sodium sulphite anhydrous ( e330 ), benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate , and sodium hydroxide ( to adjust acidity levels ) over a period of time . the product may be supplied as a clear yellow liquid ( solution ) for injection in a vial , with or without a screw cap . if you have any further questions on the use of this product , ask your doctor .
dzuveo contains the active substance sufentanil . it belongs to a group of strong painkillers called opioids . sufenteanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo : - if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). you have a serious lung or breathing problem . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you should not be given the medicine if : you have any condition that affects your breathing ( e . g . asthma , wheezing or shortness of breath ) you have ever had any of these conditions . your doctor may want to change your dose or stop treatment , or you have had a head injury or brain tumour you have problems with your heart and circulation , such as slow heart rate , irregular heartbeat , low blood volume or low blood pressure you have moderate to severe liver problems you have severe kidney problems ( your body breaks down and breaks down fat
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device should only be used to administer this medicine . dzuveo must not be used in combination with strong painkillers such as sufentanil . how much to take the recommended dose is 30 mg per day . you can take the sublingual tablet with or without food . do not crush or chew the tablet before swallowing it . your doctor will tell you how much medicine you should take , when to use it , and for how long you need to take it ( see " instructions for use " at the end of this leaflet ). do not take more than the prescribed dose , unless your doctor tells you to . for instructions on how to use the applicator , please read the user ' s manual , which is included
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need medical attention : - severe breathing problems , such as slow and shallow breathing . if any of these side effects occur , they should be reported immediately . very common side effects ( may affect more than 1 in 10 people ): nausea ( feeling sick ), vomiting ( being sick ) and feeling hot . common side effect( may affect up to 1 in10 people ), inability or difficulty sleeping . not known ( frequency cannot be estimated from the available data ). - inability to sleep , feeling weak or generally unwell . uncommon side effects are : common ( may effect upto 1 in 100 people ). you may experience difficulty sleeping ( insomnia ), sleepiness , tiredness and dizziness .
dzuveo will be stored by the health professionals at the hospital or clinic . keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze the reconstituted solution . light and oxygen should be injected before administration . this medicine must not be used if there is any visible sign of deterioration . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg of sufenil ( as citrate ).  the other ingredients are mannitol , dicalcium phosphate , hypromellose ( e464 ), croscarmellose sodium , indigo carmine [ e132 ], stearic acid , magnesium steerate in the tablet core . the tablets are round edges marked with " 3 " on one side of the tablet and a single - dose applicator ( labelled [ sublingual tablet ]). the applicators contain one sufenteanil 30 mg tablet . pack sizes of 5 or 10 tablets . not all pack sizes may be marketed in your country .
erleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has come back or has spread to other parts of the body or cannot be removed by surgical treatments . in adult men sensitive prostate cancer can no longer be removed from the body by surgical treatment . when testosterone is removed from male sex hormones ( estrogens ), it can form male - resistant prostate cancer . erleda inhibits the production of androgens by the body , allowing the cancer to grow and divide . by blocking their action , it helps to kill male men whose prostate cancer cells have stopped growing and dividing .
do not take erleada : - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you are pregnant or think you may be pregnant ( see pregnancy and contraception section ). you are breast - feeding . do not use this medicine after the expiry date which is stated on the label after exp . this medicine is not intended for use in children and adolescents . you should tell your doctor about all medicines you take to prevent blood clots ( e . g . warfarin or acenocoumarol ) - you have any heart or blood vessel conditions or heart rhythm problems ( arrhythmia , sometimes called " falls "). if any of these apply to you , or if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg three times a day ( corresponding to 60 mg / day ). you can take erleada with or without food . taking this medicine take the tablets by mouth . swallow the tablets with a glass of water . do not crush or chew the tablets . if necessary , your doctor may tell you to take other medicines while you are taking erleda . it is best to take it at the same time each day , preferably in the morning before or in the evening , with or immediately after a meal . you should swallow the tablet whole with water and do not chew , crush or split the tablet before swallowing . take the tablet with food and drink . this will help to keep track of the side effects of 
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and tell your doctor immediately if you develop any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , with central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may also be preceded by fever and flu - similar symptoms ( toxic epidermal necrolysis ). serious side effects may include side effects not listed in this leaflet . fit , seizure , fits ( uncommon : may affect up to 1 in 100 people ) when taken with erleda . you may experience a serious , potentially life - threatening condition , including fits ( convul
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalutaMIDe ( as mesilate ).  the other ingredients in the tablet core are colloidal anhydrous silica , croscarmellose sodium ( e468 ), hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose and silicified microscopic cellulose . the film coat is composed of iron oxide black , iron oxide yellow , macrogol ( 6000 ), polyvinyl alcohol ( partially hydrolysed ) talc , and titanium dioxide . what the heck are the contents of the pack the tablets are slightly yellowish , capsule - shaped , round tablets of 8 . 7 mm diameter , with " 60 " debossed
this medicine is a radiopharmaceutical product for diagnostic use only . axumin contains the active ingredient fluciclovine . it is used to carry out a type of scan ( called a pet scan ) in adults who have not previously had treatment for prostate cancer . other tests may also show that the presence of prostate specific antigen ( psa ) is present in high amounts on the surface of the cancer in patients who do not have an acreage of body surface area ( m2 ). your doctor will decide whether the need for an additional dose or not . you will need to have an amber or amber coloured test to make sure that the cancer has spread to other parts of the body . after the scan , the doctor will recommend that you have an appointment for an appointment . your doctor and the nuclear medicine doctor have considered that the clinical benefit of this procedure with the radio
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you must not be given : - after you have been told you have kidney problems . - you are on a low sodium diet . it is recommended that you do not drink alcohol before or after having a meal or a snack before you have eaten a lot of food . your doctor will tell you how long you should be on this list . children and adolescents do not give this medicine to children or adolescents under the age of 18 years because there is no information on its use in this age group . other medicines and alcohol tell your doctor or pharmacist if this applies to you . the images will be taken during pregnancy . driving and using machines
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be used in specially controlled areas . this medicine will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . dose the nuclear medicine doctor supervising the procedure will decide on the quantity of megabecquerel to give to you . the quantity to give you depends on your age , weight and size of the product you are receiving . administration of the procedure auxumin is given by injection into a vein , followed by a flush of sodium chloride solution before administration . you will be closely monitored during the procedure and for a short period of time afterwards . after the procedure the scan will be repeated every 5 minutes after the 
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies and post - marketing experience , side effects were uncommon ( may affect up to 1 in 100 people ) with exposure to the medicine . the following side effects have been reported in patients treated with axumin : very common : may affect more than 1 in 10 people pain , rash , altered taste in the mouth and altered sense of smell . this radiopharmaceutical will deliver low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects 25 if you get any side effects talk to your nuclear medicine doctor . these are listed under " warnings and precautions ". you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : axumin will be stored in the healthcare facility where it is used .
what axumin contains - the active substance is fluciclovine . - each tablet contains a total of 1600 mg . this total dose is equivalent to 1600 mg or 16000 mg / ml of solution in the vial . the recommended dose for adults and children of 3 years of age and older is : - one tablet of 3200 mg contains 300 mg ( 0 . 5 mg ) of flucclovine ( 3 200 mg or 32000 mg ). - other ingredients are : sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 under ' important information about the contents of the pack ') - all tablets contain sodium ( e524 ) and water for injections ( see sections 2 and 4 of this leaflet for more information about some of the ingredients of the flu pancreas 
the active substance of azopt is brinzolamide , which belongs to a group of medicines called carbonic anhydrase inhibitors . they work by reducing pressure within the eye . their effect is to reduce pressure in the eye which can be very harmful if used regularly . it is used by adults and children of all ages who are unable to use their regular eye drops . high pressure inthe eye can be a sign of an illness called glaucoma . if the pressure inside the eye is too high , it can damage your sight .
do not take azopt - if you have severe kidney problems - are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). you may also be allergic to medicines called sulphonamides ( also known as medicines used to treat diabetes , infections or diuretics ( water tablets ). warnings and precautions talk to your doctor before taking any of these medicines : - you have the same allergy or too much acidity in your blood ( hyperchloraemic acidosis ). if any of them apply to you , tell your doctor and do not give you . if this applies to you ( or you are not sure ), ask your doctor or pharmacist for advice before taking the medicine . kidney or liver problems . dry eyes ( cornea problems ) have been reported with use of other sulphphonamide medicines to treat glaucom
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . azopt should only be used in the eyes . use in adults the recommended dose is 1 drop in the affected eye or eyes once a day , at about the same time each day . do not use more than your doctor tells you to use . wash your hands thoroughly before you start using the medicine . it is important that you do this as soon as possible after you have opened the bottle and it is time for your next dose . 1 ) put the bottle back into the sealed bottle . 2 ) repeat the steps for your other eyes , as shown in section 1 , 2 , 3 and 4 . before opening the bottle , put the first bottle in your hands . twist off the cap . pull the cap off and snap collar off .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation ; eye pain ; and eye discharge ; itchy eye , dry eye ; abnormal eye sensation ; redness of the eye ( see section 2 ). side effects in food and drink : bad taste . uncommon side effects are likely to affect upto 1 in 100 people ). eye effects that may affect your vision : dizziness ; headache ; diarrhoea ; nausea ; vomiting ; rash ; increased tear production ; allergic reaction ( e . g . swelling of the face , lips , mouth , tongue or throat ). reporting of side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle label and the carton after exp . this medicine does not require any special temperature storage conditions . azopt is for single use only . once opened a pack containing a single bottle should be used immediately . use in children and adolescents do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of orezolamide ( as benzalkonium chloride in the form of carbomer 974p ), edetate disodium , mannitol ( e421 ), purified water , sodium chloride and tyloxapol . the other ingredients are hydrochloric acid and sodium hydroxide which help to keep acidity levels ( ph levels ) normal and to keep a normal level , keeping a close watch on syringes if needed ( see sdc and scb ). what szopt looks like and contents of the pack azyopt is a milky liquid ( a suspension ). it is supplied in a 5ml plastic ( droptainer ) bottle
forxiga contains the active substance dapagliflozin . it belongs to a group of medicines called " oral anti - diabetics ". it is taken by mouth to treat diabetes ; it works by lowering the amount of sugar ( glucose ) in your blood . this helps to control how much sugar you get into your body . for adults ( aged 18 years and older ) there are two groups of medicines that you can take at the same time . one group is called " type 1 diabetes ". this is because your body is not able to use any insulin it produces properly ; the other group of patients can take one or more of these types of diabetes , including those who are overweight ( obese ) and those with type 2 diabetes . both groups of people have their own set of diabetes and their body does not make enough insulin , and the insulin that your body produces does not work as well as it
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment : - when you start to feel sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , such as a bitter or metallic taste in your mouth or a different odour to your urine or sweat , rapid weight loss . contact your doctor or pharmacist immediately if the above symptoms suggest " diabetic ketoacidosis ", which is a serious , sometimes life threatening problem you can get with diabetes because of increased levels of " ketone bodies " in your urine and blood , seen in tests . your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . for type 2 diabetes the usual dose is one 10 mg tablet once a day . your doctor may prescribe you a 5 mg tablet if your doctor thinks you have a liver problem . how much to take the recommended dose of forxiga for type 1 diabetes is 5 mg twice daily . taking this medicine swallow the tablet whole with a glass of water . you can take the tablet with or without food . it is best to take your tablet at the same time each day , but you should continue with your diet and exercise program recommended by your doctor while you are taking it . to help your body use its blood sugar better , you can reduce your blood sugar more easily with food , exercise and diet if necessary . the amount of food you take will depend on how you respond to the medicine
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are angioedema ( very rare : may affect up to 1 in 10 , 000 people ): these can be severe and can be life - threatening . signs of angiodema include swelling of the face , tongue or throat that may cause difficulties swallowing , hives and breathing problems . they can also be caused by diabetic ketoacidosis . these can occur in patients with type 1 diabetes ( very common ; may affect more than 1 in every 10 people ). in type 2 diabetes ( rare ) they can be rare , and may affect less than1 in every 1 ,000 people . you should contact your doctor as soon as possible if you experience these types of diabetes , as you may have increased levels of " ketone bodies " in
what forxiga contains - the active substance is dapagliflozin . - each xiga 5 mg / 10 mg film - coated tablet ( tablet ) contains dapagloviflazin propanediol monohydrate equivalent to 5 mg dapagllozin ( 0 . 7 %) tablet contains : - tablet core : microcrystalline cellulose ( e460 ( i )), lactose ( see section 2 ' for information about some of the ingredients of the tablet '), crospovidone ( type a ), silicon dioxide , and magnesium stearate . film – coating : polyvinyl alcohol , titanium dioxide [ e171 ], macrogol 3350 , talc ( indigo carmine ) and yellow iron oxide ( all ) ( only in the tablet coating ). what for
mepact contains the active substance mifamurtide that can kill certain bacteria that are part of the immune system ( the body ' s natural defences ). it can be used to treat adults with osteosarcoma ( bone cancer ) that has spread to other parts of the world between 2 and 30 years after they have had surgery to remove the tumour . it can also be used in combination with chemotherapy to kill cancer cells and prevent cancer from coming back .
do not use mepact - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given medicines containing ciclosporin and other calcineurin inhibitors ( nsaids ). if your heart or blood vessels are damaged , you may be at risk of blood clots( thrombosis ) or bleeding ( haemorrhage ) and / or inflammation of the veins ( vasculitis ). mypact treatment may cause long - lasting or worsening symptoms . your doctor will monitor you closely while you are being treated and for any signs of improvement after you finish the course . asthma and other breathing disorders tell your doctor or nurse if any of your asthma suffers from inflammatory or
treatment mepact will be started by a doctor who is experienced in the use of this medicine . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one vial ( 2 mg mifamurtide ) once a day for 12 to 24 hours . your doctor will tell you the dose to take . you may need to stop yourmepact treatments or change your chemotherapy schedule . if your chemotherapy is delayed , your doctor may tell you to wait until it is safe for you to go home . usually your chemotherapy should be completed within 36 hours of your first course of treatment . how to prepare and give me Pact you will be monitored carefully for signs of an interruption in the processing of the freeze - dried powder into a liquid suspension before it is used as a suspension . once the filter has been opened
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported very commonly in patients receiving the medicine ( transient ) in combination with paracetamol . they usually develop in the first few days of treatment and can be severe . tell your doctor immediately if you experience any of the following : - stomach problems ( such as nausea , vomiting , or loss of appetite ) as with chemotherapy . contact a doctor immediately as these can be signs of continuing fever and chills after 8 weeks of treatment . you should tell your physician immediately about any signs of an infection such as rash or any problems breathing , wheezing or coughing . these may be signs that the medicine is working or that the effects are not too strong or too weak . very common side effects ( may affect more than 1 in 10 people ): 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in outer carton in order to protect from light . from a microbiological point of view , reconstituted suspension should be used immediately after reconstitution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 9 hours at 2 - 8 ( but not above 25 ). if refrigerated for use within 6 hours , this medicine should not be used if there is visible signs of deterioration .
what mepact contains - the active substance is mifamurtide . each ml contains 4 mg / 0 . 8 mbq ( corresponding to 4 million iu / kg body weight ). - if you are not sure , talk to your doctor or pharmacist . - after reconstitution with suspension , the content should be reconstituted as follows : 1 - palmitoyl - 2 - loyl- sn- glycero - 3- phosphocholine ( ph - 1 ), 2 , 2 dioleoyn - sen , phospho- 3 - serine monosodium salt ( see section 2 ). what you need to know before you are given me Pact ? the pack contains a white to off - white homogeneous
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used to treat redness in the face caused by rosacea , which causes redness of the face and can be fatal in some patients . if you are being treated , you may be at increased risk of developing a condition called rosACEa . these conditions may be caused by high levels of blood flow in the facial skin and enlargement ( dilation ) of the small blood vessels of the skin . Mirvaso acts by reducing the amount of blood vessels that are blocked by the excess blood flow , resulting in redness .
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor , pharmacist or nurse before taking Mirvaso ( see section 2 , possible side effects ). the medicine is injected under the skin ( subcutaneous use ). it must not be used in combination with certain medicines for depression or parkinson ' s disease called monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , moclobemide ), tricyclic antidepressants ( imipramine ), tetracyclic antagonistidepressants such as maprotiline ( mianserin ) or mirtazapin . you must not take these medicines unless your doctor or pharmacist tells you to stop taking them .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one pea - sized amount twice a day , once on the skin or on the face . this medicine should only be used on its own . it should not be injected into your body or into other body surfaces , such as your eyes , mouth , nose or vagina . your doctor will tell you how much mirvaso you should use . how often you should apply Mirvaso mirvasa should be applied to your face once daily . depending on how you respond to the treatment , your doctor may tell you to apply a small amount of gel ( a peach - size amount ) every day . if your symptoms do not improve after a few days , the maximum daily dose of 1gram ( 5 pea size amounts 
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects are : severe skin irritation or inflammation , skin rash ( which may cause skin pain or discomfort ), dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects include : worsening of rosacea . the treatment should be stopped immediately and symptoms should be seen immediately . see section 2 " warnings and precautions ". contact allergy / allergic reaction including rash , rare angioedema ( a serious allergic reaction which may be life - threatening ). if you experience any of these effects or if they occur , stop the treatment immediately and contact your doctor . allergic reaction with rash is very common in patients treated with mirvaso . it is not known how often this happens . if
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the tube and pump after exp . store in the original package in order to protect from light and moisture . this medicine does not require any special temperature storage conditions . tell your pharmacist if you are not sure .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of brimoniidine , followed by 5 mg / 0 . 5 mmol / 10 mL of gel , resulting in a correspondingly higher level than for a human - or animal - derived product .  the other ingredients are : carbomer : methylparahydroxybenzoate ( as phenoxyethanol ), glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water . ( see section 2 ) - each vial contains 2 mg methyl parahydroxybenzonate and 1 mg phlegm ( sph ) of propane glycol which are used to adjust the acidity 
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the body ' s immune system ). it is used in adults to help defend the body from infection and cancer . by attaching itself to the vegf protein , the protein can penetrate human vascular endothelial growth factor ( vengf ), which is found on the lining of the blood and lymph vessels of the body and helps to protect against the infection . the venggf protein causes blood vessels to grow within tumours , where it provides the tumour with the nutrients and oxygen it needs . when injected in the tumour , bevizum ab prevents tumour growth by blocking their action , improving the blood vessels and the nutrients that provide the body with nutrients
you must not be given this medicine - if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) - are allergic or hypersensitive to chinese hamster ovary ( cho ) cell products or to other recombinant human or humanised antibodies . ( it is also better to avoid mvasi in pregnant women ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine if : you are at an increased risk of developing holes in the gut wall . you may also experience inflammation inside the abdomen ( e . g . diverticulitis , stomach ulcers , colitis ) associated with chemotherapy . your doctor may want to monitor you closely if any of these apply to you . take special care with mmvas
dose and frequency of administration the dose of mvasi you will receive is based on your body weight and the kind of cancer to be treated . the recommended dose is 5 mg , 7 . 5 mg, 10 mg or 15 mg per kg of body weight . your doctor will work out the right dose for you . do not change the dose yourself unless you have been specifically trained by your doctor . if you are being treated for a serious form of cancer , you may be given a higher dose than recommended by your healthcare professional . you may receive up to 6 - 8 infusions per week , or up to 3 weeks after each infusion . frequency of infusion your doctor may decide to continue treatment with this medicine , depending on how you respond to treatment . always use this medicine exactly as your doctor has told you to . check with your doctor or nurse if : your tumour is growing
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . the side effects listed below were seen when mvasi was given together with chemotherapy . you should be aware of the possibility of experiencing these side effects whilst being treated with mvai . allergic reactions - in rare cases you may experience an allergic reaction . these may include difficulty in breathing , chest pain , redness or flushing of the skin or a rash . chills or shivering , feeling sick ( nausea ) or being sick ( vomiting ). if any of the above occur , tell your doctor or nurse straight away . other side effects include severe side effects that may be serious , include : very common ( may affect more
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . store and transport refrigerated ( 2 8 ). do not freeze . keep the vial in the refrigerator in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user . however , if the product is stored in a sterile environment , it may be stored for a maximum of 24 hours at 2 8 and subsequently stored at 25oc for up to four hours prior to administration . chemical and physical in use stability has been demonstrated for two hours at room temperature ( 20oc ) and 28oc followed by up to 48 hours below 30 . remove any particul
what mvasi contains - the active substance is bevacizumab . each ml of concentrate contains 25 mg ( 8 . 4 mg ) or 16 . 5 mg ( 6 . 6 mg ). - each 4ml vial contains 100 mg ( 9 . 8 mg ), corresponding to 16 % of the recommended dose . this is equivalent to a 400 mg dose ( 5 . 0 mg / 0 . 25 mg ); - in the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 , water for injections . what vvasi looks like and contents of the pack mvai is a concentrate for solution for infusion . the concentrate is clear to slightly opalescent and colourless to slightly yellow liquid in a glass vial with a rubber stopper .
tecartus is a type of medicine known as a gene therapy medicine . it is used to treat mantle cell lymphoma that has come back or has not responded to other medicines . if you have relapsed or if your own white blood cells are destroyed by autologous anti - cd19 - transduced ccd3 + cells , your doctor may decide to give you another medicine to help prevent this . mantled cell lymphhoma is also a cancer that has spread to other parts of the immune system ( called b - lymphocytes ). mantles cell lymphma has been caused by a change in the way some of these cells function , leading to an uncontrolled way . these include : lymph tissue , bone marrow and blood . the white blood cell in your blood can be collected and given back to you
do not use tecartus - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or nurse before using the medicine if : - you have a reduced number of white blood cells in your blood ( lymphodepleting chemotherapy ) ( see section 3 for more information ). your doctor will keep you informed of this . - the medicine is made specially for you by genetically engineered for autologous use . tests and checks are carried out before and after administration . these include : checks of your lungs , heart , kidney and blood pressure , signs of infection and inflammation of your cancer ( graft – versus - host disease ). after a transplant of your body ,
tecartus will be given to you by a doctor or nurse who is experienced in the use of your own white blood cells . they will take some of your cells from your own blood and will donate them to you through a catheter placed in your vein ( a procedure call leukapheresis ). if you do not have enough of your red blood cells in your blood , your blood will be infused into your vein , over a period of 3 to 6 hours . if your yellow blood cells do not work well enough , you will have to wait for at least 2 to 3 hours before you are given medicines . the duration of tecarus treatment is called lymphodepleting chemotherapy . your doctor will check how well your cells are working and will tell you how long you will need to stay in hospital . during this time , the doctor will keep you in hospital until you are ready to
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if your side effects get worse or if you notice any of the following serious side effects you may need urgent medical attention . the following side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure , symptoms such as dizziness or lightheadedness , fluid in the lungs . all symptoms may be due to a condition called cytokine release syndrome . loss of consciousness , decreased level of consciousness and confusion , memory loss , difficulty in thinking , feeling or being less alert . these may be signs of a rare , but serious , reaction to the medicine and can be life - threatening . if any of these side effects causes you problems 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and infusion bag . store in liquid nitrogen ( 0 . 5 ml ) for up to 150 hours . this medicine contains genetically modified human blood cells . any unused medicine or human - derived material should be disposed 36 in accordance with local requirements .
what tecartus contains - the active substance is autologous anti - cd19 - transduced incd3 + cells . each patient - specific single infusion bag contains a dispersion of anti  - cad19 car t cells in approximately 68 ml of solution ( corresponding to 2 x 106 anti ).  the other ingredients are : sodium chloride , human albumin ( see section 2 ) and water for injections ( for information on ingredients ). what Tecartus looks like and contents of the pack the product is a clear to slightly opalescent , colourless to yellow solution for infusion . it is supplied in an infusion bags packed in a metal cassette . the contents of a one - infusion bucket contain 68 vials of cell dispersal . not all pack sizes may
januvia contains the active substance sitagliptin which is a member of a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase -4 inhibitors ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type2 diabetes . you may already be taking this medicine in combination with certain other medicines ( insulin , metformin , sulphonylureas , or glitazones ), which also help to lower blood sugar that you may be taking for your diabetes together with a food and exercise plan . it is important that you continue to follow the diet and
do not take januvia - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment if : - you have inflammation of the pancreas , such as pancreatics ( see section 4 ). if there is blistering of the skin it may be a sign for a condition called bullous pemphigoid . if any of these apply to you , tell your doctor before you take the tablets . do not swallow the tablets whole , as they may be harmful to other people . your doctor may want to monitor you more closely , and may ask you to stop taking them . you may have a disease of the panas ( called pancreatis ). you may also have had gallstones 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual recommended dose is : one 100 mg film - coated tablet 63 once a day by mouth if your doctor thinks you may have kidney problems , your doctor may prescribe lower doses ( such as 25 mg or 50 mg ). take your tablet at least one hour before or one hour after a meal . you can take the tablet with or without food and drink . this medicine can be taken with certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . it is important that you continue to take januvia until your doctor tells you to stop taking it , even if there is still some medicine left in the body after taking a dose of this medicine . contact your doctor immediately for advice on the right way to take it 
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects you may need medical attention : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatictitis ). a serious allergic reaction ( frequency not known , cannot be estimated from the available data ): rash , hives , blisters on the skin / peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing . if any of these side effects causes you problems , you should stop taking this medicine and talk to your doctor straight away . side effects may include 
what januvia contains - the active substance is sitagliptin . - each film - coated tablet ( tablet ) contains one milligram ( milliliter ) of sitaglitin phosphate monohydrate , equivalent to 25 millilitres . the other ingredients are : - tablet core : microcrystalline cellulose ( e460 ), calcium hydrogen phosphat e330 , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate . in addition , the tablet film coating contains poly ( vinyl alcohol ) ( 3350 ), macrogol 3350 and talc , titanium dioxide , red iron oxide and yellow iron oxide [ e172 ]). - printing ink : shellac / pctfe / al3 + indigo carmine ( k25
what xultophy is and how it works the active substance in xULTOphy is called insulin . if you have type 2 diabetes mellitus , this is a type of diabetes that occurs when your body does not make enough insulin to control the level of blood sugar . your doctor will prescribe insulin degludec , a long - acting basal insulin , to help your body get better at controlling your blood sugar levels . you may also be given liraglutide ( also known as glp - 1 ) to help you stay on the diet and exercise plan . it is very important that you continue to take insulin during meals and at the right times of the day , and at regular intervals while you are on holiday . what is ' what's ' when you need to take ' how to use ' or what to do when you are not
do not take xultophy : - if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 39 talk to your doctor , pharmacist or nurse before taking 39 . you are taking a sulfonylurea such as glimepiride or glibenclamide . your doctor may need to adjust your dose , and may change how often you take your sugar or dietary intake , depending on your blood sugar levels . if any of these apply to you , or you are not sure , talk to a doctor . take special care with this medicine : you may be at risk of developing type 1 diabetes mellitus ( also known as ' ketoacidosis '), a condition which occurs when taking x
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . xultophy should only be used in a hospital setting where you are blind or have poor eyesight . your doctor will regularly check your blood sugar level , and may adjust your dose if necessary . the recommended dose is 41 g / m2 of body surface area per day to help you remember to take your doses . you can use the dose counter at any time of the day and time of day . use in children and adolescents dosing in children below 8 years of age should be used at the same dose as in adults . read the " instructions for use " provided in the box at the end of this leaflet for more information . do not use xulation after 8 weeks of age as it may affect the amount of medicine that you take . how to inject x
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar ( very common : may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out ( become unconscious ). serious hypoglycaemia may cause brain damage and may be life - threatening . if you have low blood glucose , take action to increase your sugar level . for more information , see the box at the end of this leaflet . serious allergic reaction ( anaphylactic reaction ) has been reported ( frequency not known ) in patients taking xultophy . it is not known how likely it is to happen ( frequency cannot be estimated from the available data ). it is important to talk to a doctor or pharmacist straight away . this is important . most of the side effects listed below have been observed with 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . you may remove xultophy from the refrigerator and store it at room temperature ( not above 30 ) for a single period of up to 8 weeks . from a microbiological point of view , the product should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 21 days at 2oc to 8oc followed by a 21 - day period .
what xultophy contains - the active substances are insulin degludec and liraglutide . each 100 ml vial contains 100 units of insulin deGludec , equivalent to 3 . 6 mg . - each vial of lisaglutide contains 3000 units of 300 units , corresponding to a concentration of 10 . 8 mg /ml . the other ingredients are glycerol ( e320 ), phenol , zinc acetate , hydrochloric acid , sodium hydroxide ( for ph adjustment ) and water for injections ( see section 2 for further information on sodium ). pack sizes of 1 , 3 and 5 vials , or a multipack containing 10 ( 3x2 ) vial , 2 x 1 vial adapters , 4 x
giotrif is a medicine containing the active substance afatinib , which blocks the activity of two proteins called egfr [ epidermal growth factor receptor receptor 2 [ erbb1 ] and her2 [ her2 ]). these proteins help to control cell growth and division . by blocking their action , they can kill cancer cells . this medicine can slow down the growth of these cells and slow down their growth . in this way , this medicine reduces the number of cancer cells in your body , and makes it less effective in stopping the growth and spread of this medicine . it is used for the treatment of cancer of the lung ( non - small cell lung cancer ). you will receive gio trif as your first treatment if you have received prior chemotherapy treatment for a certain type of cancer called squamous type if your doctor determines that prior chemotherapy
do not take giotrif : - if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment if : you have low body weight less than 50 kg you have kidney problems . your doctor may want to reduce your dose if this happens ( see section 4 ). you have side effects such as lung inflammation ( interstitial lung disease ) you have liver problems you may need to have some liver tests while you are taking this medicine you have a severe liver disease you have eye problems such as severe dry eyes , inflammation of the transparent layer at the back of the eye ( cornea ) or ulcers in the front of your eye if any of these apply to you , tell your doctor or nurse immediately . children and adolescents do not give this medicine to children and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is 40 mg twice a day . your doctor will tell you how many tablets of this medicine to take and how long you should continue to take them . giotrif can be taken with or without food . swallow the tablets with a glass of water . do not crush or chew the tablets . this will help you to remember to take your dose . you can take the tablets at any time of the day , but this will usually be at least 1 hour before or 3 hours after you have taken this medicine . it is important that you continue taking this medicine until your doctor tells you to stop . to benefit from the medicine , your doctor may prescribe a higher or lower dose depending on how well the medicine works for you and for how long your doctor needs you
like all medicines , giotrif can cause side effects , although not everybody gets them . side effects related to treatment include : diarrhoea ( very common : may affect more than 1 in 10 people ): if you get diarrea ( see section 2 , " what you need to know before you go to the hospital "): - if your child suffers from severe dirrhea ( with fluid loss ) ( common ; may affect up to 1 user in 10 ), including low blood potassium , which may be a sign of worsening kidney function . if any of the above apply to your child , or the child ' s condition gets worse , contact your doctor immediately . your doctor may decide to start appropriate antidiarrhineal treatment and start using antidiarrheal medicine prior to starting gio
what giotrif contains - the active substance is afatinib . - each film - coated tablet contains 20 mg / 20 mg of a fat inib ( as mesilate ).  the other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , all in the tablet core ; hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 , and water for injections ( see section 2 , " important information about some of the ingredients of this medicine " in section 2 for further information on the contents of this medicinal product ). what the tablet looks like and contents of the pack the 20 mg tablets are white to off - white , round tablets with " gsi " de
orkambi is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults , adolescents and children aged 6 years and older who have a f508del mutation in a protein called ' cytokine conductance regulator ' that controls the electrical activity of the lungs . the mutation is thought to be related to an abnormal fftr protein in the body . lumacaftor and ivacabtor work together by reducing the abnormal ccfTr protein . by doing so , both active substances can work more effectively in their respective ways , resulting in better control of your breathing and decrease of your lung function . as a result , your body will not be able to control how well your lungs work .
do not take orkambi : - if you are allergic to lumacaftor or ivacaltor , or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor , pharmacist or nurse before or during treatment . if this applies to you , tell your doctor or nurse immediately . you should not be treated with any other medicines , including oral ointment , while you are on or near a hospital or clinic , if the f508del mutation is present . your doctor may need to change the dose of ork Ambi , depending on whether you have liver or kidney disease . the doctor may decide to adjust the dose or stop the treatment with orkyambi if : you have abnormal blood tests of the liver . tell the doctor if any of these symptoms occur . liver problems
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take adults ( 6 to 12 years of age ) the recommended dose of orkambi is one tablet of 6 to 11 mg twice a day . your doctor will tell you the dose to take . the usual dose is two tablets of either 100 mg in the morning and 2 tablets of 2 mg each in the evening . take the tablet at least 12 hours after the last meal of the day , preferably at the same time every morning and afternoon . alternatively , your doctor may tell you to take either of these two tablets in the afternoon and evening , or a combination of 200 mg tablets ( 2 tablets for 2 to 12 hours apart ) taken orally once in the night . do not swallow or mix them . you should swallow the tablets whole with water . in case of moderate
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects seen with orkambi in combination with ivacaftor are usually mild to moderate and of a short duration . however , some patients may experience more serious side effects when they are given together with Orkambi . you should see your doctor immediately if you experience any of the following symptoms : - raised levels of liver enzymes in the blood ( which may increase the risk of liver injury ) in patients with pre - existing severe liver disease . - the worsening of liver function uncommon side effects ( may affect up to 1 in 100 people ) - pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the whites of your eyes - loss of appetite - diarrhoea - nausea or vomiting - abdominal pain or pain in
what orkambi contains - the active substances are lumacaftor and ivacastor . orkabambi 100 mg / 125 mg film - coated tablets each tablet contains 100 mg ( as lum ) or 125 micrograms ( as as a sachet ). - either a 100 mg tablet or a 200 mg tablet - each containing either 125 milligrams or 200 milliliters of ( as an adsorbant ) lumlumacantor + 125 million iu ivacaftar . - iii : - infusion : each oral tablet contains a total of 105 millilitres ( 0 . 5 mg ) of aliskiren . the other ingredients are cellulose , microcrystalline , croscarmellose sodium ,
the active substance in lynparza is olaparib . olarib is a type of cancer medicine called a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ]). it works by stopping mutations ( changes ) in a gene called brca ( breast cancer gene ). if you have cancer , it can be a problem for you to do so . it can also lead to death of cancer cells if they do not have an enzyme called " repair dna ", which is missing or does not work as well as it should . the active ingredient in this medicine is known as " ldcl ". llcl is found in about one third of the population of people with ovarian cancer ( brca ) that is caused by a mutation of a protein
do not take lynparza : - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ) or to peanut or soya . warnings and precautions talk to your doctor , pharmacist , or nurse before taking this medicine . children and adolescents do not give this medicine to children less than 2 years of age . this is because it has not been studied in this age group . if this applies to you , tell your doctor straight away . your doctor may want to reduce your dose or stop your treatment if any of these apply to you ( or you are not sure ), ask your doctor or pharmacist for advice . take special care with this leaflet , which is attached to the tablet . do not chew or break the tablet before you take it . you may get low blood cell counts ( shown in tests ). low counts
always take lynparza capsules exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the usual recommended dose is two 100 mg capsules twice a day . your doctor may decide to increase your dose to 150 mg , depending on your condition and on how well your body responds to the medicine . when to take your doctor will tell you how many capsules to take and how often to take them . do not divide , crush , or chew the capsules . it is best to take it at the same time each day , preferably in the morning and evening . swallow the capsule whole with a glass of water or other non - alcoholic drink ( e . g . milk ). do not break or crush the capsule as it may cause side effects . adults and children 8 years of age and older 
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ): - feeling short of breath , feeling very tired , having pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ) in the blood . uncommon ( might affect less than 1 in 100 people ). - allergic reactions ( hives , difficulty breathing , or swallowing , dizziness ). signs and symptoms suggestive of hypersensitivity reactions . other side effects include : very common : may affect more than 1 out of 10 people feeling sick ( nausea ) or being sick ( vomiting ) - itching - this may be a sign of an allergic reaction . tell your doctor straight away if you notice any of the signs or symptoms listed above . hyper
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . lynparza capsules should be used within 30 days after first opening . use within 3 months of first opening the capsule . any capsules that remain in the capsule should be discarded . the capsules must be thrown away safely , even if they are damaged .
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg / 0 . 5 ml containing olarib ( as lauroyl macrogol - 32 glycerides ), hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black and water for injections ( see " important information about some of the ingredients in this leaflet ") - your doctor or pharmacist has determined the correct dose for you . what allynparaza looks like and contents of the pack this medicine is a white , opaque , hard capsule imprinted with " laparib 50 mg " in black ink on one side and with an imprint of the astrazeneca logo in black on the other side . the imprint is printed on the capsule body
what nyxoid is this medicine contains the active substance naloxone , which acts as a syringe to opioids , such as heroin or methadone . it is used in combination with fentanyl , oxycodone , buprenorphine and morphine to help with the preparation of the medicine . the medicine is administered under the supervision of a physician experienced in the use of opioids for the emergency treatment of opioid overload . opioid overdose is uncommon in people who have had at least 14 days of treatment . overdose can cause breathing problems or cause severe sleepiness . if you are given an opioid overload or have been given more opioids than you should you should be given emergency medical care .
do not use nyxoid : - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . you may need emergency medical care , or emergency services , to avoid the possibility of an opioid overdose . see section 4 . the signs and symptoms that can indicate an opioid overload are listed at the end of this leaflet . if any of these apply to you , tell your doctor immediately . use this nasal spray for 2 to 3 times a day use a new nasal spray as soon as you can , unless you have already taken this medicine and you are physically dependent on opioids . opioids are not the same as heroin , but they can be taken with or without food . this is because opioids can affect the
always use nyxoid nasal spray exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended dose is 1 spray in the shoulder and ears . do not touch the breastbone or sternum , or the inside of the ear . use a fingernail to help clear the mouth and nose of any blocksages that may be made in the way the medicine gets into your mouth or nose . 1 . when breathing is the chest moving in your chest . this means you can hear breathing sounds or breathe on the cheek . overdose may lead to a reduced response to touch or sounds , slow uneven breathing .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine . stop taking nyxoid and see a doctor straight away if you notice any of the following : acute withdrawal symptoms associated with the use of opioid drugs : symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps and shivering or trembling changes in behaviour ; violent behaviour , nervousness , anxiety , agitation , mood swings ; difficulty in sleeping , sleepiness , depression , suicidal thoughts , aggression , hallucinations , abnormal dreams , panic attack , mental health problems , confusion , disorientation 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray delivers 1 . 8 ml of solution for injection , containing 0 . 1 mg / m2 of nalloxone ( as hydrochloride dihydrate ).  the other ingredients are : trisodium citrate dihydrate ( e331 ), sodium chloride , hydrogen chloric acid , sodium hydroxide and purified water ( see section 2 ) for further information on the contents of the spray . - each pre - filled nasal spray is provided in a carton containing 2 nasal sprays in blisters . the spray contains a single dose container to help protect your child ' s health and well - being .
this medicine contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that plays an important role in human fertility ). fsh is involved in the growth and development of the sacs ( fertile cells ) in the ovaries that supply the body with hormones needed for the production of sperm . it is used to help develop a mature egg cell . in women , ovaleap is used in combination with a medicine called " clomifene citrate ". this is used during assisted reproductive technology procedures ( procedures that can help you to become pregnant ). it is also used in adults who are not able to reproduce themselves if they do not have the ability to produce enough eggs . this medicine can be used in women who have not yet been conceived and who cannot have eggs , because they have not been able
do not use ovaleap : - if you are allergic to follitropin alfa ( fsh ) or to any of the other ingredients of this medicine ( listed in section 6 ). - in case you have a tumour in your hypothalamus or pituitary gland ( both are parts of the brain ). in women , large ovaries or sacs of fluids line the inner chambers of your oocytes ( ovarian cysts ) with unexplained vaginal bleeding . - when you have cancer in your  Ovaries , womb or breasts , or any condition that normally makes a normal pregnancy impossible , such as those caused by ovulation , early menopause or due to the development of fibroid tumours of the ovulating gland or malformed reproductive organs 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much ovaleap is given this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). in women with irregular periods your doctor will decide how much medicine you should receive . you will receive this medicine during the first 7 days of your menstrual cycle . the medicine will be given to you by a doctor or nurse . your doctor , nurse or pharmacist will calculate the correct dose based on your body surface area ( m2 ). the recommended dose is either 75 mg or 150 mg per day . depending on your response to this medicine , your doctor may decide to give you a lower dose ( i . e . up to 7 days in a row ), or 37 . 5 mg ( one 75 mg injection ) of this medicine
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : serious side effects in women allergic reactions such as skin rash or raised itchy areas of skin ( signs of severe allergic reactions may include weakness , drop in blood pressure , difficulty breathing and swelling of the face 37 very rare ( may affect up to 1 in 10 , 000 people ) if you have this type of reaction , your doctor will stop your ovaleap injection and start your treatment immediately . tell your doctor , nurse or pharmacist immediately , as these may occur with the ovarian hyper - stimulating hormone ( ovulation ) in women very rare : these can be very serious . if these side effects become severe , they may be life - threatening . contact your doctor immediately if they get serious or serious : lower stomach 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . you may take this medicine for a single period of up to 3 months when stored at room temperature ( below 25 ). if you have the impression that the effect of this medicine is too strong or too weak , talk to your doctor or pharmacist . if more than 3 months have passed between the storage conditions , the cartridge may be stored for up to 28 days below 25 and away from direct heat ( direct sunlight ). keep the pen cap on the ovaleap pen when you are ready to use it , even if there is still some liquid left in it . this medicine must not be used if it is cloud
what ovaleap contains - the active substance is follitropin alfa ( fl ) in the form of a substance called cyp3adsorbed on human plasma ( human plasma ). ovaleep 300 units in 0 . 5 ml solution for injection : each cartridge contains 300 units ( 20 micrograms ) of 22 iu ( 6 million international units ) ( corresponding to 1 , 000 international units or 2 ). - when reconstituted as recommended , the solution contains 600 units ( 4 microgram ) or 44 microgram ( 1 microgram in each cartridge ). not all pack sizes may be marketed in your country . your physician will prescribe the right dose for you based on your condition . - if you are not sure , talk to your doctor , pharmacist or nurse straight away 
voriconazole accord contains the active substance voricanazole . vorikonazole is an antifungal medicine that works by killing or stopping the growth of the fungi that cause infections . it is used for the treatment of patients ( adults and children over the age of 2 ) with : invasive aspergillosis ( a type of fungal infection due to Aspergillus sp ), candidaemia ( another type of FUNgal infection caused by candida spp ) in non - neutropenic patients ( patients without abnormally low white blood cells count ), serious invasive candida sep . infections when a fungus becomes resistant to treatment , and the patient must first be given fluconazoles ( another antifungals medicine ), which is also used to treat serious fungal infections caused by scedosporium spi /
you must not be given voriconazole accord : - if your doctor or nurse thinks you may be allergic to vorikonazole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given any other medicines , especially herbal medicines . the medicines in the following list must not only be used during voricanazole acord treatment : 46 terfenadine ( used to treat allergy ) astemizole ( used as an allergy to cisapride ( used for stomach problems ) pimozide ( for treatment of mental illness ) quinidine ( used in adult patients for irregular heart beat ) rifampicin ( for treating tuberculosis ) and efavirenz ( for allergy to pollen ) do not take vori
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the dose you receive is based on your weight and the type of infection you have . your doctor will calculate your body surface area in square meters ( m2 ). the usual dose is 40 mg per kilogram of body weight each day for the first 24 hours . after that , you will receive a dose of 400 mg every 12 hours for 24 hours ( followed by 200 mg each 12 hours in the morning and 24 hours between each 24 hour period ). your doctor may decide to increase your dose to 200 mg / kg each day depending on how you respond to treatment , or to 300 mg each day . use in children and adolescents voriconazole accord can be used in children aged 2 to less than 12 years and adolescents aged 12 to 14 years who weigh less than 50 kg and who weigh 50 kg or more
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , most are likely to be minor and temporary . however , some may be serious and need medical attention . serious side effects stop taking voriconazole accord and see a doctor straight away rash , jaundice , changes in blood tests of liver function and pancreatitis . other side effects very common ( may affect more than 1 in 10 people ) visual impairment ( change in vision including blurred vision ), visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness and swinging vision . common : if you get any of these , tell your doctor as soon as possible . very common - may affect up to 1in 10 people loss of vision (
what voriconazole accord contains - the active substance is vorikonazole . each 50 mg film - coated tablet ( tablet ) contains 50 milligrams of verorax . - one 200 mg tablet contains veroxacin . the other ingredients are : the tablet core contains lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone ( k25 ), magnesium stearate , and in the tablet coating hypromellose ( e464 ) and titanium dioxide , in addition , the other ingredient ( excipients ) are lactoses monohydrate and triacetin , all of which are present in the form of a substance called amber - yellow coloured gel and are contained in a glass vial . this will give the impression that the film
mvabea is a vaccine that will protect you against ebola virus disease in the future . it will be given to individuals aged 1 year and older who will be vaccinated against the following three strains : a 2 - dose course of vaccinations to protect you from getting a full course of , single dose courses , courses or courses . your doctor will decide which vaccine you need to receive , depending on your individual needs . the recommended dose for adults and children from one month of age , will be determined by the doctor , pharmacist or nurse . this vaccine will not protect against the three types of filovirus that cause your body to produce its own protection ( antibodies ) against the other types . if you are not sure , talk to your doctor or pharmacist before you are given this vaccine . you will not be able to have a complete vaccine against the z
you should not receive mvabea during the vaccination course if you have ever had a severe allergic reaction to any of the active substances in the vaccine listed in section 6 . - you have had , or have previously had : - unexplained , - an allergic reaction against an antibiotic called ' gentamicin '. the vaccine may not be suitable for all age groups . warnings and precautions talk to your doctor or nurse before you are given the vaccine if : you have previously experienced or might now have , in the past , any other vaccine injection . you or your child fainted after an injection because of bleeding or bruise easily you currently have a fever or an infection you take medicines that affect the immune system such as high - dose corticosteroids ( such as prednisone ) or chemotherapy ( cancer medicines ) because of a
mvabea is given to you by a healthcare professional . it is given into a muscle ( intramuscular injection ) in the upper arm or thigh or a blood vessel . your doctor or nurse will give you the first vaccination with zabdeno vaccine 8 weeks later . if you miss your scheduled dose , you may not get re - administer the second vaccine . you will receive the first and second vaccines as separate doses . primary vaccination first vaccination will be given in a hospital or clinic , with the help of a doctor , who will decide when you should receive the second vaccination . follow - up doses in primary vaccination your doctor will decide on the dose that is right for you . the dose may be changed , depending on the type of vaccine that has been injected . in primary and secondary vaccination first vaccine with zbden
like all medicines , this vaccine can cause side effects , although not everybody gets them . most side effects occur within 7 days of receiving the injection . the following side effects have been reported : very common ( may affect more than 1 in 10 people ) pain , warmth , or swelling where the injection is given feeling very tired muscle ache joint pain common ( will affect up to 1 in every 10 patients ) being sick ( vomiting ) itching around the area of the injection uncommon ( will be seen by a doctor or nurse ). uncommon ( may be seen in at least 1 in 100 people ). redness , skin hardness where you have the injection and generalised itching . if any of these side effects causes you problems , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in append
what mvabea contains - the active substance is zaire ebolavirus ( inactivated ) 29 micrograms / tai forest ebavirus nucleoprotein marburg ( 0 . 7 ml per vial ) produced in chicken embryo fibroblast cells . this vaccine contains trace residues from the manufacturing process . these include gentamicin , sodium chloride , trometamol , water for injections , and hydrochloric acid ( for ph adjustment ) in the vial and as a suspension in a single - dose glass vial with a rubber stopper and yellow cap . pack size of 20 vials .
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . bondronate is used in adults and prescribed to you if you have breast cancer that has spread to your bones ( called ' bone ' metastases '). it helps to prevent your bones from breaking ( fractures ). it can also be used if other bone problems are not well controlled with surgery or radiotherapy bonedronat can also help to reduce a raised calcium level in your blood because of a tumour . it works by reducing the amount of calcium that is lost from your bones . as a result , your bones become weaker .
do not take bondronat : - if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) or to calcium in your blood . warnings and precautions this medicine can cause a side effect called osteonecrosis of the jaw ( onj ), which is a type of bone damage in the jaw that occurs more often in adult patients receiving bondronate for cancer - related conditions . onj can also occur after stopping treatment . it is important to try and prevent onj developing as it is such a painful condition that can be difficult to treat . as with other medicines , in some cases it can be serious . in order to reduce the risk of developing osteonesis ofthe jaw , there are some precautions you should take . before starting treatment , tell your doctor , pharmacist or nurse if : you
this medicine is normally given to you by a doctor or other medical staff who have experience with the treatment of cancer . it is given as an infusion into your vein your doctor will do regular blood tests while you are receiving bondronat . this is to check that you are being given the right amount of this medicine . how much you will be given the dose depends on your illness . if you have breast cancer that has spread to your bones , the recommended dose is 3 mg per kg of body weight . your doctor may lower your dose to 3 - 4 times per week . you will usually receive an infustion in your vein over at least 15 minutes . in some cases , a raised calcium level in your blood is recommended ( see section 1 , 2 and 2 for more information ). depending on the severity of your illness you may receive the medicine by infusion or as directed by your doctor . however ,
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a nurse or a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain and inflammation new pain , weakness or discomfort in your thigh , hip or groin . you may have early signs of a possible unusual fracture of the leg bone . very rare : may affect less than 1 in 10 . 000 people pain or sore in your mouth or jaw , as these may be signs of severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone ). ear pain and discharge from the ear . this could be a sign of an ear infection . bone damage in the cheek has been reported in patients treated with bondronat 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . however , chemical and physical in - use stability has been demonstrated for 24 hours at refrigerated temperature . store in the original package in order to protect from light . your doctor , pharmacist or nurse will throw away this medicine . these measures will help protect the environment .
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial of concentrate is a concentrate for solution for infusion . one vial contains 2 mg i bandronic al - aspartate ( as sodium monohydrate ). the other ingredients ( excipients ) are sodium chloride , acetic acid , sodium acetate , water for injections ( see section 2 ) and sodium ( 0 . 5 % w / v ) ( see end of section 2 for further information on some of the ingredients in this medicine ): - concentrate : sodium - free , clear , colourless liquid in a glass vial with a bromobutyl rubber stopper . not all pack sizes may be marketed .
what zeposia is and what it is used for this medicine belongs to a group of medicines that affect the production of white blood cells ( lymphocytes ) that help the body to fight infection and growth . this is called a " relapsing remitting multiple sclerosis ". rrms is a type of active disease that affects the entire body . what stevens - johnson describes ms as it is known as " rdms ", a disease where the body ' s defenses become weaker than normal . a condition in which a person has a problem with the nerves in the brain and spinal cord , which stops the cells from working properly . when this happens , it can cause symptoms such as numbness and difficulty in walking .
do not take zeposia : - if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have a severely weakened immune system you have ever had a heart attack ( angina ), stroke , mini - stroke or transient ischemic attack ( tia ). you have severe heart failure within the last 6 months you have or have had irregular or abnormal heartbeats ( arrhythmias ). your heart may not work properly when you start treatment , or you develop severe infection ( hepatitis , tuberculosis ), cancer , severe liver problems , you are pregnant or breast - feeding . you are breastfeeding . your doctor may want to monitor you more closely .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will tell you exactly how many capsules of zeposia to take each day . this will depend on your heart rate and what medicine you are taking . you will be given a ' treatment initiation pack ' with instructions on how to start treatment . the recommended dose is : adults : one capsule of 0 . 23 mg of ozanimod per day ( morning , afternoon and evening ). children : 1 to 4 weeks before starting treatment , the recommended starting dose is 3 capsules in total , given every 4 weeks . your doctor may decide to increase your dose to a higher or lower dose , depending on your child ' s weight . children , adolescents , children and adolescents ( 6 years and older )
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following side effects very common ( may affect more than 1 in 10 people ) slow heart rate , urinary tract infection ( blood pressure ). uncommon - may affect up to 1 in 100 people allergic reaction . the signs may include a rash . other side effects include : very common : may affect less than 1 per 10 people infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) or voice box ( larynge ) viruses , including a type of white blood cell called lymphocytes common and may affect any part of the body . not known : frequency cannot be estimated from the available data . your doctor may want to monitor you more closely for signs of infection
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store below 25 . this medicine does not require any special temperature storage conditions . if you notice any damage or signs of tampering to the pack , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zeposia contains - the active substance is ozanimod ( as hydrochloride ). one capsule of zeposa 0 . 23 mg contains one , 000 iu ( 8 . 25 mg ) of oznimod in a single - use sachet . - each capsule contains two , three - dose capsules , each containing one - mg capsule , which contains one dose , corresponding to a maximum of a millilitre ( ml ) per mlitre ( 15 . 5 mg ). - two capsules in each sphere ( 20 . 35 mg ), containing two doses . the other ingredients are : capsule content : microcrystalline cellulose , silica , colloidal anhydrous , microscarmellose sodium , magnesium ste
temybric ellipta contains three active substances : fluticasone furoate , umeclidinium bromide , and vilanterol : the three active ingredients in this medicine belong to a group of medicines known as corticosteroids ( also known as steroids ). fluizasone fuoate belongs to : - a class of medicines called bronchodilators which work in different ways to reduce airways and make it easier for air to get in and out of the house . what is the difference between copd and chronic obstructive pulmonary disease ( copd ) is a long - term condition characterised by breathing difficulties that gradually get worse . in copd the muscles around the airways tighten , making it difficult to breathe and keep the muscles relax . this is why it helps to control airway flow and relieve pressure
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using any of these medicines . do not take temibric
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . use temybric ellipta regularly . it is very important that you continue to use it until your next scheduled dose , even if there is still some medicine left in the body . if this happens , contact your doctor as soon as possible to re - use the inhaler . when you get a sudden attack of breathlessness or wheezing , get help immediately . in order to relieve such an attack you must use a quick - acting reliever inhal
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse straight after using this medicine , stop using it and contact your doctor immediately . pneumonia ( infection of the lung ) in copd patients the most common side effect is a decrease in the number of cases . stop using temybric ellipta and seek medical help immediately if you get symptoms of a lung infection such as fever or chills . increased mucus production , change in mucuses colour , increased cough , and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ): sore throat , runny nose , ear infection , cough feeling sick ( nausea ), vomiting , diarrhoea , stomach pain , nausea , constipation ,
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 micrograms of fluticasesone folate , 65 microgram ( equivalent to 55 microgram ) Umeclidium and 22 microgram( ml )) vilantrol ( trifenatate ). the other ingredients are lactose monohydrate ( see section 2 under ' important information about some of these ingredients '), magnesium stearate ( e470b ) and water for injections ( see also section 2 ' sodium content ') and sodium saquinavir ( a type of fat ) in the form of a gel - coated inhaler
what zinforo is this medicine is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called ' cephalosporin antibiotics '. what it is used for zin foro is used to treat adults with infections of the skin or the tissues below the skin . this is known as an infection of the lungs , also known as ' pneumonia ', in which the medicine works by killing certain bacteria , which can cause serious infections .
do not take zinforo : - if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). you may also be allergic to other cephalosporin antibiotics . you have had previous severe allergic reactions to other antibiotics such as penicillin or carbapenem . if any of these apply to you , tell your doctor before taking zin foro . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor may want to monitor you more closely while you are being treated . take special care with  Zinforo you may : have kidney problems . have ever had seizures ( convulsions ) during treatment with any non - severe allergic reaction after taking another antibiotic with penicillin / carbapapenem 26 have severe diarrhoe
the recommended dose of zinforo is 600 mg once a day for adults , adolescents and children aged 12 years and older . your doctor may decide to increase your dose to 600 mg twice daily for up to 8 weeks . if you have some infections after the first dose , the dose may be increased by up to 12 mg . it is given as a drip into a vein ( intravenously ) over a period of 5 minutes , followed by 60 minutes or 120 minutes . depending on how you respond to the medicine , your doctor might decide to give you an increased dose . usually , treatment usually lasts for 5 to 14 days depending on the type of skin infections you are likely to get . the recommended starting dose is 5 to 7 mg / m2 of body surface area per day . you will be checked by your doctor for signs of pneumonia . patients with kidney problems your doctor will decide
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zinforo and see a doctor straight away if you notice any of these symptoms - you may need urgent medical treatment : - sudden swelling of your lips , face , throat or tongue - a severe rash - swallowing or breathing problems - this may be a sign that you may have a serious allergic reaction ( anaphylaxis ) - diarrhoea - stool containing blood or mucus . tell your doctor as soon as possible if any of the side effects gets serious or last longer than a few days . your doctor may prescribe medicines to help slow bowel movement . this is common ( may affect up to 1 in 10 people ). it is important that you do a blood test called a ' coombs test
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store below 30 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is 600 micrograms ceftaroline fosamil . the other ingredients are arginine , maize starch , talc , and water for injections ( see section 2 ). what the medicinal products contain - the powder is a pale yellowish - light yellow powder for concentrate for solution for infusion in a vial . one vial contains 10 ml of solution .
pregabalin pfizer belongs to a group of medicines used in the treatment of epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neuropathy pain : pregabaltin ppfizer is used to treat long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neuroopathic pain , for example , diabetes or shingles . pain sensations may be described as hot , burning ( throbbing , shooting , stabbing ), sharp , cramping , or aching . it may also be associated with tingling or numbness . this is different to the stresses and strains of everyday life .
do not take pregabalin pfizer - if you are allergic to pregabalsin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking pregabaltin ppfizer and during treatment : - some patients taking premixil have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat , as well as diffuse skin rash . should you experience any of these reactions , you should contact your physician immediately . - pregabralin has been associated with dizziness and somnolence , which could increase the occurrence of accidental injury ( fall ) in elderly patients . therefore you should be careful until you are used to any effect the medicine might have , or may cause blurring or loss of vision or other changes in
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is for oral use only . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder : take the number of tablets as instructed by your doctor . the dose , which has been adjusted for you and your condition , will generally be between 150 mg and 600 mg each day . your doctor will tell you the dose to take . you should swallow your tablet whole with a glass of water . do not chew , crush or split the tablet before swallowing . for adults , adolescents and children weighing at least 150 kg the usual dose for adults is 150 mg once daily , while adolescents weighing 600 kg or more . adults : you should take pregabaltin ppfizer twice in the morning and once in the
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): dizziness , drowsiness , headache . common : may affect up to 1 in10 people : increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest . irritability . disturbance in attention . lack or disturbance in memory . memory impairment . loss of memory / tremor , difficulty with speaking ; tingling feeling in hands or feet . not known : frequency cannot be estimated from the available data . some side effects have been reported since the marketing of pregabalin pfizer . talk to your doctor or pharmacist if you experience any of the following : feeling of spinning , vertigo , flashes of light
what pregabalin pfizer contains each hard capsule contains 25 mg ( 50 mg , 75 mg ), 100 mg ( 150 mg ) 200 mg ( 225 mg / 300 mg ). the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica and black ink . the printing ink contains black iron oxide , propylene glycol and potassium hydroxide ). each pack contains 75 , 100 , 200 and 225 tablets . not all pack sizes may be marketed .
xadago is a medicine that contains the active substance sofinamide . it increases the amount of dopamine in your brain . this helps to improve your brain function and is used in adults to treat parkinson ' s disease . x ad adego is used by adults to reduce the frequency of fits ( sudden seizures ) in people who are not able to move and people who have difficulties moving at the same time . the medicine can also be used on its own if it is taken with levodopa or with other medicines that are also used for the same purpose and are not suitable for use in children .
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the following medicines : monoamine oxidase ( mao ) inhibitors : selegiline , rasagiline ; moclobemide ; phenelzine , isocarboxazid ; or tranylcypromine ( used for treatment of parkinson ' s disease and depression ); pethidine ( a strong pain killer ). you must wait at least 7 days before your first injection and during your second injection before you start and during the second injection . if any of these apply to you , tell your doctor or pharmacist before starting and during treatment with mao inhibitors
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of xadago 50 mg or 100 mg taken by mouth once daily . you should swallow the tablet whole with a glass of water . do not chew , crush or split the tablet before swallowing it . if your doctor thinks this applies to you , tell your doctor immediately . patients with moderately reduced liver function should take the tablet at least 50 minutes before you take it , and at the same time each day . your doctor may recommend a lower dose of one 50 mg tablet , depending on how well it works for you and your child ' s condition . for children and adolescents , the usual dose is two 50 mg tablets once a day , taken with or without food . take the tablets with water or between meals 
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure , collapse ) has been reported in patients with neuroleptic malignant syndrome ( nms ). it may also be associated with confusion , sweating , muscle rigidity ( hyperthermia ), increase level of enzyme creatine kinase in your blood ( serotonin syndrome ). in this case you may experience confusion ( hypertension ), muscle stiffness , hallucinations ( hypotension ). the most frequently reported side effects are those related to parkinson ' s disease . when xadago is taken with safinamide , levodopoulos , glibenclamide ( a type of substance ) in the blood . other possible side effects include : very
what xadago contains - the active substance is safinamide . each 50 mg or 100 mg tablet contains a total of 50 mg / 0 . 5 ml of methansulfonate . the other ingredients are microcrystalline cellulose , crospovidone type a , magnesium stearate and silica colloidal anhydrous - tablet coating : hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red (" e172 ) ( see section " important information about some of the ingredients in the film - coating " in section 2 ), and iron oxide black ( engraved " in black ink on one side and plain on the other side . what you need to know before you have been prescribed the tablet - you should be aware of the following : what 
zytiga is a medicine containing an active substance called abiraterone acetate . it is used to treat men with prostate cancer that has spread to other parts of the body in males , women and men . while at rest , the level of testosterone in men is low ( low ) and there is no evidence that it is working properly . zetiga reduces testosterone and is used in prostate cancer in men and women . you and your partner will be monitored while you are being treated for the development of disease or when hormone therapy is being used as a treatment that lowers testosterone ( androgen deprivation therapy ) or when you are taking another medicine , prednisone .prednisolone has been shown to reduce high blood pressure in women whose body is experiencing fluid retention ( build - up of water in your blood ).
do not take zytiga : - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). you are pregnant warnings and precautions talk to your doctor , pharmacist , or nurse before you are given this medicine if : you have severe liver damage you have prostate cancer . your doctor may need to adjust your dose . this medicine should not be used in children and adolescents . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . you have liver problems ( for example , high blood pressure , heart failure , low blood potassium ). if the medicine contains too much , you may have heart rhythm problems or other heart or blood vessel problems , such as an irregular or rapid heart rate , short
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once daily . your doctor will tell you how many tablets of this medicine to take . take the tablets with food . do not chew , crush or split the tablets . this medicine is for oral use . taking this medicine by mouth is not recommended . you can take zytiga with food or between meals . swallow the tablets whole with water . it does not matter whether you take them with or without food ( e . g . apple sauce ). how long should i take to get the full dose ? if your doctor tells you to , do not change your dose without first talking to your doctor . how long to take prednisone before you start taking it , or before taking it together with pred
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact a doctor immediately if you experience muscle weakness , muscle twitches , a pounding heart beat ( palpitations ), or if the level of potassium in your blood is low . your doctor will tell you how to deal with potassium . other side effects include : common ( may affect up to 1 in 10 people ): - build - up of fluid in your legs or feet , which may be a sign of low blood potassium ( shown in liver function test ), high blood pressure , urinary tract infection , diarrhoea , vomiting , abdominal pain , nausea , constipation , dry mouth , hair loss , loss of appetite , weight gain , skin rash , itching ,
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg amylase ( 0 . 5 mg / 5 ml ).  the other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate ( e487 ) ( see section 2 , " important information about some of the ingredients of the tablet ) and water for injections ( see end of section 2 under ' important information for medical or healthcare professionals on how to prepare and take the tablets '). what the tablets look like and contents of the pack - zytigea tablets are white to off - white , oval tablets with " a "
hefiya contains the active substance adalimumab . it is a medicine used for the treatment of the following inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis paediatric plaque psoriasis , pediatric crohn ' s disease , and pediatric non - infectious uveitis in adults . the active ingredient in this medicine belongs to a group of medicines called tetanyl - positive peptide ( tnf ), which is made up of a monoclonal antibody that is made from two human - or animal - derived antibodies , which are designed to recognise and bind to other unique proteins in the body . by attaching to these aminoglobulins , the target of thiomers
do not use hefiya : - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ) - when you have a severe infection , including tuberculosis , sepsis ( blood poisoning ) or other opportunistic infections ( unusual infections associated with a weakened immune system ). it is important that you tell your doctor if any of these apply to you . symptoms of infections such as fever , wounds , feeling tired , dental problems should be considered . - in case you have moderate or severe heart failure . it is also better to avoid infecting other people . warnings and precautions talk to your doctor or pharmacist before you are given this medicine if : you have had or have had a serious heart condition . allergic reaction 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual starting dose is 40 mg once a day for patients who weigh 20 kg or 40 kg . your doctor may increase the dose to 20 mg once daily if your child weighs 40 kg or more . polyarticular juvenile idiopathic arthritis age or body weight how much and how often to take ? notes children , adolescents and adults from 2 years of age weighing 30 kg and older who weigh 40 kg and more than 40 mg each day . note that some patients weighing 10 kg to less than 30 kg should take 20 mg twice daily . enthesitis , adolescent , and arthritis age of 6 years should take 30 mg every other week . this can be given as a 40 mg dose . children and adolescents from 6 to 15 kg 
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . side effects may occur at least up to 4 months after the last hefiya injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash or hives ; swollen face , hands , feet ; trouble breathing , swallowing ; shortness of breath with exertion or upon lying down or swelling of the feet . tell your doctor as soon as possible , as you may be more likely to get signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , flu - like signs or symptoms , such as cough , sore throat , runny nose 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . alternative storage : when needed ( for example when you are travelling ), hefiya may be stored at room temperature ( up to 25 ) for up to 14 days , but not above room temperature storage . once removed from the refrigerator , you should record on the carton the date when you first removed it from refrigerator and the date after which it should be used within 14 days or discarded , even if it is later returned to the refrigerator or if the product is used within the 14 - day period , whichever is earlier . you may want to record the date
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg / 0 . 4 ml adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid ( e507 ), sodium hydroxide and water for injections ( see section 2 ). what you need to know before you use heifia ): what the medicine looks like and contents of the pack the 20 mg solution for injection ( injection ) is supplied in a pre  litre clear , colourless to slightly yellowish solution . the solution is clear to slightly opalescent and colourless . it is available in : clear type i glass siringe with a stainless steel needle
ritemvia contains the active substance " rituximab ", which is a type of protein called a " monoclonal antibody ". this attaches to a specific target in the body . b - lymphocytes are cells that are found on the surface of a certain type of white blood cell called " cyp3a4 ". when this stick to the cell , the target " yp4a4+ " dies ". if this target cannot be reached by other medicines ( chemotherapy ) it may not be possible to reach your target cell . your doctor may discuss this with you . for the initial treatment with ritemevia may be used for : a ) granulomatosis with polyangiitis or microscopic polyangitis ritamvia is used for the treatment of patients with a history of 
do not take ritemvia : - if you are allergic to rituximab , other proteins which are similar to the active substance , or to any of the other ingredients of this medicine ( listed in section 6 ). - when you have a severe active infection or a weak immune system . warnings and precautions severe heart failure or severe uncontrolled heart disease , granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . talk to your doctor or pharmacist before you are given this medicine if : you have or have ever had a hepatitis infection . your doctor may want to monitor you more closely while you are being treated with retween b . this is because in people who have ever been in close contact with someone who has hepatis b infection 
ritemvia will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . your doctor will tell you what dose you need to take . it is very important that you receive your first dose of ritonavir via a drip ( intravenous infusion ). medicines given before each ritemevia administration before it is given , the doctor will discuss with you which combination of medicines ( pre - medication ) is best for you . in order to minimise the risk of side effects your treatment will be started . for non - hodgkin ' s lymphoma if you are given a single course , you will receive one course of 4 doses . repeated treatment courses with ritamvia are possible . if
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion , you may develop fever , chills and shivering . you may also experience pain at the injection site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat irritation , cough , sore throat and difficulty breathing . these reactions usually disappear in a few days or weeks . if they persist , tell your doctor or nurse straight away . other side effects may include : very common ( may affect more than 1 in 10 people ): diarrhoea ,
what ritemvia contains - the active substance is called rituximab . each ml of concentrate contains 100 mg /ml . - each millilitre of reconstituted ( diluted ) solution contains 10 mg of ritsimabe . the other ingredients ( excipients ) are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections ( see section 2 ). what ritamvia looks like and contents of the pack the concentrate is a clear , colourless solution . it is supplied as a concentrate for solution for infusion in a glass vial ( 0 . 5ml vial ). pack of 2 vials .
capecitabine teva belongs to the group of medicines called " cytostatic medicines ", which stop the growth and spread of cancer cells . the active substance in this medicine is capsecitabin , which itself is not a cytotic medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine ( more in tumour tissue than in normal tissue ). capecitebine  Teva is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , it is used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery ; it is thought to have been tested and approved by the european medicines agency ( e . g ., heparin ) or to combine with other medicines .
do not take capecitabine teva : - if you are allergic to cappecitabine or any of the other ingredients of this medicine ( listed in section 6 ). you must inform your doctor if this applies to you . you must state that you have an allergy or over - reaction to this medicine . warnings and precautions severe reactions have been reported in patients treated with fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ). - are pregnant or breast - feeding , have low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ) - have severe liver or kidney problems - do not produce enough of the enzyme dihydrochlorimidine dehydrogenase ( dpd ) ( complete pd deficiency 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you , so you can take the tablet at the same time each day . dose the dose of cappecitabine teva is based on your body surface area . this is calculated from your height and weight . the usual dose for adults is 1250 mg / m2 of body surface surface area taken two times daily ( morning and evening ). two examples are provided here : a person whose body weight is 64 kg and height is 1 . 64 m has a body surfacearea of 1 , 7 . 7 m2, and should take 4 tablets of 500 mg and 1 tablet of 150 mg two
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva immediately and contact a doctor if any of these symptoms occur : diarrhoea : if you have an increase of 4 or more bowel movements compared to your normal bowel movement each day or any dirrhea at night . vomiting : when you vomit more than once in a 24 - hour time period . nausea : you lose your appetite , and the amount of food you eat each day is much less than usual . stomatitis : your doctor will tell you what to do to prevent pain , redness , swelling or sores in your mouth and / or throat . hand - and - foot syndrome : this is more likely to happen when you take this medicine with food .
what capecitabine teva contains - the active substance is capecitebine - each tablet contains 150 mg film - coated tablet . - one tablet of 150 mg can be divided into two equal doses . the other ingredients are : - tablet core : lactose , microcrystalline cellulose , hypromellose ( e464 ), croscarmellose sodium , magnesium stearate , macrogol 400 , and talc . tablet coating : carnauba wax , iron oxide , red iron oxide and black ink . not all pack sizes or tablet strengths may be available in your country . your doctor will prescribe the best dose for you based on your child ' s weight and the weight , which will depend on their weight and weight . what capécitabine toeva looks like and contents of the
silodosin recordati belongs to a group of medicines called alpha1a - adrenoreceptor blockers ( aortic and ulnarrhoea ) which work by blocking receptors in the blood vessels of the prostate , bladder and urethra . by blocking these receptors , it causes smooth muscle in these tissues to relax . this makes it easier for you to pass water and relieves your symptoms . you should not miss a dose of siloncordati if you do not feel better or if your symptoms do not improve after a short period of time . your doctor has prescribed silofsin recordingi to help you pass water more easily than if it does not help you at all . it is also used in adult men to treat the urinary symptoms associated with benign enlargement ofthe prostate
do not take silodosin recordati - if you are allergic to the active substance , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if any of these apply to you , tell your doctor immediately . during your cataract surgery , you may experience cloudiness of the lens ( cataract surgery that exposed the eye to light ). 26 while you are being treated with this type of medicine , there may be a loss of muscle tone in the iris ( the coloured part of the eye ) during such a surgery . your doctor will take appropriate precautions to ensure that the correct use of medicine and surgical techniques is maintained . you should inform your doctor as soon as possible after your operation . some patients who are undergoing cataract surgery may fainted or felt di
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one capsule of silodosin recordati 8 mg taken orally once a day . take the capsule at about the same time each day , preferably in the morning , but not later in the evening . patients with kidney problems your doctor may prescribe a lower dose for patients with moderate kidney problems . for this purpose the usual dose is two capsules ( 4 capsules ) taken twice daily , for at least 4 hours after the first dose . you should swallow the capsule whole with a glass of water . do not chew or break the capsules as this may cause dizzy or feel weak . if this happens , you should contact your doctor as you may need to take sillodonin recordingi once more , or contact your
like all medicines , this medicine can cause side effects , although not everybody gets them . possible allergic reactions include swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin and hives . the most common side effect reported with silodosin recordati is dizziness . this is usually mild to moderate and usually goes away within a few days . if you do get dizzy or get occasionally fainting , you should contact a doctor as soon as possible . it is important that you sit or lie down straight away until you get up for the day . however , in some cases you may need to lie down until you are used to the effects of this medicine . complications from a cataract surgery ( eye surgery ) may occur very commonly . contact lenses may be necessary . some patients may experience blurred vision when standing up , especially when standing
what silodosin recordati contains - the active substance in this medicine is called slurilsulfate . - each capsule contains 8 mg or 8 mg of siloudo. the other ingredients are : mannitol ( e421 ), magnesium stearate , sodium laurilsULfate in the capsule shell ; gelatin , titanium dioxide in the film - coated tablet ( sdc - 4 mpa s ) and yellow iron oxide , the black and white hard capsules are engraved with the code ' sv8 ' in black ink on the cap and the number ' 993 '. sillodusin recordsati 4 mg contains approximately 4 mg / ml ( approximately 8 mg ) in each capsule . the rest of the ingredients are sil
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angioTENsin is a substance occurring in the body , which causes your blood vessels to narrow , thus increasing your blood pressure . kinzimono blocks the effect of this substance so that the blood vessels relax . this results in a very fast and steady blood - sugar - lowering effect , causing your blood to float more and more , and lower your overall health . what is essential ? high blood pressure is the condition at which most people don ' t realize they have essential characteristics . people who don ’ t know what they are and what they need to know before they start to take . high blood , in turn , can damage blood vessels in several organs , leading sometimes to heart attack , heart or kidney failure ,
do not take kinzalmono - if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions children and adolescents do not give this medicine to children under 3 years of age , and should not be taken if they are more than 3 months pregnant . ( it is also better to avoid kinzilmono in early pregnancy see pregnancy section .) - had severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or any other severe liver disease . - have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren . it is recommended that every time you take a tablet , the tablet should be taken with food . this is because kin
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of kinzalmono is one tablet a day . it does not matter at what time of the day you take your tablet but taking the tablet at the same time each day will help you remember to take it . you may take it with or without food . your doctor will tell you how many tablets you should take . try to take the tablets with some water or other non - alcoholic drink . swallow the tablet whole with a glass of water . do not chew , crush or split the tablet before swallowing . tell your doctor about any changes in the way the tablet works . for treatment of high blood pressure , the usual starting dose for kinzimono for most patients is 40 mg once daily to control blood pressure over the 24 - hour period .
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention : you should see your doctor immediately if you experience any of the following symptoms : sepsis * ( often called " blood poisoning ", is a severe infection with whole - body inflammatory response ), rapid swelling of the skin and mucosa ( angioedema ); these side effects are rare ( may affect up to 1 in 1 , 000 people ) but are extremely serious and patients should stop taking the medicine and see their physician immediately . if these effects are not treated they could be fatal . possible side effects of kinzalmono common side effects these may affect more than 1 in 10 people : low blood pressure ( hypotension ) in users treated for reduction of cardiovascular events . uncommon side effects may affect 1 to 100 people 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in the original package in order to protect from light and moisture . your medicine should be taken orally at the same time each day . you should not take your kinzalmono tablet if you notice that the blister has been opened or a tablet is broken . this medicine does not require any special temperature storage conditions . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines no longer used . these measures will help protect the environment .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg .  the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e420 ) and magnesium stearate ( see end of section 2 for important information about some of the ingredients in this medicine ). what the medicine looks like and contents of the pack the 20 mg tablets are white to off - white , round tablets , with " gsi " debossed on one side and " nvr " on the other side . the tablets are provided in blister packs of 14 , 28 , 56 and 98 tablets . not all pack sizes may be marketed .
afstyla is a human clotting ( coagulation ) factor viii product . it contains the active substance lonoctocog alfa , which is used to clot bleeding episodes in adults , adolescents and children of all ages with haemophilia a ( inborn factor  vii deficiency ). factor vii is an important component of blood cloting . when a person tries to bleed , there is an increased tendency to . if you have been told by your doctor that you don ' t have enough factor ixi in your body , and your own blood may not coagulate quickly enough . the active ingredient in a fsyla , however , is not a cure for all affected persons .
you must not be given afstyla - if you have ever had an allergic reaction to any of the active substances in your body ( see section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given orally , or while you are being treated with : 46 - the active substance in your treatment diary should not be used after the expiry date which is stated on the label of the vial and the carton after exp . - your doctor may decide to reduce the dose or stop the administration if any of these apply to you . do not take a dose more than once a day , unless your doctor advises you to do so . you should keep a record of the batch number , which you can keep on the treatment diary , and keep it at all times in order to protect it from light . your doctor will advise you if
your treatment should be started by a doctor who is experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of afstyla for treatment of your disease the site and the bleeding your clinical condition should be determined by your doctor . reconstitution and administration general instructions the powder should be mixed with the solvent ( liquid ) immediately after dilution . if not used immediately aseptic conditions may not be possible . use in children and adolescents the doctor will determine the appropriate storage conditions and the appropriate disposal method for use in the child and adolescents . you should use the solution immediately if it is coloured or slightly opalescent . after withdrawal , the solution should be clear and colourless . it should not be used in children under the age of 18 years . do
like all medicines , afstyla can cause side effects , although not everybody gets them . contact your doctor immediately if you experience symptoms of allergic reactions . allergic reactions may include the following symptoms : hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness and anaphylaxis ( bleeding ). patients who have received factor viii medicines may develop inhibitor antibodies ( see section 2 ): common ( may affect up to 1 in 10 people ) if they occur during or after previous treatment with factor vii ( more than 150 days of treatment ) the risk is uncommon ( less than 1 in 100 people ). if this happens , your doctor may stop treatment temporarily or permanently . it is important that you also read the package leaflet for this
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . the afstyla powder can be stored at room temperature ( up to 25 ) for a single period not exceeding 3 months . keep vial in the outer carton in order to protect from light . use the reconstituted product immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 8 , unless reconstitution has taken place in controlled and validated aseptic conditions .
what afstyla contains the active substance is lonoctocog alfa . each ml of solution contains 250 micrograms ( corresponding to 2 . 5 mg ) of solution for injections the solution contains 100 microgram ( 0 . 100 iu ) ( 9 . 7 mg ), lonoctcog all - one vial in the vial . after reconstitution with 2 , 5 mg of solution , the solution is administered to you as follows : a ) two vials of solution each containing 200 microgram( 1 , 000 microgram ) in the pre - filled syringe . if you are not sure , talk to your doctor , pharmacist or nurse before you are given a solution . the recommended dose is : the first dose contains 400 microgram of lonococogg al
the name of your medicine is praxbind . it contains two different active substances , idarucizumab and saquinavir . iducizum ab is a reverse agent . dabigatran ( pradaxa ) is also a blood thinner medicine that helps to prevent blood clot formation . by blocking the effect of praxxbind on the blood vessels it forms a substance that can rapidly trap dabig atran . your doctor will tell you what to do if you need to take a dose . you should keep in regular contact with your doctor , and do not change the dose unless you are in close contact with a doctor or hospital emergency surgery . urgent procedures may be necessary to prevent uncontrolled bleeding .
do not take praxbind : - if you are allergic to idarucizumab or any of the other ingredients of this medicine listed in section 6 . warnings and precautions talk to your doctor or pharmacist before taking this medicine if : you suffer from a genetic disease called hereditary fructose intolerance ( hfi ) or the substance sorbitol ( e420 ) which is present in very small amounts . this medicine may increase the risk of serious adverse reactions . if any of these apply to you , tell your doctor . you should not take this medicine in combination with dabigatran or with other medicines that help to prevent blood clots . the amount of dabig atran in your body is very small . therefore , it is not known how often this happens , and how often you take medicines that prevent blood
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 5 mg vial of 2 . 5 mg dabigatran per day . you should take this medicine for at least 5 minutes before you inject yourself . this medicine should be injected into a vein . your doctor will tell you how much praxbind you will need to take . do not stop taking this medicine without your doctor ' s advice . during your treatment , your doctor may reduce the risk of blood clot formation . if possible , you may inject dabig atran at any time during the 24 hours after you inject this medicine . it is very important that you keep using this medicine until your doctor tells you it is safe for you to carry on using it as long as you are using it , even if it is 
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains the active substance is idarucizumab . the other ingredients ( excipients ) are sodium acetate trihydrate , acetic acid ( e330 ), sorbitol (  e420 ), polysorbate 20 and water for injections . what the solvent vial looks like and contents of the pack the concentrate for solution for injection is a clear to slightly opalescent , colourless to slightly yellow solution in a glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temac is used for the treatment of specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme ( gbm ). in these patients , it is used alone or in combination with radiotherapy ( concomitant phase of treatment ) and in children ( monotherapy phase of treating children and adolescents from 3 years of age and older ) in adult patients with malignant gliomema , such as those patients with glibblastomas multifocale or anaplastic astrocytoma in which these tumours have come back or get worse after standard treatment .
do not take temomedac - if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ) or have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . if certain kinds of blood cells are severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells help to fight infection and for proper blood clotting . your doctor will check your blood to make sure you have enough of these cells during treatment . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have a low number of white blood cells ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac . this is based on your size ( height and weight ) and whether you have a recurrent tumour and have had chemotherapy treatment in the past . you may be given other medicines ( anti - emetics ) to take before and / or after taking temac to prevent or control nausea and vomiting . patients with newly - diagnosed glioblastoma multiforme may be undergoing treatment with two phases : - treatment together with radiotherapy ( concomitant phase ) followed by treatment with one dose before and one dose thereafter ; - alone or together with chemotherapy ( monotherapy phase ). you will take two doses in one day of treatment with 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you have any of the following : a severe allergic ( hypersensitive ) reaction ( hives , wheezing or other breathing difficulty ), uncontrolled bleeding , seizures ( convulsions ), fever , chills and severe headache that does not go away . temomedac treatment can cause a reduction in certain kinds of blood cells . this may cause you to have increased bruising or bleeding ( anaemia ), red blood cells and fever and reduced resistance to infections . the reduction in blood cell counts is usually short - lived . in some cases , it may be prolonged and may lead to a life - threatening , possibly fatal , effects . your doctor will monitor you closely , and act if necessary . patients with an
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 30 in the original package in order to protect from light and moisture . tell your pharmacist if you notice any change in the appearance of the capsules .
what temomedac contains - the active substance is temozolomide . - one ml solution for injection ( injection ) contains five times a day ( corresponding to 5 mg / kg body weight ). - another one for use in children and adolescents : - when the dose is increased , the doctor may decide to give you a lower dose , such as two 20 mg capsules containing five 20 mg temazolomide ( as a single dose ). the other ingredient in temac is 100 mg : one 100 mg tablet contains 100 mg of temozalomide in one injection . the other ingredients are temokac 140 mg tablets , one 140 mg capsule contains 140 mg of the two syringe containing one dose containing two 140 mg tablet ( as two separate doses ) in one day , and one 180 mg
cialis is a treatment for adult men with erectile dysfunction ( also known as impotence ). this is when a man cannot get , or keep a hard , errect penis suitable for sexual activity . you should not be given cialised to help you get ahard e rect peni . your doctor will tell you what to do , when to take it and how long you should continue to use it . ciali contains the active substance tadalafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors which work by helping the blood vessels in your penis to relax . this will stop the flow of blood into the penis . the result of this is improved sexual performance . it is important that you do not have to engage in sex for as long as your doctor tells you to . do not
do not take cialis : if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you are taking any form of organic nitrate or nitric oxide donors such as amyl nitărite . this is one of a ' s very rare , but very common , group of medicines (" nitsits ") used to treat angina pectoris (" chest pain ") in adult patients . if any of these medicines are too strong or too weak , talk to your doctor or pharmacist . you may be more likely to get serious heart disease , or you have recently had a heart attack within the last 90 days or you are going to have a stroke in the last 6 months or you plan to go to a hospital for the treatment of your heart 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . cialis tablets are for oral use . swallow the tablets with a glass of water . the tablets can be taken with or without food . how much to take the recommended dose is 5 mg twice a day . your doctor will tell you how many tablets of 2 . 5 mg to take . do not take more tablets than your doctor tells you to . try to take your daily dose at about the same time each day and this will help you to remember to take it . it is important that you do not stop taking the tablets without your doctor ' s advice . you should sexually stimulate your sexual performance at any time during the 24 hours before you have sex , and only take one tablet each day , if it is convenient for you to do so . taking 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : allergic reactions such as rashes ( frequency not known ) and chest pain have been reported in association with the use of nitrates ( frequency cannot be estimated from the available data ). priapsim may cause a prolonged and possibly painful erection . if you get cialis and get a new one , you should contact your doctor immediately . sudden loss of vision has also been reported ( frequency unknown ). other side effects have occurred with the same frequency as with other medicines : common ( may affect up to 1 in 10 people ) or uncommon ( may effect up to1 in 100 people ). headache , back pain , dizziness , drowsiness , hallucinations , nightmare . tell your doctor
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg / 0 . 25 mg of tatafil ( as mesilate ).  the other ingredients are : tablet core : lactose monohydrate ( see end of section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose ( e460 ), sodium laurilsulfate , magnesium stearate . film - coating : talc , sodium monohydrate and hypromellose , triacetin , titanium dioxide . printing ink : iron oxide yellow , iron oxide red . - indigo carmine iron . the company logo and the company symbol are imprinted with ' c7 ' on one side and plain
enyglid is an oral antidiabetic medicine that contains the active substance repaglinide . it helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your panceras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enzyglid can be prescribed to you if you have type2 diabetes and your doctor will start treatment with this type of medicine based on exercise and weight reduction , depending on how well your body is able to use its own insulin effectively . you should continue to follow the advice on diet and exercise given to you by your doctor or nurse . metformin is also used to treat diabetes .
do not take enyglid : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have type 1 diabetes . if the acid level in your blood is raised ( diabetic ketoacidosis ). you have a severe liver disease . you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ) you have liver problems you have moderate liver 28 disease ( see section 2 . what you need to know before and during treatment ). if any of these apply to you , tell your doctor or pharmacist before taking the medicine . your doctor may want to monitor you more closely . there is little information on the use of eninessglid in patients with a severely liver disease or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual starting dose is 0 . 5 mg twice a day . swallow the tablets with a glass of water immediately before or up to 30 minutes before each main meal . your doctor may increase the dose to 4 mg twice daily if necessary . you can take enyglid with or without food . take the tablets at about the same time every day to reduce the amount of sugar in your blood . if your blood sugar is too low , it may become too high , leading to a hypo . however , you should not take a double dose to make up for a forgotten tablet . try to take your next dose at the usual time , preferably at the same times every day , once at bedtime . it is important that you carry on taking 
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is a very common side effect of enyglid . this side effect is very common ( may affect more than 1 in 10 people ), but it can also occur in some cases ( very rare : may affect up to 1 in every 10 , 000 people ). hypoglecaemic reactions are generally mild / moderate , but may occasionally progress to hypoglatemic unconsciousness or coma . allergy allergy is very rare ( may effect up to1 in 10 . 000 people not known ). symptoms may include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . these may be signs of anaphylactic reaction . other side effects may include : common ( can affect upto 1 in10 people ): stomach pain . common (
what enyglid contains - the active substance is repaglinide . each tablet contains either 0 . 5 mg , 1 mg or 2 mg / 8 , respectively . the other ingredients are : - core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine ( type a ), poloxamer - coating : yellow iron oxide ( e172 ) only in the 1 mg tablets - and - cap on the other side : red iron oxide and e 172 in the 2 mg tablets in the 5 mg film - coated tablets : white , round and biconvex with bevelled edges , debossed with " nvr
the active substance in this medicine is azacitidine mylan . it is an anti - cancer agent . the active ingredient in this medicinal product is called azacitatidine . aza citidine is used in adults , adolescents and children over one month of age to help prevent and / or reduce the production of mds . this medicine belongs to a group of medicines called ' recombinant dna technology '. it works by interfering with the natural chemical and physical function of the cells in the blood . what is a reason why this medicine has been prescribed for you , it is used to treat : - a stem cell transplantation to treat patients with higher - risk myelodysplastic syndromes ( mdes ). - chronic myeloidomonocytic leukaemia ( cmml ) and acute
do not take azacitidine mylan : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). - in patients with advanced liver cancer . warnings and precautions talk to your doctor , pharmacist , or nurse before and while taking this medicine if : you have decreased counts of platelets , red or white blood cells . you have kidney disease or liver disease you have ever had a heart condition or heart attack you have lung disease you are going to have blood test you will have blood tests before and during treatment . your doctor may decide to reduce the dose , interrupt , stop or change the dose yourself if any of these apply to you . during treatment with azacitamylan your doctor will start a ' cycle '. this is to check that you have enough blood cells and that your liver and kidneys are working
before giving you azacitidine mylan , your doctor may give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor will decide your dose of this medicine , depending on your general condition , height and weight . you will be given one treatment cycle " of 4 to 6 treatment cycles ". this medicine is given as an injection under the skin ( subcutaneous use ). it may be given by your doctor or nurse . it could be given on the same day each week , or on the other side of your thigh , tummy or upper arm . if you have any further questions on the use of this product , ask your doctor , nurse or pharmacist .
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting and reduced appetite . confusion , restlessness , fatigue and symptoms of kidney failure are listed below . if any of these side effects causes you problems , please tell your doctor . very common : may affect more than 1 in 10 people : diarrhoea , indigestion , heartburn , pain in the abdomen , constipation , dry mouth , loss of appetite , weight loss , sleepiness . uncommon 
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the vial label and the carton after exp . this medicine does not require any special temperature storage conditions . you should store this medicine in the original package in order to protect from light . once the suspension has been dissolved in water for injections , it must be used within 1 hour of preparation . if necessary , your doctor or nurse will check the suspension and if it is not used within 8 hours after it has been stored in the refrigerator ( 2 - 8 ). if you do not need to use the suspension after it is prepared using water for injecting yourself , you should use it immediately . however , if the suspension is prepared by a healthcare professional , they are responsible for disposing of it correctly . the following instructions are intended for healthcare professionals
what azacitidine mylan contains - the active substance in each vial of powder contains 100 milligrams / 0 . 5 ml zociidine . after reconstitution with 4 millilitres of water for injections , the reconstituted suspension contains 25 mg / 1ml of azacritidine , - in the other ingredients of the powder : mannitol ( e421 ). what acitide mylan looks like and contents of the pack azacionitidine melan is a white powder for suspension for injection ( injection ) supplied in a glass vial containing 100 mg dilution ( 100 mg in each carton ). each pack contains 1 vial or 7 vials . not all pack sizes may be marketed .
duotrav eye drop solution contains a combination of two active substances , travoprost and timolol in one eye : duoprosth is a prostaglandin analogue and it works by helping to reduce the amount of fluid within the eye . when used together with a beta blocker , both reduce fluid inside the eye and reduce pressure within the area of the eye that is not being absorbed . duototrav eyes drop solution is used to reduce high pressure in the eye which can be a sign of an illness called glaucoma .
do not use duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions respiratory problems such as asthma or severe chronic obstructive bronchitis . severe lung disease that causes wheeziness and difficulty in breathing , especially after long - standing cough . breathing problems that do not go away such as severe hay fever . you should be aware of the following : a slow heartbeat , heart failure or a disorder of heart rhythm ( irregular heartbeats ). the colour of the liquid in your eye should be clear , cloudy , or you can see particles floating in it . talk to your doctor , pharmacist or nurse if any of these apply to you .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in the eye or eyes , once a day in the evening . duotrav should only be used in your eyes . you should not use more than your doctor tells you to use . your doctor will tell you how many drops to use and how often to use them . how much to use you should keep your eye drops on a regular basis . do not use after the expiry date which is stated on the bottle label and the carton after ' exp '. for adults , adolescents and children aged 2 years and above , the recommended starting dose for children aged 3 months and above is 4 drops per day . using a bottle : 1 . wash your hands . hold the bottle , pointing down , between your thumb and fingers 
like all medicines , this medicine can cause side effects , although not everybody gets them . you should stop using the drops and start using duotrav at the same time each day . very common side effects ( may affect more than 1 in 10 people ) - effects in the eye eye redness . common side effect( may affect up to 1 in10 people ). - damage to the eyeeye eye surface inflammation or surface damage . - eye pain , blurred vision , abnormal vision - dry eye , itchy eye or eye discomfort , signs and symptoms of eye irritation ( such as burning and stinging ). uncommon side effects are : - decrease in the amount of drops in the drops . not known ( frequency cannot be estimated from the available data ) effects in children and adolescents ( 12 years of age and above ). reporting of side effects with this medicine if you get any side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicinal product does not require any special storage conditions . after opening : do not store above 30 . store in the original package in order to protect from light and moisture . throw away the container 4 weeks after first opening to prevent infections .
what duotrav contains - the active substances are travoprost and timolol . each ml contains 40 mg / 0 . 5 mmol . - each millilitre contains a total of 10 - 20 mg of tranvoproster and 5 - 100 micrograms ( mg ) / 1 m2 / 3 - bicarbonate ( corresponding to 20 - 25 microgram / 10 microlitre ). - one another : polyquaternium - 1 , mannitol ( e421 ), propylene glycol , polyoxyethylene hydrogenated castor oil , and water for injections ( see end of section 2 ), boric acid and sodium chloride , sodium hydroxide and hydrochloric acid . the other ingredients are purified water and sodium hydro
nplate ' s active ingredient is romiplostim , a protein that is used to reduce low platelet counts in adults with immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease that affects your body  s immune system that produces too many of a type of protein called platelets . platelets are important as they help your blood to form blood clots . very low platelets counts can lead to bruising and serious bleeding ( see section 1 ) when you have had your spleen removed , or if you have chronic itp and have previously taken corticosteroids ( or immunoglobulins ), but have not worked well enough or are not suitable for you . your doctor will discuss with you the benefits and risks of using n plate .
do not use nplate - if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . - you are also allergic to other medicines that are produced by recombinant dna technology called escherichia coli ( e. coli ). warnings and precautions before you are given this medicine , you should be aware that you have a low blood platelet count ( thrombocytopenia ). you should not be given n plate if the number of blood clots is too low . your doctor may want to monitor you more closely to make sure that you do not have enough platelet counts . you may also be at increased risk for blood clits . this is because a high number of people can develop blood
always use nplate exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . adults and adolescents ( aged 1 to 17 years ) your doctor will tell you how many doses you should take . your doctor may decide to give you an injection under the skin ( subcutaneous ). the usual dose is 1 mg / kg of body weight given once a week . how to use use the instructions for use are given at the end of this leaflet . use in children and adolescents do not give this medicine to children less than 1 year of age . if your doctor tells you to , it is very important that you follow your doctor ' s instructions exactly . do not try to give yourself an injection yourself if this does not help . for adults , adolescents , children and infants ( from 1 month of age and above ) the dose of 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : itp common ( may affect up to 1 in 10 people ): headache ; allergic reaction ; upper respiratory tract infection ; very common ( might affect more than 1 in10 people ). bone marrow disorder ; increased bone mmarrow fibres ; trouble sleeping ( insomnia ); dizziness ; tingling or numbness of the hands or feet ( paraesthesia ; migraine ); redness or the skin ; flushing ; pain in the joints ; joint pain ; itching ; muscle pain . if any of the side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist . you may need to stop taking nplate and see your doctor immediately 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . nplate may be stored for up to 30 days at room temperature ( not above 25 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nplate contains - the active substance is romiplostim . one ml solution for injection contains a total of 230 micrograms ( 0 . 25 milligrams ) of the active ingredient . - each millilitre contains 125 microgram ( iu ) ( corresponding to a concentration of 122 . 5 microgram / milliliter ). - one vial provides a sufficient amount to deliver a single dose . when prepared as directed by your healthcare provider , the product should be administered as a sterile , clear , colourless solution . each vial contains either : - a volume containing a maximum of 12 . 4 million units ( 30 microlitres ), - two vials of 250 microgram and - three traces of romisplost ( 500 micro
this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : - a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making it difficult for air to get in and out . by doing so , this medicine blocks the tightening of these muscles in the lungs . it helps to open the airway and so reduce the number of air sacs in your lungs to open them . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using tovanator breezehaler and during treatment : - patients with kidney problems - suffer from an eye problem called narrow - angle glaucoma - have difficulty passing urine . during treatment your doctor may decide to reduce your dose , interrupt or stop treatment . if any of these apply to you , tell your doctor or pharmacist immediately . you may experience tightness of the chest , coughing , wheezing or breathlessness immediately after you inhale totovanor brezeezer . this may be a sign of bronchospasm ( difficulties in breathing or swallowing ), swelling of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the usual dose is to inhale the content of one capsule each day . this will help you to remember when to use it . you only need to be inhaled once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . use in children and adolescents do not give this medicine to children under the age of 75 years . your doctor will tell you how many capsules to use at the same time each day and how often you should use them . for the best results , in this pack , you will find an inhaler and capsules ( in blisters ) that contain the medicine as inhalation powder . only use the capsules with the in
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyronicum brmide equivalent to 50 microgram ( mg ) / 0 . 25 milligram ( ml ) of glycopronium . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram( 1 . 5 microgram ) ( 5 . 0 microgram per day ). the other ingredients in the manufacturing process are lactose monohydrate and magnesium stearate ( see section 2 ). what you need to keep your mouthpiece open , inhale and swallow the capsules whole with water . they are packed in hard capsules as they contain a white powder and are marked with the product code " gp44 " on the body 
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by blocking receptors in the brain to which dopamine and serotonin belong . these receptors have been shown to have calming effects and relieving aggressive behaviour . the most commonly reported acute symptoms are mild - to - moderate agitation . in patients with schizophrenia or bipolar disorder , diseases characterised by symptoms such as schizophrenia ( hearing , seeing or sensing things which are not there ), mistaken beliefs , incoherent speech and behaviour and emotional flatness . people with this condition may also feel depressed , guilty , anxious or tense , and may also experience feelings of sadness , jealousy , aggression , irritable feelings , depression , suicidal thoughts , aggressive behaviour and apathy 
do not take adasuve : - if you are allergic to loxapine or amoxapene . symptoms include wheezing and shortness of breath . these may be signs of lung problems like asthma or chronic obstructive pulmonary disease ( copd ). this can lead to narrowing of the airways ( bronchospasm ). wheeze , cough , chest tightness , or shortnessof breath 25 . this can be a sign of neuroleptic malignant syndrome ( nms ). it is a condition that can occur when you start taking antipsychotic medicines . you should be aware of the early signs of these symptoms . high fever associated with rigid muscles and stiff muscles may occur during exercise and for a short time after beginning treatment . your doctor will tell you how to treat these conditions . other medicines and
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 9 . 1 mg for each kg of body weight . your doctor may increase your dose to 2 4 . 5 mg for every kg you weigh . depending on your condition , your doctor will tell you how much adasuve you should take . wash your hand before you go to bed . do not put the device near your mouth . if the device is not working properly , you may experience one or more of the following symptoms : extreme tiredness , sleepiness , trouble breathing , low blood pressure , throat irritation , a bad taste in the mouth , muscle or eye movements that do not go away . contact your doctor immediately if these effects occur . take the medicine pack with you , so that it is clear to see what
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor or nurse straight away if you notice any breathing symptoms ( e . g . wheezing , cough , shortness of breath , chest tightness or irritating ) while you are taking adasuve . these may be signs of a problem with your airways such as asthma or copd . light - headedness or fainting may occur as a result of your blood pressure getting worse . worsening agitation , confusion , fever , muscle stiffness . this may be a sign for a severe condition called " neuroleptic malignant syndrome ". other side effects include : very common ( may affect more than 1 in 10 people ): - numbness , tingling or burning sensation of the lips , tongue or
keep out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep an open or torn pouch in order to protect from light . accidental ingestion can cause physical damage .
what adasuve contains - the active substance is loxapine . each single - dose inhaler delivers 5 micrograms of loxalpine which delivers 4 . 5 microgramms of the active ingredient , delivering a total of 240 mg / ml . this corresponds to an inhalation dose of 3 . 8 microgram of the drug , which is delivered in the form of a single dose . if you are not sure , talk to your doctor , pharmacist or nurse about how to take your next dose at the end of this package leaflet ( see section 2 ) for more information about the dose you should be taking , including information on the other side of this leaflet , for example : - your doctor or nurse will show you how to use this in - person - you will need to use adesuve
the active substance in azacitidine betapharm is an anti - cancer agent . it belongs to a group of medicines called ' long - acting drugs '. the active ingredient in this medicine is called zautidine ( s )- tiagoid . sctfr is made up of two active substances , one of which belongs to the group of substances called cytokines , and the other beings that are involved in the growth and spread of cancer cells . the other ingredient in the medicine is azacitabine betaphar is azotidine , which is used to treat adult patients who are not able to have a stem cell transplantation to treat adults with higher - risk myelodysplastic syndromes ( mds ). it is also used in adult patients with certain conditions , including patients with chronic mye
do not take azacitidine betapharm : - if you are allergic to azaсitidine or any of the other ingredients of this medicine ( listed in section 6 ). - in patients with advanced liver cancer . warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment with azacitabetapharm there have been decreased counts of platelets , red or white blood cells in the blood , and kidney disease have liver disease have or have had a heart condition , heart attack or lung disease . blood test your doctor will do blood tests before you start and regularly during treatment . your doctor may decide to reduce the dose . you will be monitored closely for a short period of time , during or after treatment , until you have reached a ' cycle '. this is to check that you have enough blood cells and that your liver and kidneys are working properly
before giving you azacitidine betapharm , your doctor may give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor will decide your dose of this medicine , depending on your general condition , height and weight . you will be given a total of 3 treatment cycles of this " treatment cycle " consisting of 4 weeks , followed by 6 weeks without treatment . this medicine is normally given by injection under the skin ( subcutaneously ) by a doctor or nurse . it may be given under your skin on your thigh , tummy or upper arm . if you have any further questions on the use of this product , ask your doctor .
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting and reduced appetite . confusion , restlessness , fatigue and symptoms generally go away within a few days . not known : frequency cannot be estimated from the available data . if any of these occur , tell your doctor or pharmacist . your doctor may decide to reduce your dose of azacitidine betapharm or stop taking this medicine and see a doctor as soon as possible . side effects may include : common : may affect up to 1 in 10
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the carton and the vial label after exp . this medicine does not require any special temperature storage conditions . if you have any further questions on the use of this medicine , ask your pharmacist or nurse . the suspension should be administered within 45 minutes after it has been dissolved in water for injections . once the suspension has been prepared it should be used within 8 hours . however , if this is not possible it must be stored in a refrigerator at 2 - 8 , but in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 8 hours at room temperature ( 20 - 25 ). the suspension must not be put back in the refrigerator . after preparation , the reconstituted product must be used
what azacitidine betapharm contains - the active substance in each vial is acetate . one vial contains 100 mg dna . if you are not sure , talk to your pharmacist or nurse . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg pfu ( 0 . 25 % w / v ). a hospital pharmacist is also responsible for preparing the suspension . the other ingredient in the medicine are mannitol ( e421 ). what zacitine betaphar looks like and contents of the pack azacitabetapharm is supplied as a white to off - white powder for suspension for injection in a glass vial containing 100 mg of aza citidine . it is available in packs containing one or three vials .
the active substance in cerdelga is eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults , adolescents and children of all ages . gaucher diseases type 1 is a rare , inherited condition in which a substance called glucosylceramide builds up in the cells of your body . this happens through the spleen , liver and bones of your affected organs . by blocking this substance , you can help eat better your body use its own cells and this medicine . you should keep using this medicine for as long as prescribed by your doctor , but only for a short period of time , because it may cause slow speed or poor metabolisers to become dehydrated . your doctor will recommend the best course of cerdesga based on a simple laboratory test . if you are given more 
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking medicines containing moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ) 31 - when taking moderate cyst3a inhibitors , such as erythromycin , itraconazole . these medicines reduce your body ' s ability to break down and digest the medicine . do not give this medicine to children under the age of 18 years because it may reduce your ability to do normal daily activities . your doctor may want to change your dose , and you may need to take it more often . you should tell your doctor or pharmacist if any of these apply to you .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many tablets of metaboliser to take . the recommended dose is one tablet a day . - take a tablet at the same time each day , preferably in the morning , and in the evening . this will help you remember to take the tablet . you can take cerdelga with or without food . swallow the tablet with a glass of water . do not chew , crush or break the tablet as it may affect the way the tablet is absorbed into the blood stream . how to take take the tablets : - open the sleeve with your thumb and finger . push the tablet through the blister / wallet to release the tablet ( see ' steps ' below ). - do not push the button
like all medicines , this medicine can cause side effects , although not everybody gets them . common : may affect up to 1 in 10 people headache , dizziness , change in taste ( dysgeusia ), palpitations , throat irritation , heartburn ( dyspepsias ), feeling sick ( nausea ), diarrhoea constipation , abdominal pain , stomach ache ( upper abdomen pain ), acid reflux disease ( gastrooesophageal reflux disease ), bloating ( abdominal distension ), inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( diarrhea ), stomach discomfort , indigestion , high blood sugar ( hypoglycaemia ), weight gain , low blood sugar . not known ( frequency cannot be estimated from the available data ) low blood pressure , fainting , feeling of weakness
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and sleeve after exp . cerdelga is for single use only . store in a refrigerator ( 2 8 ). do not freeze . keep the blister in the outer carton in order to protect from light .
what cerdelga contains - the active substance is eliglustat . each hard capsule contains 84 mg / 0 . 5 ml solution for injection , corresponding to a concentration of 84 gbq at the date and time of calibration . the other ingredients are microcrystalline cellulose ( e460 ), lactose monohydrate ( see section 2 ' important information about some of the ingredients of cerdesga '), hypromellose , and glycerol dibehenate . capsule shell : gelatin , potassium aluminium silicate , titanium dioxide , yellow iron oxide and indigotine . printing ink : shellac , black iron oxide , propylene glycol and ammonia solution in black ink on the cap of the bottle . not all pack sizes may be 
what zoledronic acid hospira is and how it works - the active substance in zoleric acid hydrochloric acid is a substance that belongs to a group of substances called bisphosphonates . - zolezonic acid works by attaching itself to the bone and slowing down the rate of bone change . it is used : - to prevent bone complications , e. g . fractures , in adult patients with bone metastases ( spread of cancer from primary site in the bone ). what is calcium - related to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased . this condition is known as tumour - driven hypercalcaemia ( tih ).
follow carefully all instructions given to you by your doctor . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . you should not be given zolzolicaci acid spira : - if you are allergic ( hypersensitive ) to one of the active substances or another bisphosphonate ( group i ) ( see section 6 ). if this applies to you , tell your doctor and may change your dose . he or she may need to give you a lower dose , or to stop treatment at any time while you are being treated . warnings and precautions talk to your doctor or dentist before you are given this medicine if : you have or have had a kidney problem ( for example , pain , swelling or numbness of the jaw , a feeling
- zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously , i . e . through a vein , (' iv ' administration ). - your doctor will recommend that you drink enough water before each treatment to help prevent dehydration . carefully follow all the other instructions given to you by your doctor , pharmacist or nurse . you should not receive more than one infusion ( 4 ml ) once a week . there is no information on the use of infusion in children below 4 years of age . people with a kidney problem your doctor may decide to give you a lower dose if your kidney problem is not well controlled . how zolledronic acids are given if you are being treated for the prevention of bone complications due to bone metastases , you will be given
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common ones are usually mild and will probably disappear after a short time . tell your doctor about any of the following serious side effects straight away : common ( may affect up to 1 in 10 people ): - severe kidney impairment ( will normally be determined by your doctor with certain specific blood tests ). - low level of calcium in the blood . uncommon : may affect less than 1 in 100 people - pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth or jaw discharge - numbness or a feeling of heaviness in the jaw or loosening of a tooth . these could be signs of bone damage in the jaw ( osteonecrosis ). tell your dentist immediately
keep out of the reach and sight of children . do not use zoledronic acid hospira after the expiry date which is stated on the carton and blister after exp . store in the original package . this medicine does not require any special storage conditions . if you have any unwanted tablets , do not throw them away . ask your pharmacist how to throw away tablets you no longer use . these measures will help protect the environment .
what zoledronic acid hospira contains - the active substance in each ml of concentrate is called zoledronic . one vial contains : - 4 mg zolezeric acid ( as monohydrate ). - 3mg : the other ingredients are mannitol , sodium citrate , water for injections , and in a vial ' s syringe '. what azoledronica acid spira looks like and contents of the pack zolzolezic acid is supplied as a liquid concentrate for solution for infusion , which is a clear , colourless to slightly yellow , sterile concentrate . each pack contains 4 vials of concentrate , with a desiccant to reduce moisture in the air .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) when having cancer treatment chemotherapy ( chemotherapy destroys nerve cells that communicate with the brain ). this reduces the amount of food that people eat , and makes them less able to stay asleep . when this happens , people get sick ( being sick ) more easily than they should . how varubies works when chemotherapy affects these nerve cells , which can cause nausea and vomiting .
do not take varuby : - if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). this medicine is an herbal medicine containing st john ' s wort ( hypericum performatum ) which is used to treat depression and difficulty sleeping ( see section 2 , " how to take this medicine "). warnings and precautions 27 talk to your doctor , pharmacist or nurse before and during treatment : 27 - in case you have severe liver or kidney problems or are taking certain medicines called rifampicin to treat tuberculosis and other infections , or carbamazepine to treat epilepsy and to prevent nerve pain , phenobarbital to help you sleep and / or relieve nerve pain ( e . g ., enzalutamide ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much varuby to take the recommended dose is one 180 mg tablet once a day . you can take it with or without food . the dose may be adjusted by your doctor by up to 90 mg depending on how you respond to the medicine . take the tablet at least 2 hours before or 2 hours after your chemotherapy cycle . during chemotherapy , you may experience sickness , which can be very serious . it is very important that you continue with this medicine until your doctor tells you otherwise . do not stop chemotherapy unless you are feeling sick or being sick after chemotherapy . your doctor will tell you how long you should keep taking this medicine , and how long your treatment will last . to help you remember when to go back to your normal schedule , take your tablets at the same time each day 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : rare side effects ( may affect up to 1 in 1 , 000 people ) if you experience symptoms of an allergic reaction such as sudden shortness of breath , swelling of the lips or tongue , change in taste or swelling of skin or tissue , sudden rash , fever and faster heartbeats , stop taking varuby and seek medical advice immediately . your doctor will decide if appropriate treatment is needed . other side effects include : common : may affect more than 1 in 10 people headache , constipation , feeling tired . uncommon : if any of the side effects gets serious , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg / 0 . 5 milligrams / 180 milliliters of rolulapitant ( as mesilate ).  the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' variosat containing lactoses '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . printing ink : shellac , red , 100 mg tablets marked with ' v100 ' on one side and '
what enerzair breezhaler contains - the active substances are indacaterol , glycopyrronium - mometasone furoate indabacaterol and glycopyrurium belong to a group of medicines called bronchodilators . they work in different ways to relax the muscles of the small airways in the lungs . this helps to open the airways , making it easier for air to get in and out . when the medicine is taken regularly , it helps the smaller airways to remain open for longer . that means it can help open more airy airways and help you breathe more easily throughout the day . it also helps to reduce the number of puffs that you take in the evening and evening hours . the combination of two active substances , indigo carmine ( a type of steroids ) and corticosteroids helps
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor and do not take the tablets . warnings and precautions talk to your doctor , pharmacist or nurse before you are given any of these medicines . you may be allergic to the active substances . do not open the vials after you have been given . take special care with enzerzair be aware of the following : heart problems , including an irregular or fast heartbeat . thyroid gland problems . diabetes , which can cause high blood sugar . seizures . severe kidney problems ( see section 4 ). severe liver problems : low level of potassium in your blood .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much enerzair breezhaler to use the usual dose is to inhale the content of one capsule each day . it does not matter at what time of the day you use the medicine . you only need to use it once a day because your asthma is getting worse . your symptoms will be controlled by your doctor . if necessary , your doctor may tell you to use an inhaler and capsules for inhalation use . this will help to get the best results for your health . in this pack , the capsules will be stored in a safe place to protect them from moisture . the inhaled dose will only be used when the medicine has been fully absorbed . do not swallow any capsules that are open or close to the capsule .
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious stop using enerzair breezhaler and get medical help immediately if you have any of the following : common ( may affect up to 1 in 10 people ) difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other possible side effects include the following listed below . very common : may affect more than 1 in every 10 people sore throat or runny nose , sudden difficulty breathing and feeling of tightness in the chest , feeling of restlessness or a general feeling of being unwell . not known : frequency cannot be estimated from the available data . if any of these side effects causes you problems , talk to your doctor or pharmacist 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ) and mometasone furoate . each delivered dose ( the dose leaving the mouthpiece of the inhaler ) contains 150 micrograms ( mg ) of indecaterol( as ace ), 63 microgram( ml )) of galactomyelitis , corresponding to 50 microgram ( i . e .) of carbapril ( a ) per dose , equivalent to 160 microgram [ 1 - 0 . 5 mg ] ( 1 , 2 - 10 mg ), equivalent to 5 - 5 microgram / dose ( correspondingly to 134 microgram in the form of glucose ). the other ingredient is
the active ingredient clopidogrel belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood obstructs ( thrombosis ). if you have not been properly hydrated your doctor may or may not have been prescribed clopi grel acino pharma gmbh to help prevent blood clits (" thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombosesis . this can lead to atherathrombotic events ( such as stroke , heart attack , or death ).
do not take clopidogrel acino pharma gmbh : - if you are allergic ( hypersensitive ) to the active substance or to any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and whilst you are taking , or during treatment , if : you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . you have severe liver disease . if any of these apply to you , your doctor may need to give you another medicine before and while you are being treated , as there is insufficient experience with the use , the effects and benefits of clopgrel ambh in patients on a similar way . children and adolescents the safety and efficacy have not been established in this age group .
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg film - coated tablet per day to be taken orally with or without food , and at the same time each day ( for example , one tablet containing two or three tablespoons of water ). you should swallow the tablets with a glass of water and do not chew or break the tablets before swallowing . it is important that you take all the tablets as prescribed by your doctor and that you receive the full recommended dose . do not exceed the prescribed dose , unless your doctor tells you to do so . your doctor will tell you how long you should continue with your treatment and whether to continue with the diet and lifestyle of your child ' s doctor , pharmacist or nurse . 
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common in 10 people 100 uncommon in 10 users in 1 , 000 rare in 10 000 very rare in very rare cases very rare if you get any side effects you should contact your doctor immediately : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and whites of the eyes ( jaundice ). not known ( frequency cannot be estimated from the available data ): dizziness , headache , diarrhoea , vomiting , nausea , pain in the abdomen ,
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton , blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains - the active substance is clopizid . each tablet contains 75 mg of cpr - containing : - tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating ; macrogol 6 - 6 ethylcellulose ( f462 ) titanium dioxide (  e 171 ) what the tablet looks like and contents of the pack the tablet is white to off - white , marbled , round and biconvex . it is available in cardboard cartons containing 14 , 28 , 30 , 50 , 84 , 90 and 100 tablets . not all pack sizes may be marketed .
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults . it belongs to a group of medicines called ' antiretroviral medicines '. it contains two active substances : doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) and lamivudine , which is a nuclear medicine (' natalgi - 2b '), a nucleolarized analogue reverse transcriptor ( rtis ) in the blood . tenofovir disoproxil , another aminostyrene - related anti - hiv - tetanus ( ' nutr - 1 - alfa - 3b ) inhibitor , and 
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil , or any of the other ingredients of this medicine listed in section 6 . if your doctor or pharmacist prescribes you the following medicines : carbamazepine / oxcarbazepine or phenobarbital - phenytoin ( medicines to prevent seizure ) rifampicin - the active substances are st john ' s wort ( hypericum perforatum ), a herbal remedy for depression and anxiety , and products that contain mitotindopa . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you are being treated with a medicine to prevent
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much delstrigo to take the recommended dose is a complete regimen . a single tablet should be taken to treat hiv infection at least 1 hour before you start taking certain medicines , such as doravirine ( a group of medicines that can affect your immune system ). taking this medicine swallow the tablet whole with water . do not crush or chew the tablet . this medicine can be taken with or without food . take the tablet at the same time each day to help you remember to take it . your doctor will tell you how long you should continue to take this medication . you should keep to your doctor ' s advice on how long your treatment will last . it is very important that you continue with your treatment on a regular basis ; if and when you need to
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor straight away if you notice any of the following : common ( may affect up to 1 in 10 people ) abnormal dreams , difficulty in sleeping ( insomnia ), headache , dizziness , sleepiness , cough , nasal symptoms feeling sick ( nausea ), diarrhoea , stomach pain , vomiting , wind ( flatulence ), hair loss , rash muscle symptoms ( pain or stiffness ) feeling tired ( somnolence ) not known ( frequency cannot be estimated from the available data ) allergic reactions ( e . g . swelling of the face , lips , mouth , tongue or throat ) rash joint pain ( arthralgia ) joint pain muscle spasms , back pain 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . this medicine does not require any special temperature storage conditions . keep the bottle tightly closed in order to protect from moisture . delstrigo is for single use only . once the bottle has been opened , the contents should be used immediately .
what delstrigo contains - each tablet contains 100 mg doravirine , 300 mg lamivudine , 245 mg tenofovir disoproxil ( as fumarate ) - the other ingredients are : tablet core : croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate ( e470b ), microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fum arate in the core of the film - coating material : carnauba wax e903 - printing ink : shellac , iron oxide yellow , lactose monohydrate , titanium dioxide e171 , triacetin . - pack size : 776 film 
spravato contains the active substance esketamine . this belongs to a group of medicines called anti - depressants . you have been given this medicine to treat your depression . it is used to treat the symptoms of depression , which include feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities , feeling of being slowed down , and more often when you are taking another antidepressant . see section 2 , " how to take ". it helps to keep you alert to the signs and symptoms of a mood swing ( mood swings ).
do not use spravato - if you are allergic to esketamine ( the active substance in ketamine ) or any of the other ingredients of this medicine ( listed in section 6 ). - when you have an aneurysm ( a weak spot on a blood vessel wall that bulges out ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : - you have recently had a heart attack within 6 weeks or a temporary increase in blood pressure . this may increase the risk of serious complications in these conditions . if any of these apply to you , you should not be treated with this medicine and tell your doctor before using it . your doctor may need to adjust your dose , if necessary , because you may be at a higher risk of developing , or even fatal , problems with your blood flow
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the spravato nasal spray should be used with the nasal spray device provided in the pack . the recommended dose is 1 spray ( 2 sprays ) once a day . there are 3 nasal spray devices available . each time you use a nasal spray , you can use it for up to 4 sprays ( 4 spray devices ). there is no need to use more than one nasal spray in the morning and evening . use in children and adolescents 4 years of age and older your doctor will tell you how many sprays you should use . your doctor may tell you to use it more often than every 2 weeks . taking this medicine you may experience nausea and vomiting ( see section 2 of this leaflet ). if this happens , treatment should be continued for at least 30 minutes
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : very common ( may affect more than 1 in 10 people ) feeling disconnected from feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity in your mouth area spinning sensation vertigo vomiting nausea common : may affect up to 1 in every 10 people feeling extremely happy , euphoria , feeling agitated , not feeling irritable , lack of energy , difficulty sleeping , dizziness , sleepiness , increased or decreased sense of touch or sensation in the mouth area , spinning sensation when you stand up or sitting up , stomach ache , constipation , flatulence , wind , dry mouth , fast heartbeat , low blood sugar , high blood sugar ( sugar 
what spravato contains - the active substance is esketamine . each nasal spray device delivers a single dose ( 0 . 5 ml ) of esesketamine hydrochloride , delivering a total of 28 mg egesketamine ( as mesilate ).  the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections . see section 2 ( for more information about some of the ingredients in this medicine ): this medicine is supplied as a nasal spray solution for injection . this medicine contains a clear , colourless solution and is available in a pack containing one single - use nasal spray unit , each vial containing 1 , 2 , 3 , or 6 nasal spray devices , in separate cartons , with
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat adults with melanoma that has spread to other parts of the body or cannot be removed by surgery if you have cancer that has a change ( mutation ) in a gene called ' melanoma ' ( mrc - mc ) gene that has been altered by a protein in the human genome called cd38 . zelmoraf targets proteins that are involved in the md38 protein and slows down the progression of your cancer .
do not take zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash , and fainting sensation . warnings and precautions talk to your doctor , pharmacist , or nurse before taking any of zeloraf ( see section 4 ). allergic reactions are rare . allergic reactions occur more often in patients treated with zelbaf than in adults . if any of these apply to you , tell your doctor or pharmacist straight away . you should be aware of the early signs and symptoms of an allergic reaction , such as : - swelling ofthe face - lips or tongue ( with difficulty breathing or rash and / or fainting sense ) or severe skin reactions (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is 4 capsules taken twice a day ( for example , 8 capsules with food ). the dose may be increased or decreased depending on how you respond to the medicine ( see section 4 , " possible side effects "). your doctor may decide to temporarily stop your treatment with zelboraf , if necessary , to reduce the risk of vomiting . swallow the capsule whole with water . do not chew , crush or split the capsules before swallowing . if possible , take your capsules at least 4 hours before or at least 8 hours after food . you may find it easier to take it at the same time each day . this will help you to remember when to take your dose . your doctor will tell you how long you should continue your
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions may occur , including swelling of the face , lips or tongue , difficulty breathing rash fainting sensation has been reported in some patients treated with zeloraf in combination with radiation treatment . for more information , see the box at the end of this leaflet . side effects related to radiation may occur during or after zelbaf treatment if you are exposed to radiation from the skin , isophagus , bladder , liver , rectal , and lungs . contact your doctor immediately . you may experience one or more of the following symptoms : skin rash , blistering , peeling or discoloration of the skin shortness of breath a cancer of the central nervous system ( cns ). tell your doctor as soon as possible if
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after exp . this medicine does not require any special storage conditions . if you have any unwanted tablets , do not throw them away . ask your pharmacist how to throw away tablets you no longer use . these measures will help to protect the environment .
what zelboraf contains - the active substance is vemurafenib . - each film - coated tablet contains 240 mg / 0 . 5 ml reconstituted extractable tablet ( corresponding to a co - precipitate of vemorafeniab ). the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium ( e468 ), hydroxypropyl cellulose , and magnesium stearate film coating : iron oxide red , macrogol 3350 , polyvinyl alcohol ( partially hydrolysed ) talc and titanium dioxide , all in the tablet core of a carnauba wax and white alcohol ink . what zeboraffe looks like and contents of
duoplavin contains two active substances : clopidogrel and acetylsalicylic acid ( asa ) which belong to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , it helps to prevent blood vessels from forming . antiplatelets medicinal products reduce the chances of blood  clots forming ( atherothrombosis ) in adults and children . the combination of two active ingredients , climax , reduces the risk of atherosclerotic events ( events that can be life - threatening , such as stroke , heart attack , or death ). you should continue to take duaplavin until your doctor tells you otherwise . your doctor will prescribe duo
do not take duoplavin : - if you are allergic to clopidogrel , acetylsalicylic acid ( asa ) or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic to other products , including non- steroidal anti - inflammation products . warnings and precautions talk to your doctor , pharmacist , or nurse before taking any of your medicines . painful and / or inflammatory conditions of muscles or joints have been reported in patients treated with a medical condition such as asthma , nasal discharge , runny nose , polyps ( type of growth ) in or around the nose if : you have or are currently a patient having bleeding such as a stomach ulcer or bleeding within the brain , severe or severe allergic reaction . your doctor may decide to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of duoplavin is one tablet a day . swallow the tablet whole , with some water . you can take the tablet with or without food . try to take your medicine at the same time each day to help you remember to take it . it does not matter whether you take it for one or two days , but taking it with a meal may help prevent a heart attack . if possible , take your tablet with you and talk to your doctor , pharmacist , or your nearest hospital emergency department because of the increased risk of bleeding . keep your tablet bottle with you so that you can easily describe what you have taken , when you last took it , and how long you should keep it with you , even when you are at the hospital 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin . this may be the signs of an allergic reaction . other side effects may include : very common ( may affect more than 1 in 10 people ): diarrhoea , vomiting , nausea , constipation , dizziness 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 25 . this medicine does not require any special temperature storage conditions . tell your pharmacist if you notice any visible sign of deterioration after administration or if the solution is not clear . these measures will help to protect the environment .
what duoplavin contains the active substance in each 75 mg film - coated tablet is 75 mg . the other ingredients are : 46 tablet core : clopidogrel and acetylsalicylic acid ( asa ): each tablet contains 75 milligrams / 0 . 5 millilitre ( ml ) cprp . tablet coating : co - transporter ( sb - 4 ) the active substances in the tablet core are crospovidone , oblong , biconvex , and opportunistic . each tablet also contains : two additional ingredients : one additional ingredient is : the other excipients ( in this case ), o pre - filled , homogeneous , hydrogen sulphate ) and one extra ingredient : du
simbrinza contains two active substances , brinzolamide and brimonidine tartrate in one tablet : - the active substances are brinzolami and belongs to a group of medicines known as carbonic anhydrase inhibitors . - it is inhaled into the bloodstream by a mechanism that reduces the amount of sugar in the body and leads , in some cases , to lower levels of brinmonidine saltrate in the blood , and in other compounds , such as alpha - 2 adrenergic receptor agonists , which reduce pressure within the eye . the active ingredients in simbr inza work together to lower pressure in the eyes , resulting in improved vision for adults aged 18 years and older and to prevent eye conditions such as glaucoma and ocular hypertension ( high pressure in both eyes ).
do not take simbrinza : - if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 of this leaflet ). - is allergic to sulphonamides , medicines used to treat diabetes or infections , or diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors ( medicines used in the treatment of depression or parkinson ' s disease ), certain antidepressants . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before you are given the medicine if : you have severe kidney problems you have too much acidity in your blood ( hyperchloraemic acidosis ) you have less than 2 years of age or older ( see section 4
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in the affected eye or eyes , once a day in the evening . do not use simbrinza in both eyes . wash your hands thoroughly . 1 2 do not remove the cap and snap collar . keep the bottle tightly closed in order to protect from moisture . after opening , the medicine should be used immediately . if needed , your doctor may need to replace the bottle . twist off the bottle cap , if it does not . snap collar is loose . hold the bottle and hold the medicine firmly , until it is time for your next regular dose . use your fingers to push the bottle down and hold it in front of your thumb and fingers . tilt your head back . pull down your lower eyelid with a clean finger
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine . if you have a reaction to the medicine ( frequency not known , cannot be estimated from the available data ), you may need to stop taking the medicine and see a doctor immediately . an allergic reaction may occur . severe skin reactions ( rash , redness and itching all over your body or eyes trouble breathing , chest pain or irregular heart beat tell your doctor immediately extreme tiredness and dizziness . side effects of simbrinza may occur with other medicines that may be used to treat brine , brine and / or brine together ( see section 2 ). you may experience a combination of two or more of the following reactions : very common side effects ( may affect more than 1 in 10 people ): diarrhoea ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . this medicinal product does not require any special storage conditions . after opening the bottle : use within 4 months to prevent infections and use a new bottle . keep the bottle tightly closed in order to protect from moisture .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of brinazoamide and 2 mg of brimoniidine tartrat equivalent to 1 . 3 mg brimondidine . the other ingredients are benzalkonium chloride ( see section 2 under ' simbr inza contains alcohol '). - particulate matter : the other ingredient ( excipients ) are : propylene glycol , carbomer 974p , boric acid , mannitol ( e421 ), sodium chloride and tyloxapol ( containing hydrochloric acid and sodium hydroxide ) and purified . - in the solvent : purified solution : water for injections . not all pack sizes may be marketed .
what filgrastim ratiopharm is and how it works filgrastastim is a protein produced in bacteria called escherichia coli by recombinant dna technology . it belongs to a group of proteins called cytokines and is similar to , or less similar , a natural protein ( granulocyte - colony stimulating factor [ g - csf ]) produced naturally in the body by biotechnology , so it is produced by the bone marrow . this results in the production of new blood cells and more blood cells called white cells . white cells are important as they help your body fight infection . your doctor will tell you how long you will need to keep getting them . if you don ' t have enough white blood cells , your body may not be able to handle them well enough . you may need
do not use filgrastim ratiopharm : - if you are allergic ( hypersensitive ) to mattinase or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given filgrastort . you should tell your doctor immediately if : you experience a cough , fever and difficulty breathing . this may be a sign of a pulmonary disorder . your doctor may want to monitor you more closely , as you may have side effects . - you have sickle cell disease 57 you get left upper abdominal pain or pain at the tip of your shoulder . it may be due to the spleen disorder ( see section " possible side effects "). you will have to have regular blood tests while you are being treated with filgraştim ratioopharm to check the number of
always use filgrastim ratiopharm exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . your doctor will tell you exactly how many tablets to use . do not use more than the recommended dose and take the tablets at the same time each day . it is very important that you do not break or chew the tablets before you use them . keep in touch with your family and friends to make sure that you don ' t miss any doses . when you first start using filgrasestim ratioopharm , your doctor may tell you to take your tablets at any time during this time . the usual dose of filgratim ratiophenpharm for chemotherapy is 0 . 5 million iu per kg of body weight . this will usually be given to you in the morning and evening . however , in some disease types your treatment may last up to 14
do not use filgrastim ratiopharm if you have sickle cell disease . 57 tell your doctor right away if : you get left upper abdominal pain or pain at the tip of your shoulder . this may be a sign of a spleen disorder . see section 4 . possible side effects your doctor will do regular blood tests while you are taking filgrasestim ratioppharm to check the number of neutrophils ( a type of white blood cells ) in your blood . your doctor may decide to reduce the dose , interrupt , or completely stop treatment . children and adolescents there is no information on the use of this medicine in children below the age of 18 years . other medicines and filgraştim ratiophanphan children there is limited experience of using other medicines , including medicines obtained without a prescription . pregnancy and breast - feeding ask your doctor or pharmacist for advice before taking
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the blister in the outer carton in order to protect from light . from a microbiological point of view the product must not be used if the solution is cloudy or if it contains visible particles . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgrasestim . one ml of concentrate for solution for infusion contains 60 million international units [ miu ] ( 600 microgram ) of filgraskastim - each vial contains 30 miu in 0 . 5 millilitres , corresponding to 30 micrograms / kg . if you have the impression that the effect of this medicine is too strong or too weak , talk to your doctor or pharmacist . the alternative formulation consists of a suspension for injection or infusion , which may contain up to 48 hours in a vial , and in which case a maximum of 48 hours has been produced . when diluted , each milliliter contains 48 microgram( s ) [ 1 . 8 million iu ], the other ingredients are : sodium hydroxide
what riluzole zentiva is and why it is important ? the active substance in this medicine is called rizole which belongs to a group of substances called the nervous system . how rilsuzola zetiva works the body makes too much glutamate ( a chemical messenger ) in the brain and spinal cord . by blocking this substance , it allows the nerve cells to function normally . this results in weakness , muscle waste and paralysis . the destruction of nerve cells in motor neurone disease may occur if there is not enough left in the body . it is also used to treat patients who have not been previously treated for their disease . patients who are at risk of too much galutamate ( an indicator of how well the nerve works ). it is thought to work by reducing the amount of glutamates that is released from the nervous cells .
do not take riluzole zentiva : - if you are allergic to rilsule or any of the other ingredients of this medicine ( listed in section 6 ). - in case you have any liver disease or increased blood levels of some enzymes of the liver ( transaminases ). warnings and precautions talk to your doctor , pharmacist , or pregnant woman before you are given this medicine . you should tell your doctor immediately if : you have or have had any liver problems such as yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick , problems with your kidneys , fever . this may be a sign of a low number of white blood cells , which may increase the risk of infection . children and adolescents do not give this medicine to children under 18 years of age because there
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day by mouth . take the tablet about 12 hours before or after you have taken riluzole zentiva . you can take the tablets with or without food , and at any time of the day . if necessary , your doctor may tell you to take a different dose , for example , one tablet in the morning and one in the evening , at the same time every day , until you have settled settled on the right dose . it is important that you take all three tablets with some water and in the same place every day until your doctor agrees that the correct dose has been reached and has been agreed with the doctor , pharmacist , or your nearest hospital emergency department for advice . keep the tablet bottle with you so that you
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever ( increase in temperature ). riluzole zentiva may cause a decrease in the number of white blood cells . your doctor will take a blood sample to check the numbers of whiteblood cells and if necessary , to help prevent infections . - tell your doctor and do not take any more . you may experience the following symptoms : yellowing of your skin and the whites of your eyes ( jaundice ), itching , feeling sick or being sick , as this may be a sign of liver disease ( hepatitis ). you will have to take regular blood tests before and during treatment with a reputed firm grip on the tablet . cough , difficulties in breathing , wheezing , cough
what riluzole zentiva contains - the active substance is ribasic calcium phosphate ( e339 )- the other ingredients are : micro crystalline cellulose , anhydrous colloidal silica , magnesium stearate , croscarmellose sodium ; hypromellose , macrogol 6000 , titanium dioxide , etc . ( see section 2 ). what silate tablets look like and contents of the pack the tablets are white to off - white , biconvex , round tablets debossed with ' r 50 ' on one side and plain on the other side . the tablet can be divided into two equal doses . slide tablets of 202 mm in diameter , and are provided in a carton containing one or two glass syringe
emgality contains the active substance galcanezumab , a medicine that blocks the activity of the calcitonin gene associated with migraine ( cgrp ). it is used to treat migraine in adults who have at least 4 migraines per month and who also have migraines at some time during their lives . a combination of two active substances has been shown to reduce the frequency of migraine headache in adults . it also helps to improve your quality of life .
do not use emgality : - if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before using this medicine , if : you have a serious cardiovascular disease . you have serious cardiovascular diseases . your doctor may need to change your dose . allergic reactions EMgality can cause serious allergic reactions and some of these reactions may progress to severe levels , some of which may be life threatening ( see section 4 . possible side effects ). you must look out for signs of such signs and conditions carefully read the package leaflet of the medicine carefully . children and adolescents do not give this medicine to children or adolescents under the age of 18 years because it has not been studied in this age group . other medicines and emegality tell your doctor or
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of emgality is one 240 mg subcutaneous injection once a week . you should inject a total of two 480 mg injections ( 0 . 5 ml ) each day . your doctor will tell you exactly how many injections you need to receive . after proper training , your doctor may decide to give you a lower dose . if your doctor thinks a higher dose is needed , he / she will advise you how much to inject . use in children and adolescents your doctor , nurse or pharmacist will show you how to inject yourself . do not use more than the prescribed dose , or if someone else uses your medicine , talk to a doctor or go to hospital . take the medicine pack with you 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality are rare ( may affect up to 1 in 1 , 000 people ). tell your doctor straight away if you notice any of the following : - rash or itching . these are signs of serious allergic reactions . they may be life threatening . - difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin or a red rash with raised bumps . other side effects very common side effects these may affect more than 1 in 10 people : reactions at injection site or injection site . not known ( frequency cannot be estimated from the available data ): injection site reaction . reporting of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after dilution , if not used immediately , storage times and conditions before use are the responsibility of your doctor , pharmacist or nurse and would normally not be longer than 7 days at room temperature ( 20 - 25 ) for a single period of up to 30 days in which the product should be used or discarded . this medicine should be disposed of in accordance with local requirements .
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcanab in 1 ml solution ( corresponding to a concentration of 1 iu / millilitre ).  the other ingredients ( excipients ) are l - histidine ( e331 ), l- histhidine hydrochloride monohydrate , polysorbate 80 , sodium chloride , and water for injections . what hemagality looks like and contents of the pack egality is presented as a solution for injection in a clear glass syringe . the solution is colourless to slightly yellow and clear to opalescent and colourless or pale yellow . not all pack sizes may be marketed in your country . your doctor , pharmacist or nurse will
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hvvd ) in adults , in which the blood vessels in the liver become damaged and blocked by blood clots . this condition requires the use of medicines prior to a stem cell transplantation in order to destroy the damaged cells of the body ' s immune system . by replacing these damaged cells , defotide can be removed from blood vessels and help to prevent the blood coagulation . you will be given this medicine if you have any questions about your condition .
do not use defitelio - if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) or to other medicines used to prevent blood clots ( e . g . tissue plasminogen activator warnings and precautions ). this is a type of medicine used in the treatment of bleeding . in severe cases of heavy bleeding , you may need a blood transfusion ( for example after surgery ), or problems with blood circulation or with a constant blood pressure . please tell your doctor if any of these apply to you . children and adolescents do not give this medicine to children under the age of 1 year . other medicines or medicines that help to prevent or reduce bleeding : acetylsalicylic acid , heparins , warfarin , dabigatran ,
the treatment with defitelio will be started by a doctor who is experienced in stem cells transplantation . it will be given to you into one of your veins ( called an ' intravenous infusion ' or drip ). this treatment will take about 21 minutes . your doctor will decide how many treatments you need . if your symptoms return however , your doctor may lower your dose . use in children and adolescents children and teenagers under 18 years of age should not be given . before you are given defitelfio , tell your doctor or nurse if you are concerned that you may have been given too much or too little . do not take a double dose to make up for a forgotten dose , just take the next dose at the usual time . this is because it is very important that you do not miss a dose of this medicine , even if there is still some
like all medicines , defitelio can cause side effects , although not everybody gets them . some of these side effects may be serious and need medical attention . if any of these effects occur , they should be treated immediately . very common ( may affect more than 1 in 10 people ): low blood pressure . common : may affect up to 1 in10 people : bleeding in general bleeding including the nose bleeding , the brain bleeding and the gut vomiting blood bleeding in the lungs bleeding from blood in the urine , from the mouth bleeding from the skin coagulopathy ( disturbance in blood clotting ) not known ( frequency cannot be estimated from the available data ). if you get any of the side effects above , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in append
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the infusion storage in order to protect from light . after dilution , if not used immediately , storage times and conditions prior to use are the responsibility of your doctor , pharmacist or nurse and would normally not be longer than 24 hours at 2 to 8 oc , but should not be used if the solution is cloudy or if it contains particulate matter . any unused product should be thrown away in accordance with local requirements .
what defitelio contains - the active substance is defibrotide . each 2 . 5 ml vial contains 200 mg of defibrotote . after dilution , each mml solution contains 80 micrograms ( 8 . 7 mg ) / 0 . 25 mmol , corresponding to 80 mg / 10 . 1 mg defibrotone .  the other ingredients are : sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ) and water for injections . see section 2 for further information on the contents of the pack . for solution for infusion : pack of 10 vials of 2.5 mg concentrate . not all pack sizes may be marketed .
daklinza contains the active ingredient daclatasvir . it is used to treat adults with hepatitis c , an infectious disease that affects the liver , caused by his / her pet ' s immune ( defence ) system . when the medicine is given to you , the immune system ( the body  s natural defence system ) will produce its own protection ( antibodies ) against the other medicines it takes for you . your doctor will discuss with you which medicines you will be taking with you to take . if you have questions about any of the above , please ask your doctor or pharmacist .
do not take daklinza - if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) or to any other medicines taken by mouth including the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( for epileptic seizures ) rifampicin / st . john ' s wort ( for treatment of tuberculosis ) dexamethasone ( a steroid used to treat allergic and inflammatory diseases ) medicines that contain the active substance known as tetanus ( see section " other medicines and dakobajosin "). do not give this medicine to children under 6 years of age because it has not been studied in this age group .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of daklinza is one 60 mg tablet once a day . do not chew , crush or split the tablet as it has a very unpleasant taste . you should swallow the tablet whole with a glass of water . your doctor may tell you to take a different tablet each day , but this will usually help you to remember to take it . when you are switching from one tablet to the other , you may need to take some other medicines while you are taking daknza . it is very important that you continue to take these medicines until your doctor tells you to stop . if your daily dose is too high or too low , talk to your doctor about how long you should continue the treatment . in some cases you may be given dakli
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is given in combination with sofosbuvir and ribavirin , the following side effects have been reported : very common ( may affect more than 1 in 10 people ) headache ; fatigue common ( will affect up to 1 in every 10 people not known ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain or joint pain aching or tender muscles not known ( frequency cannot be estimated from the available data ) side effects reported in clinical trials in combination in children and adolescents ( 12 years of age and older ): joint pain ( aching , tender muscles ) when given together when given alone , when given at the same time , in children who are taking dakinza , as in patients who are already taking both of these medicines :
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of dulbecco - alfa - bms ( as dihydrochloride ), anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate in the tablet core as well as hypromellose , titanium dioxide ( e171 ), macrogol 400 , indigo carmine aluminium lake , and yellow iron oxide , 51 , all marked with " dms 50 " on one side and " nvr " on the other side . the tablet can be divided into two equal doses . one tablet may contain " 30 mg " on either side of the tablet or " rms 60 " on
proquad is a vaccine intended to be given to prevent measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will make antibodies that can help protect you or your child from the meases , mucus , or rubella , caused by rubella or varicellina viruses , which in turn cause the antibodies to develop in the diseases caused by these viruses and so prevent them from coming back in the body after the vaccine has been given , and the effects may be longer than 12 months after the end of the programme , but the safety and efficacy benefit outweighs the risk due to the lack of a national vaccination programme ( nvr ) in individuals who are not vaccinated against the m
do not receive proquad : - if you are allergic to any varicella vaccine , to measles , mumps or rubella vaccine or any of the other ingredients of this vaccine ( listed in section 6 ) or to neomycin . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this vaccine if : you have a blood disorder ( a type of cancer that affects the immune system ) and you are receiving treatment with medications that weaken your immune system ( such as low - dose corticosteroid therapy , asthma or replacement therapy ). you have or have ever had a weakened immune system due to a disease ( including aids ), or you have congenital or hereditary immunodeficiency ( low level of immune competence ) you have active untreated tuberculosis ( aid
proquad will be given to you by your doctor or nurse . the vaccine will be injected into the muscle of the upper thigh or upper arm . it can only be given by a nurse or a doctor if the doctor has told you that it would be safe for you to come in for injections . your doctor will decide which is best for you . this will usually be in the muscle at the top of your sleeve , or in the upper arm area . if your doctor has decided that the best place for you is injected , the injection site should be chosen by your healthcare professional . you should not have a blood clotting disorder or low levels of platelets in the vaccine . however , in the case of an injection under the skin , there is an increased risk of bleeding . when a member of your family or close friend is given the vaccine it is unlikely
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . some of these reactions may be serious and may include difficulty in breathing or swallowing . if you have an allergic reaction , tell your doctor or pharmacist . other side effects of proquad may include : uncommon ( may affect up to 1 in 100 people ): seizures ( fits ) with a fever rare ( might affect up 1 in 1 , 000 people : bronchiolitis - difficulty breathing , cough , and unsteadiness with walking . the following side effects have been observed with use in children and adolescents . they are usually mild and usually go away within a few days after a dose . however , some patients may experience more than one dose at a time . very rarely , patients with hives have had these reactions and may experience difficulty in walking or breathing 
what proquad contains - the active substances are : measles virus1 ( edmonston strain ) 3 . 00 mumps virus1 - jeryl lynnTM ( level b ) strain 4 . 30 mm rubella virus2 ( strain 3 .00 mbq ) - varicella virus3 - merck strain 39 . 99 pfu / ml * produced in tissue culture by recombinant dna technology 1 produced in chick embryo cells ( fibroblasts ) ( mrc ). - powder sucrose , hydrolysed gelatin , urea , sodium chloride , and sorbitol( e420 ), monosodium glutamate and sodium phosphate and sodium bicarbonate . the other ingredients of proqua
jylamvo is an anticancer medicine that is used to prevent unwanted reactions . it is an immunosuppressive agent with an anti - inflammatory effect julylamva is used in adults for the treatment of rheumatic and skin diseases : - in adults with active Rheumatoid arthritis , or polyarthritic forms ( the joints that support rigidity ) and severe juvenile idiopathic arthritis ( jia ) in children and adolescents aged 3 years and older who have not used other forms of nsaids and who are inadequate o severe and disabling psoriasis when treatment with phototherapy ( i . e . treatment with soralen or ultraviolet a radiation ( puva ) therapy has not worked or is no longer suitable for you .
do not take jylamvo : - if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor , pharmacist , or nurse before taking the medicine if : you have a severe kidney impairment or a liver impairment you have or have had blood disorders ( e . g . bone marrow hypoplasia , leukopenia or thrombocytopenia ) or significant anaemia 34 you suffer from a weakened immune system because of a serious infection such as tuberculosis or hiv . you have ulcers in the stomach or other parts of the intestines or an inflammation of the mucous membrane of the mouth , including mouth ulcers , which have been reported with non - oncologic indications
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jylamvo can cause severe side effects or even death . your doctor will decide if the treatment should be stopped . this includes : rheumatoid arthritis , severe juvenile idiopathic arthritis ( s ) and severe psoriasis . in severe cases , your doctor may prescribe a different dose , or stop treatment , depending on how you respond to the treatment . patients with ssoriatic arthritis the recommended dose of syl amvo is a long - term treatment for several years , but it should not be used for more than one year . the doctor will discuss with you the best course of treatment for your child . there is no experience with the use of the medicine in children with adult
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you get any of the following : wheeziness or difficulty in breathing , swelling of the eyelids , face or lips , rash or itching ( especially affecting your whole body ). other side effects may include : breathing problems , feeling of illness , dry , irritating cough , shortness of breath and difficulty in breath , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the mouth , tongue or throat , coughing up blood or other signs of side effects such as : very common ( may affect more than 1 in 10 people ): diarrhoea , constipation , nausea , vomiting , stomach pain , pain in the stomach or bowel , dizziness
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and vial label after exp . store below 25 . keep the medicine tightly closed in order to protect from accidental spillage . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user . the following information is intended for the specialist only : - keep the vial in use in a refrigerator ( 2 8 ). - dispose of any unused medicine or waste material in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg methotredxate ( as mesilate ).  the other ingredients are : macrogol 400 , glycerol , orange flavour , sucralose , epidermal parahydroxybenzoate ( e218 ), sodium methyl parahydroxybenzoate( e1200 ), citric acid , tri - sodium citrate , purified water . see section 2 " important information about the contents of this medicine ". what if you use a bottle , you will find a brown glass bottle with 60 microlitres of solution , sealed with a child - resistant closure . the bottle also contains a dose - adaptor , and a white dosing syringe .
what enurev breezhaler is this medicine contains a medicine called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what Enurev braezhalers is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : - a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . by doing so , this medicine blocks the tightening of these muscles in the lungs . it makes it easier for air to get in and out of the bloodstream . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using your first dose . - patients with kidney problems - suffer from an eye problem called narrow - angle glaucoma - have difficulty passing urine . during treatment , your doctor may decide to reduce your dose , stop treatment and start treatment on your own . take the next dose at the same time as this medicine . tell your doctor immediately if : - you experience tightness of the chest , coughing , wheezing or breathlessness immediately after using the product , as these may be signs of bronchospasm ( difficulties in breathing or swallowing ), swelling of the tongue , lips or face
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much enurev breezhaler to use the usual dose is to inhale the content of one capsule each day . your doctor will tell you how many capsules to use . the recommended dose is one capsule twice a day , for at least 24 hours . use in children and adolescents do not give this medicine to children younger than 75 years of age . this medicine should be inhaled at the same time each day and this will help you to remember to use it . you will find an inhaler and capsules ( in blisters ) that contain the medicine as inhalation powder . do not swallow the capsules . if there is any capsules left in the blister , write down the name and batch number of the product on the label of the inhal
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia , which is a combination of typical symptoms , excessive thirst , hunger and frequent urination ) rash , itching , hives , difficulty breathing or swallowing , dizziness ( signs of allergic reaction ) swelling mainly of the tongue , lips , face or throat ( possible signs of angioedema ). if any of these side effects causes you problems , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyronicum brmide equivalent to 50 microgram ( 0 . 5 milligram ) of glycopronium . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram( g )) of carboxymethyl sulphonylsulfatase ( e339 ) per capsule ( corresponding to 10 microgram / ml ). the other ingredients ( excipients ) are lactose monohydrate and magnesium stearate ( see end of section 2 for further information about ingredients ). what  Enurev brezeyhaler looks like and contents of the pack enuresv breezehaler 44 mg in
the active substance in riximyo is called rituximab . this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when this happens , the cell dies . if the cell cannot be destroyed , and the bpd reaches its target , it destroys it . your doctor may give you a lower dose of riximyyo , which may be used for the treatment of several different conditions in adults . the active ingredient in the medicine is called " anti - hodgkin ' s lymphoma ". these are a disease of the lymph tissue ( part of the immune system ) that affects a certain type of black blood cell ( called b- Lymphocytes 
do not take riximyo - if you are allergic to rituximab , other proteins which are like the active substance , or any of the other ingredients of this medicine ( listed in section 6 ). you have a severe active infection at the moment you have been diagnosed with a weak immune system . you have severe heart failure or severe uncontrolled heart disease , such as granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . if any of these apply to you , tell your doctor before you are given the tablets . warnings and precautions talk to your doctor , pharmacist or nurse before and while you are being treated with this medicine if : you have ever had a hepatitis infection . your doctor may decide to keep you under closer observation whilst you are receiving
riximyo will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given a single dose ( a drip ) into a vein ( intra - venous infusion ). medicines given before each rximyon administration before it is given , your doctor will discuss with you the possible side effects that may occur . your doctor may decide to change your treatment , or not . for non - hodgkin ' s lymphoma patients who have had a need for a dose , they may be given one or more other medicines ( premedication ) to prevent or reduce side effects and reduce your dose . when your treatment is started for the first year , you will receive
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion , you may develop fever , chills and shivering . you may also experience pain at the injection site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , diarrhoea , indigestion , heartburn , pain in the abdomen , nausea , vomiting , sore throat and mouth ulcers . these side effects mostly occur with the first few days of treatment , and occasionally with the next few weeks . other side effects may include : very
what riximyo contains - the active substance is called rituximab . - each 10 ml vial contains 100 mg or 100 mg of ritsimabe ( 10 mg / 0 . 5ml ) after reconstitution with 50 mg or 500 mg ( 20 mg or 50 mg ), respectively , for administration as directed by your healthcare professional . the other ingredients are : sodium citrate , polysorbate 80 ( e433 ), sodium chloride , sodium hydroxide and hydrochloric acid ( see end of section 2 for further information on some of the ingredients in this medicine ). solvent : water for injections ( see section 2 ) this medicine is a clear to slightly opalescent and colourless to slightly yellowish solution . it is supplied as a concentrate for solution for infusion . pack sizes of 2
the active substance topotecan , which belongs to a group of medicines called cisplatin . they act in different ways to help protect your child ' s health and well - being . one of these medicines works by blocking receptors in the brain and spinal cord , allowing the body to recognise and attach itself to its targets . in this case topotercan actavis is used to treat small cell lung cancer that has come back after chemotherapy . advanced cervical cancer if surgery or radiotherapy is the preferred treatment option in this casement . topotécan actingavis treatment is combined with medicines containing cistapolatin and erythromycin .
do not take topotecan actavis : - if you are allergic to topotencan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor will check your blood cell counts regularly and may adjust your dose if necessary . if this applies to you , tell your doctor and do not change your dose without talking to your pharmacist . you may need to take another dose before you start taking totoecan actingavis ( see section 4 , " possible side effects "). if any of these apply to you ( or you are not sure ), ask your doctor or pharmacist for advice . children and adolescents do not give this medicine to children or adolescents under 18 years of age because there is no experience with the use in this age group . there is limited experience with use of to
topotecan actavis will be given to you by a doctor who is experienced in the treatment of the disease . your doctor will carry out blood tests before you start treatment and regularly during treatment . adults small cell lung cancer : the usual dose is 1 . 5 mg per square metre of body surface area , given once a week for 5 consecutive days . this treatment cycle will normally be repeated every three weeks , but may also be repeated at intervals if needed . cervical cancer - the usual starting dose is 0 . 75 mg per sq . m2 ( 2 - 3 days ), given once per week , for three consecutive days and then at least four weeks before you are given cervical cancer in combination with another anticancer medicines called cisplatin . the doctor will decide if and when you will receive a dose of cistapis . patients with impaired
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects stop taking topotecan actavis and tell your doctor straight away if you notice any of the following serious sides : - infections . common ( may affect up to 1 in 10 people ) - fever . - signs may include your general condition and local symptoms such as sore throat or burning sensation , severe stomach pain or fever , diarrhoea or bowel inflammation ( neutropenic colitis ). in some cases , topecan actingavis may reduce your ability to fight infections and increase your risk of lung inflammation . rare ( may be seen in 1 in 1 , 000 people ). - difficulty in breathing . not known ( frequency cannot be estimated from the available data ): swelling of the face , lips , mouth , tongue or throat 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . this medicine does not require any special temperature storage conditions . keep the vial in the outer carton in order to protect from light . after reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25 and 2 to 8 , when stored in a refrigerator ( 2 - 8 ). from a microbiological point of view , the drug product solution should be used immediately after preparation , and diluted in solutions for infusion ( nacl 0 . 9 % w / v ) or glucose 5 % for 4 hours at room temperature ( 20 - 25 ) and then stored for 12 hours in the refrigerator ( 25 - 24 ). if not used immediately , in 
what topotecan actavis contains - the active substance is taiwanese . one vial contains 1 mg or 4 mg of topotenecan ( as hydrochloride ). after reconstitution 1 ml concentrate contains 1 g / 0 . 5 mmol tepotekan ( as esilate ).  the other ingredients ( excipients ) are mannitol ( e421 ), tartaric acid , hydrogen chloric acid and sodium hydroxide ( see end of section 2 for more information about some of the ingredients in the concentrate ). solvent : water for injections , concentrated , clear , colourless liquid in a clear glass vial with grey bromobutylic stopper and aluminium seals with plastic flip - off caps . the vial is placed in
the active substance of rivastigmine hexal is rivascalistigmine which belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson  s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivage helps to increase the levels of one of the enzymes responsible for the synthesis and breakdown of the three substances . these enzymes help the body to make better use of the rest of the brain and reduce the symptoms you may be experiencing .
do not take rivastigmine hexal : - if you are allergic to rivassim , the active substance in rivainstigmine himxal or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have had a previous skin reaction ( allergic contact dermatitis ) to any other medicine of the group of substances . if this has happened to you , tell your doctor and may need to adjust your dose . do not stop taking the medicine unless your doctor tells you to . warnings and precautions talk to your doctor , pharmacist or nurse before you are given riv . you should be observed closely while you are being treated for the following conditions whilst being treated : irregular or slow heartbeat ; an active stomach ulcer ; difficulties in passing urine ; seizures ; asthma or severe respiratory
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . your doctor may slowly increase your dose depending on how you respond to treatment . the highest dose that should be taken is 6 . 0 mg twice a day . you should swallow the tablet whole with some water . do not chew , crush or split the tablet . this is because it has no effect on the way this medicine works . try to take your tablet at the same time each day , ensuring that there is always enough medicine in your body to help you remember to take it . for the best results for your health , you should not take more than three days without talking to your doctor . taking this medicine tell your
like all medicines , this medicine can cause side effects , although not everybody gets them . you may get side effects more often when you start your medicine or when your dose is increased . usually , the side effects will slowly go away as your body gets used to the medicine . very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ), diarrhoea common ( might affect up to 1 in 100 people ). anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling , difficulty sleeping , insomnia , feeling confused , lack of energy , problems with digestion , constipation , dry mouth , fast heartbeat , increased blood sugar , high blood sugar change in perception of self , restlessness , depression 
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . store below 30 .
what rivastigmine hexal contains - the active substance is : 64 active substance : rivascalmine hydrogen tartrate . - other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ) and titanium dioxide , which are printed in black ink . the printing ink contains a white to almost white ink called " gilead " and " st john ' s wort ". the ink is composed of shellac , and is axially printed with " rvt " on one side and " 1 . 5 mg " on the other side . one ink has been cut in half and is debossed with the company symbol . each 
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat adults with a type of kidney cancer called renal cell carcinoma , or liver cancer when a specific anticancer medicine , called sorafenib ( srtk ) is not suitable or has failed to work adequately . how cabômetyc works the body ' s immune system attacks proteins called receptor tyrosine kinases ( catalyses ), which are involved in the development of new blood vessels that supply them . these proteins can be present in high amounts in cancer cells . the active ingredient in cabrometyn is shown in a blood test .
you must not be given cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before you are given this medicine . before you have been given the medicine , tell your doctor if : - you have high blood pressure , or have had an aneurysm ( enlargement and weakening of a blood vessel wall ) or a tear in or cracking of the caberie wall if any of these apply to you , you may experience diarrhoea , have a recent history of significant bleeding , are due to have surgery in the last month or if surgical procedures ( including dental surgery ) are planned . - your doctor may want to monitor you more closely , especially if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine is for oral use . swallow the tablets with a glass of water . you can take cabometyx with or without food . your doctor will monitor you and adjust your treatment if necessary to reduce the risk of serious side effects . the recommended dose is one tablet a day . take the tablet at the same time each day ( for example , one tablet in the morning and one in the evening ). do not change the dose unless your doctor tells you to do so . how long to take treatment you will need to take - you will usually start by taking the tablet gradually over a period of approximately 60 minutes . - take the tablets at least 2 hours after taking the tablets , then at least 1 hour between doses . depending on how you respond to
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects of cabometyx may be similar to other medicines you may be taking at the same time . tell your doctor straight away if your side effects get worse or if you notice any of the following side effects you may need urgent medical treatment : symptoms include pain in the abdomen , nausea ( feeling sick ), vomiting , constipation , fever and a gastrointestinal perforation ( a hole in your stomach or intestine that can cause severe or uncontrollable bleeding ). symptoms include vomiting blood , black stomachs , diarrhoea , indigestion , stomach pain , vomiting blood or black stomach ulcers . not known : frequency cannot be estimated from the available data . your doctor may prescribe a different dose for you . reporting of side effects
what cabometyx contains - the active substance is cabozantinib ( s ) in its active substance , malate . one tablet ( 0 . 5 ml ) contains 20 mg ( 20 mg ) cabouzantib . the other ingredients are microcrystalline cellulose , lactose anhydrous , hydrogenated ( e507 ) and water for injections ( see section 2 ). - each tablet contains 40 mg ( 40 mg ), cabazantineib in its raw material , and malate that comes in vials , equivalent to 40 mg in each cabuzzard . - one tablet contains cabombyx 60 mg , corresponding to a whopping 60 mg tablet , which corresponds to 60 mg ( 1 , 5 , 6 , 7
the active substance in pemetrexed hospira is a medicine used in the treatment of cancer . pemetreixed hospiral , in combination with cisplatin , another anti - cancer medicine , is used for treatment of malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy , has been given as separate treatment in each of the four active substances , except for the initial treatment of patients with advanced stage of lung cancer , while also providing additional support for pemetreexed hopira if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; however , it may still be used as a treatment for patients with a certain type of lung tumor whose disease has progresse
do not use pemetrexed hospira : - if you are allergic ( hypersensitive ) to pemetrexxed or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . you should discontinue breast - feeding during treatment with pemetreexed hospirana . your doctor may ask you to receive a vaccine against yellow fever . do not receive pemetreexed hopira in order to prevent problems with your kidneys . before each infusion you will have samples of your blood taken to evaluate whether you have sufficient kidney and liver function and to check that you have enough blood cells in the pancreas ( see section 4 ). you may not be properly hydrated when you are given pemetreced , or if your blood cell counts are too low . 
the dose of pemetrexed hospira is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area in square meters ( m2 ). your doctor will use this body surface area for treatment purposes . this dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or doctor will have mixed the pemetreexed hompira powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution for injection before it is given to you . you will always receive pemetreexed aspira by infusion into one of your veins . the infusion will last approximately 10 minutes . when used in combination with pemetreixed hospiraconazole the doctor or hospital pharmacist
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : fever or infection ( common ): at a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . signs include : chest pain , having a fast heart rate , or pain ( uncommon ). redness , swelling or sores in your mouth . allergic reaction : skin rash , burning or prickling sensation , fever . skin reactions may also be serious and could be life - threatening . death has been reported with pemetrexed hospira use in children and adolescents . this medicine has been associated with 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . when prepared as directed , chemical and physical in - use stability of infusion solutions of pemetrexed was demonstrated for 24 hours at refrigerated temperature ( 2 - 8 ). from a microbiological point of view , the resulting product should not be used if it is discoloured or if particulate matter is present . parenteral medicines : this medicine is for single use only . any unused solution must be discarded after reconstitution .
what pemetrexed hospira contains - the active substance is Pemetrex elbasidase . - each sachet of pemetreixed has been prepared by recombinant dna technology . one vial containing 100 milligrams contains 100 micrograms / millilitre ( 0 . 5 ml ) of pemeterxe d ( as pemetrexxed disodium hemipentahydrate ). - one vially of pemètrexeded houspira 500 milliliter ( 00 microgram ) is supplied as a single - use pen . each vial contains 500 microgram ( 1 , 000 microgram [ 1 . 1 microgram]) , of pemetrixeed ( 2 . 2 microlitres ) pemetre
ganfort contains two active substances called bimatoprost and timolol . they work together to reduce pressure in the eye . bimatopho prost belongs to a group of medicines called prostamides . it works by blocking the activity of a prostaglandin analogue , a substance that the eye turns into a clear , watery liquid . this helps to bring down the pressure inside the eye and reduces the risk of glaucoma . when used regularly , it helps to keep the eye clean , dry and comfortable to wear contact lenses , and helps to reduce the risk in both eyes . if you are using gamfort eye drops , you may be at high pressure in one eye , which may increase the risk for glauscoma when it is too high . you should use both of these treatments twice 
do not use ganfort eye drops : - if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using this medicine if : you have respiratory problems such as asthma , severe chronic obstructive bronchitis ( severe lung disease that causes wheeziness and difficulty in breathing ) you have long - standing cough you have heart problems ( such as low heart rate , heart block , or heart failure warnings , precautions ). this medicine is not recommended for use in patients with coronary heart disease ( symptoms include chest pain , chest pain or shortness of breath , cough with or without breath ). you have had heart problems before . you have diabetes . your doctor may want to
always use ganfort exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . for treatment purposes , the bottle should only be used in the eye . the bottle must not be inserted into the neck of the medicine ( see section 5 ). instructions for use 1 . wash your hands . do not touch the inside of your head . 2 . pull down your lower eyelid until there is a small pocket at the back of the bottle . 3 . gently squeeze the bottle into your eye for treatment . 4 . close the lid of your eye 5 . bring the bottle close to the eye with a finger . don ' t touch your eye or nose .
like all medicines , ganfort can cause side effects , although not everybody gets them . you should stop using the drops and see a doctor straight away if you notice any of the following side effects after using the dropper . the drops are for single - dose use only . very common side effects ( may affect more than 1 in 10 people ) are : - the eye redness . common side effect(s ): may affect up to 1 in 9 people 100 - a feeling of the eye burning , itching and stinging , irritation of the conjunctiva ( the clear layer at the front part of your eye ), sensitivity to light , eye pain , sticky eyes , dry eyes or feeling of something in the eye , or small break in the vision . not known ( frequency cannot be estimated from the available data ) side effects reported with gan
keep out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and the bottle label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . solution for eye infections should be used within 4 months after first opening . discard any unused solution via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains - the active substance is bimatoprost , 0 . 3 mg / ml solution for injection contains timolol ( equivalent to 5 mg ) - each vial contains a single syringe ( corresponding to 6 . 8 mg of benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate ( e330 ), purified water , hydrochloric acid and sodium hydroxide . - this medicine is a clear , colourless to slightly yellow eye drop solution in a plastic bottle . each pack contains 1 or 3 bottles with a screw - cap and 3 or 4 bottles without a mouthpiece . not all pack sizes may be marketed .
the active substance gefitinib attaches to a protein called ' epidermal growth factor receptor ' ( egfr ). this protein is involved in the growth and spread of cancer cells . geFITINib mylan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan : - if you are allergic to the active substance , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking gefit inib . some lung problems may get worse after you have been treated with gefitib in the past . your doctor may want to adjust your dose , if this applies to you . you may have problems with your liver . tell your doctor about any of these . children and adolescents do not give this medicine to children or adolescents under 18 years of age because it has not been studied in this age group . other medicines and gefiteinib this medicine should not be used in combination with any other medicines . the following medicines may change the effect of the medicine or its effects on the body . phenytoin and carbamaz
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet per day . swallow the tablet whole with a glass of water . you can take the tablet with or without food . do not take antacids on an empty stomach . alternatively , take the tablets at about the same time each day ( for example , at bedtime or at night ). for children ( 2 years of age and older ), adolescents and adults , the dose may be increased by up to 1 mg per day depending on body weight . take gefitinib mylan with food , drink or any other liquids ( e . g . water , apple sauce or milk ). drink the mixture immediately after drinking . this will help you to remember to take it . it is best to take your tablet
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives ( nettle rash ) and difficulty breathing . serious breathlessness or sudden worsening breathlessness accompanied by a cough or fever . these may be signs of an inflammation of the lungs called ' interstitial lung disease '. uncommon ( may affect up to 1 in 100 people ) gefitinib may cause severe skin reactions which may spread to other parts of the body . if this happens , you should stop taking the medicine and see your doctor immediately . signs may include reddening , unusually intense pain in the upper right side
what gefitinib mylan contains - the active substance in each film - coated tablet is 250 mg / 0 . 5 ml in a pre - filled syringe , with " gsi " on one side and " nvr " on the other side . -- the other ingredients are : lactose monohydrate , microcrystalline cellulose ( e460 ), crospovidone ( type a ), povidone( k30 ), sodium laurilsulfate , magnesium stearate in the tablet core and polyvinyl alcohol , macrogol 4000 , titanium dioxide , red iron oxide and yellow iron oxide in the film coating , all in black ink on the tablet coating and in the sachet cap and indigo carmine - like surface finish . what ge
reblozyl contains the active substance luspatercept and is used to treat myelodysplastic syndromes ( mds ) in adults , adolescents and children of all ages . these syndromes are caused by many different blood and bone marrow disorders that can cause red blood cells become abnormal . signs and symptoms of a low red blood cell count ( anaemia ) can also be caused by inadequate use or insufficient availability of blood for the first time , and for the treatment of patients in need of red blood blood cell transfusions . the efficacy of the product has not been established and is therefore not recommended in patients with a certain type of anaemic population , but it can be used alone if inadequately controlled by treatment with erythropoietin therapies . patients with beta - thalassaemia the diagnosis of th
do not take reblozyl : - if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) or if there is still a possibility that you may be pregnant ( see pregnancy section ). warnings and precautions talk to your doctor or pharmacist before taking this medicine if : you have thalassaemia or have had your spleen removed . you have ever had a blood clot . this may require hormone replacement therapy . your doctor will advise you whether you can take preventive measures or stop taking medicines to prevent or reduce the formation of a new blood clumping together with high blood pressure . it is important that you aren ' t be treated with retinopathy . if any of these apply to you , tell your doctor before you start taking the medicine . children and adolescents
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests before you start using reblozyl . you will be asked to weigh . the dose you receive is based on how much you weigh and the results of the tests carried out before and after you have been given the injections . use in children and adolescents the recommended dose is 1 . 0 mg per kg of body weight , given once every three weeks . this dose may be adjusted by your doctor depending on your blood pressure and on how you respond to the medicine . in patients with myelodysplastic syndromes the maximum single dose is 1. 75 mg for each kilogram of your body weight each week . for patients with beta - thalassaemia the maximal single dose should not exceed 1 , 25 mg per kilogram of the body weight once every
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , especially if only on one side of the body , blurred vision , which may be symptoms of a stroke or blood clots swelling of the area around the eyes , including the face and lips , mouth , tongue or throat allergic reactions including rashes and swollen hands , ankles or feet , sudden decrease in the number of red blood cells ( anaemia ) common side effects ( may affect up to 1 in 10 people ) diarrhoea , vomiting , nausea , constipation , stomach pain 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and the carton after exp . store and transport refrigerated ( 2 8 ). do not freeze . after reconstitution , the product may be stored at ambient room temperature ( up to 25 ) for up to 24 hours . from a microbiological point of view , reblozyl should be used immediately . any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains - the active substance is luspatercept . each vial contains either 25 mg or 75 mg of luspatiercept ( as excipients ). after reconstitution , each ml of solution contains 50 mg / 0 . 5 mmol of solution for injection ( injection ). - other ingredients are : citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( a ) ( mainly used in patients who are not able to have a good , stable , colourless liquid ). not all pack sizes may be marketed . your doctor or nurse will give you instructions on how to store and transport the solution for infusion ( see section 2 ). what you need to know before you go to bed , and what you
the active substance in fotivda is tivozanib , which is a protein kinase inhibitor . tivolinib works by stopping the growth of the cancer and slowing down the rate of growth of cancer cells by opening new blood vessels . in patients with advanced kidney cancer , other treatments ( alpha or interleukin - 2 ) may be considered to be more appropriate in treating your disease .
do not take fotivda if : you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). you are taking st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor , pharmacist or nurse before taking fotiva . you have high blood pressure . your doctor may need to adjust your dose , either temporarily or permanently , if your blood pressure is too high or too low . it may also be necessary to reduce your dosage if you are already taking a medicine , or if it does not work as well as it should . in this case , you should have been carefully checked by your doctor before starting fotiv da , to make sure that you have enough blood pressure before starting treatment 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of fotivda is 1340 mg / 21 mg capsules taken once a day for 7 days ( 1 capsule ) and capsules should be swallowed whole with water or a glass of water . do not crush or chew the capsules . capsules must be taken at least 4 hours after the first intake . your doctor may decide to reduce your dose , either temporarily or permanently , if necessary , to take a higher or lower dose . if severe side effects occur , your doctor will decide if to stop fotiva therapy . for further information , see ' warnings and precautions ' in section 4 . patients who weigh less than 890 kg should take 21 capsules in the morning and 7 capsules at the evening 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure ( a common side effect that may affect up to 1 in 10 people ) if you get this side effect ( see section 2 " warnings and precautions "), you must stop taking fotivda and contact a doctor immediately . high blood blood pressure can be associated with symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state or feeling anxious , confused or disorientated . your doctor may want to monitor your blood pressure more closely . you should not take fotivdas if it is a problem you are not sure what to do . if this happens , talk to your doctor or pharmacist . it is important that you take the medicine as prescribed by your doctor . in some cases , people who are suffering from high blood
what fotivda contains - the active substance is tivozanib . each hard capsule contains either 890 mg of tivonib ( as tivolinib hydrochloride monohydrate , equivalent to 8 90 mg / ml ), or mannitol ( e421 ), and magnesium stearate in the core . the other ingredients are : gelatin , titanium dioxide , indigo carmine , yellow iron oxide , propylene glycol , strong ammonia solution for injection , and titanium dioxide and tartrazine aluminium lake , which are printed with inks containing shellac , propane glycol ( type a ) and strong ammona solution . also , the colourless solvent is a clear colourless liquid in an off - white glass vial . one vial of
stribild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of the effects of the active substance , in the form of emtricitabine . this is a type of medicine that can be used to treat a non - nucleoside reverse transcriptaser inhibitor ( nrti ) and tenofovir disoproxil , which is an antireversal medicine commonly known as " nti " and a " t2 " receptor tetide ". strebild is available as a single tablet regimen for the treatment of human immunodeficiency virus ( hiv ) infection in adults , adolescents and children of all ages . 
do not take stribild - if you are allergic to elvitegravir , cobicistat or emtricitabine , tenofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking treatment with any medicine that is used to lower your blood pressure ( e . g . one tablet or two tablets per day ). if this applies to you , tell your doctor immediately . your doctor may need to change your dose of any medicine you are taking with a higher or lower dose , especially if your kidney function is impaired , and you are also taking any of these medicines : alfuzosin ( used to treat an enlarged prostate gland ) amiodarone , quinidine ( used for irregular heartbeats ) 47 da
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take adults ( 12 to less than 18 years of age ) the recommended dose is 35 mg taken by mouth once daily . your doctor will tell you the dose to take . depending on how you respond to your medicine , your doctor may change the dose or stop the treatment temporarily or permanently . you should take medicines such as oral supplements , antacids , laxatives containing minerals ( such as magnesium , aluminium , calcium , iron , zinc ) taken in the morning and evening ( at least 4 hours apart ) for 4 hours . take stribild at about the same time every day . swallow the tablets whole with a glass of water . do not chew , crush or split the tablets . it is best to take the tablets
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood cholesterol sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether some of the unwanted effects are caused by stribild or by other medicines that you are taking at the same time . it is very important to take care not to infect other people . the viv disease itself is an extremely serious side effect that needs immediate medical attention . if you have lactic acidosis ( excess lactic acids in the blood ) this is a very common side effect which may affect more than one in 10 people taking some hivi medicines . some
what stribild contains - the active substances are elvitegravir , cobicistat , emtricitabine , and tenofovir disoproxil . each single - use tablet ( 150 mg ) contains either : a tablet containing 150 mg of elevigravir ( as 150 mg in each tablet ), or 200 mg / 0 . 5 ml ( as tenovir ) or 245 mg , respectively , for a total of three tablets a day . the other ingredients ( excipients ) are croscarmellose sodium ; hydroxypropyl cellulose ( e463 ); lactose monohydrate ; and magnesium stearate ( see end of section 2 ). not all ingredients are marketed .
the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes a condition with symptoms of excitement or euphoria . the efficacy of zyPrexa has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to the effects of olangzapinе treatment .
do not take zyprexa : - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , or a filled or swollen face . if this has happened to you , tell your doctor and may need to stop you taking this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment if , during treatment you may experience a runny or blocked nose , and if possible , you may be given medicines to treat glaucoma ( increased pressure in the eye ). if any of these apply to you ( or you are not sure ), talk to the doctor or pharmacist before you take your tablets . children and adolescents do not give this medicine to children
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many zyprexa tablets to take and how long you should continue to take them . the usual starting dose of zyPrexa is between 5 mg and 20 mg . consult your doctor if your symptoms return but do not stop taking the medicine without talking to your doctor first . if necessary , your doctor may reduce your dose to one or more of the following doses : rapid beating of the heart , agitation / aggressiveness , problems with speech , unusual movements ( especially of the face or tongue ) and reduced level of consciousness . other symptoms may be similar to those described below : headache , nausea , vomiting , diarrhoea , abdominal pain , constipation , excessive gas in stomach 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately and stop taking zyprexa if you experience unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins . this side effect is uncommon , and affects more than 1 in 100 people . especially in the legs ( symptoms include swelling , pain and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if any of these symptoms occur , stop taking the medicine and contact a doctor immediately .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . zyprexa should be used within six months of first opening the blister . these measures will help to protect the product from moisture .
what zyprexa contains - the active substance is olanzapine . each zyPrexa tablet contains either 2 . 5 mg , 5 mg or 7 . 5, for doses ranging from 10 mg to 15 mg or 20 mg . the exact amount you need to take depends on the tablet type you are taking on the day of the week . - your doctor has added lactose monohydrate ( see section 2 ), hyprolose , crospovidone ( type a ), microcrystalline cellulose , magnesium stearate ( e470b ) and hypromellose ( cb2 ), titanium dioxide , and carnauba wax , all in the tablet core , to increase the acidity of the different zypresa tablet strengths . some of these strengths may be taken with or without food , in
what prolia is and how it works prolis contains two active substances : denosumab , a protein ( monoclonal antibody ) that attaches to another protein that causes bone loss and osteoporosis . in some cases , your doctor may need to reduce your dose , or stop treatment , temporarily or permanently . by attaching to a target protein called oestrogen , it helps to make the bones stronger . it does this by reducing the amount of hormones produced during the menopause . as a result of these levels , the body ' s own body produces less oesterogen and this leads to bones becoming thin and fragile , which can be a sign of osteoposses . one of the active substances in this medicine is called testosterone and glucocorticoids . both of these substances help to
do not use prolia : if you have low calcium levels in the blood ( hypocalcaemia ). if your doctor thinks you may be allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before you are given proton / syringes before you will be given prolaia ( see section 4 ). you should be told immediately if any of these apply to you . you may not be able to take proloa . if , while you are being treated for a skin infection , you may develop symptoms such as a swollen , red area of skin usually in your leg that feels hot or tender ( cellulitis ), and symptoms may include fever . these symptoms may be due to an allergy to latex
always use prolia exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one pre - filled syringe of 60 mg / ml given once every 6 weeks as a single injection under the skin ( subcutaneous ) in your upper thighs , abdomen or upper arm . do not try to inject yourself unless your doctor tells you to . your doctor may give you stickers , calcium and vitamin d supplements to help you get the best results and lower your doses . it is very important to follow your doctor ' s instructions for injections and that he or she will tell you how long you should continue with your treatment . for more information , see the box at the end of this leaflet . if your doctor determines that you need to be treated with prol
like all medicines , this medicine can cause side effects , although not everybody gets them . prolia may cause skin infections ( cellulitis ). tell your doctor immediately if you develop any of these symptoms while being treated with proloa : - you may be swollen , red area of skin on one side of your leg that feels hot and tender ( symptoms may be fever ), which may be severe . - your doctor may decide to reduce your dose of protease while you are being treated . you may experience pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw or jaw ( discharge ), numbness or a feeling of heaviness or loosening of a tooth . these may be signs of bone damage in your jaw . your doctor will tell you how long you should continue to take prol
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . your pre - filled syringe may be removed from the refrigerator and left at room temperature ( up to 25 ) for a single period of up to three months . the injection may be stored outside of the refrigerator at a maximum of 25 days . if not used within 30 days , it should be discarded . discard any unused product via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what prolia contains - the active substance is denosumab . each 1 ml syringe contains 60 mg ( 60 mg / 0 . 60 mmol ) of denosomab in 60 mg solution . the other ingredients ( excipients ) are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections ( see end of section 2 ) and sodium chloride ( see also end of the pack for more information about some of the ingredients ) in the vial . what prologia looks like and contents of the package proloa is a clear to slightly opalescent and colourless to slightly yellow solution for injection in a ready - to - use pre - filled siringe with or without a needle
ambirix is a vaccine used in adults , adolescents and children from 1 year up to and including 15 years to prevent two diseases , called hepatitis a and hepatis b . it is given to you by your doctor or nurse in a hospital or clinic under the supervision of your doctor , pharmacist or nurse . the vaccine works by causing the liver to become swollen and inflamed with the virus . if the virus is found in an infected person , it can be found in faeces , serum or saliva . symptoms are usually found at least 3 to 6 weeks after you have had infection . you feel sick , have a fever , aches and pains , or have other signs of infection , such as : very common ( may affect more than 1 in 10 people ) if this happens to you ,
do not receive ambirix : if you are allergic to the active substance , or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if this has happened to you , tell your doctor immediately . you may be having an allergy reaction to any vaccine against hepatitis a or hepatis b diseases . warnings and precautions talk to your doctor , pharmacist or nurse before you are given the vaccine if : you have a severe infection with a high temperature ( over 38 ). the vaccine will not be given to you in a minor infection such as a cold should not be a problem , but your doctor should check that the vaccine is having the desired effect . your doctor may want to monitor you closely during your treatment with am
your doctor or nurse will give you ambirix as an injection into a muscle , usually in the upper arm . the injection will be given into the vein of the thigh muscle . you will receive a total of two injections . if the injections are given within 12 months , the second injection should be given between 6 and 12 months after the first injection . your doctor will tell you when you may need extra doses , or future booster dosing , depending on how well the disease is treating you or your child ' s health care professional decides that the disease needs to be treated . it is important that you follow this advice carefully so that your doctor can decide if and when you need to receive the next dose . in the unlikely event that you miss an injection , tell your doctor , pharmacist or nurse straight away . however , if it is almost time for the next injection
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering and swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . side effects reported in clinical trials with ambirix were : common ( may affect up to 1 in 10 people ) headache loss of appetite feeling tired or irritable pain in arms or legs , dizziness , confusion or disorientation . these side effects were uncommon in children not previously treated . during clinical trials , more than 1 in 100 people decreased appetite , generally feeling drowsy or sleepy , loss of energy ,
what ambirix contains 26 the active substances are : hepatitis a virus ( inactivated ) 1 , 2 - 720 iu elisa units / hprc , 20 - human diploid ( mrc1 ) cells - aluminium hydroxide , hydrated ( 0 . 05 ml ), saccharomyces cerevisiae , aluminium phosphate - 0, 4 % , sodium chloride and water for injections - the solvent is a clear , colourless to slightly yellow liquid , supplied in a pre - filled syringe ( see end of this leaflet for further information on the contents of the pack suspension for injection ) and solution for injection ( see also section 2 ) what you need to know before and during treatment . ambir
the vaccine is a meningococcal group b vaccine . bexsero is given to children and adolescents ( from 2 years of age ) to help protect against disease caused by the neisseriameningitidis type b bacteria . these bacteria cause infections , including meningitis ( inflammation of the covering of the brain and spinal cord ) and sepsis ( blood poisoning ). when given , the vaccine works by helping the body to make its own protection ( antibodies ) against the disease .
do not receive bexsero if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before vaccination if : you have a severe infection with a high temperature ( over 38 ). if this applies to you , your doctor may recommend vaccination . a minor infection such as a cold should not be a problem . your doctor or nurse will check whether the vaccine is working for you . you have haemophilia or any other problem that may prevent your blood from clotting properly , such as the use of blood thinners ( anticoagulants ) during treatment , or if your immune system is weakened ( for example , eculizumab ). you are not sure if any of these apply to you or your child , ask
bexsero will be given to you or your child by a healthcare professional . the recommended dose is 5 mg given as an injection into a muscle , usually in the thigh or upper arm . your doctor or nurse will decide for how long your child needs to receive the vaccine . if your child is from 2 to 5 years of age and needs at least three injections , the doctor may decide to give the vaccine or give you an additional injection ( booster ) at the time of the first injection . it may take up to 2 months for the interval between injections to be injected . this is usually given at least 1 month apart . depending on your child ' s response to the booster , your child may receive up to 12 to 15 injections ( 6 weeks after the last injection ). your child will receive one injection of the booster at a time interval of up to 24 months after the first
like all vaccines , this vaccine can cause side effects , although not everybody gets them . when bexsero is given to your child , the following side effects may occur : very common ( may affect more than 1 in 10 people ): - pain / tenderness at the injection site - redness of the skin around the injection area - swelling of the leathery part of the upper layer at the inject site ( hardness ) at the site of injection - hardness around the area of skin at injection site other side effects of this vaccine are listed below by how likely they are to happen . very common : may affect any person - this vaccine may affect up to 1 person in 10 - a combination of fever - loss of appetite - diarrhoea - feeling sick ( nausea ) - vomiting - muscle spasms - joint pain -
what bexsero contains - the active substance is recombinant neisseria meningitidis group b nhba fusion protein 1 , 2 or 3 times per week , equivalent to 50 micrograms / kg . - each vial contains : two vials : one vial containing two doses , each containing one dose , either 1 mg or 2 mg or 3 mg , of which one dose is equivalent to three doses of one type a , based on the other , which is the active ingredient . the other excipients are : - in a vial of two strains of two types , one of which is made up of two separate strains . these strains are divided into two equally divided syringes ( s ). the other ingredients are 
the active substance in this medicine is nitisinone mdk . this medicine belongs to a rare disease called hereditary tyrosinemia type 1 in adults , adolescents and children aged 1 year and older . in this disease your body is unable to break down the amino acid térosine ( amino acids are building blocks of our proteins ) which are then broken down by the body . by lowering the amount of nitianinone in your body , you can help to reduce the levels of the harmful substances that are produced by this medicine . it is thought to work by preventing the breakdown of some of the amino acids that can build up in the tissues of cells and forming new ones . if you have any questions about how this medicine works or why this medicine has been prescribed for you , ask your doctor . how does this medicine work ? this medicine reduces the
do not take nitisinone mdk - if you are allergic to nitsinone or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . pregnancy and breast - feeding : if your doctor or pharmacist determines that you should not be treated with a dose higher than the recommended dose , he or she may give you a lower dose . your doctor may decide to reduce the number of red eyes in your eyes . if this applies to you , tell your doctor immediately for an eye examination . eye problems may be a sign of inadequate dietary control ( see section 4 ). before you start the treatment , your doctor will take blood samples to monitor you during the treatment to check for side effects . blood disorders may affect the liver and the disease affects the way
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine will be started by a doctor who is experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 mg per kg of body weight , for a total daily dose of 20 mg . in this patient population , the usual dose is two capsules of nitisinone mdk per day . after swallowing the capsules , a small amount of water or formula diet will be given to you by your doctor . you should not take more capsules than your doctor tells you to . your doctor will tell you how many capsules you need to take . do not change the dose or stop taking this medicine without talking to your doctor first . take the medicine pack with you so that it is
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial and the carton after exp . this medicinal product does not require any special storage conditions . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and should not be longer than 2 hours at a temperature not above 25 .
what nitisinone mdk contains - the active substance is nitianine . - each capsule contains a total of two active substances , - one in each capsule , and the other in the other . one , two in each hard capsule contains 2 mg / 0 . 5 mg nitsinone ( a complication of two separate capsules ). - two in one hard capsule each containing two capsules contains two doses , one in one capsule contains three doses of two different types : one containing one dose of one of the three active substance . the other ingredients are : - capsule content : gelatin , titanium dioxide ( e171 ) - printing ink : shellac glaze - all in the capsules are made of cellulose , iron oxide red and black iron oxide black ink
the name of this medicine is docetaxel accord . it is a substance derived from the needles of yew trees , which are used to make up the needle ' s own hair . dozeaxel belongs to the group of anti - cancer medicines called taxoids . the name " taxoids " is used in the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ) and prostate cancer . gastric cancer e . g . head and neck cancer : - for adult patients with advanced breast cancer the combination of docetaxil along with doxorubicin , or trastuzumab , and capecitabine is used for early breast cancer and lymphoma of the primary form of lymph nodes .
docetaxel accord should not be used : - if you are allergic ( hypersensitive ) to the active substance , or any of the other ingredients of docetaxil accord ( listed in section 6 ). if the number of white blood cells is too low you have a severe liver disease . warnings and precautions before each treatment with docetal accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to function properly before and during treatment with doncetaxell accord . if white blood cell disturbances , fever or infections may occur . tell your doctor , hospital pharmacist or nurse immediately if your symptoms of abdominal pain or tenderness , diarrhoea , rectal haemorrhage , blood in stool or fever should be reported . children and adolescents do not give this medicine to children under the age of 18 years
docetaxel accord will be administered to you by a healthcare professional . usual dose the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m2 ) and will determine the dose you should receive . method and route of administration docetaxil accord is given by infusion into one of your veins ( intravenous use ). the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . the frequency of dosing may vary depending on your blood tests , the dose and the dose response you experience . in particular , please inform your doctor in case of diarrhoea , sores in the mouth , feeling of numbness or pins and needles , fever and give her / him results of your blood
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord alone are : decrease in the number of red blood cells or white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea , tiredness . in most cases , the hospital staff will monitor you closely for adverse events while you are receiving docetaxil accord and other chemotherapeutic agents . during the infusion at the hospital the following allergic reactions are likely to occur . very common ( may affect more than 1 in 10 people ): flushing , redness , itching , burning sensation , pain in the joints , muscle spasms , back pain
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . store and transport refrigerated ( 2 - 8 ). do not freeze . keep the vial in the original carton in order to protect from light . after dilution , the medicine should be administered immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user . the infusion bag may be stored at room temperature ( up to 6 hours below 25 ) for up to one hour prior to infusion . once thawed , reconstituted and infusion is ready for use , once removed from the refrigerator , storage in non - pvc bags must be allowed up to 48 hours between 2 and 8 . storage in the refrigerator at 2 to
what docetaxel accord concentrate vial contains - the active substance in each ml of concentrate for solution for infusion consists of 20 mg dna . one vial of 1ml concentrate contains 20 mg docetaxil . - one ampoule of 4ml reconstituted concentrate contains 80 mg doceaxel and one ampoules of 8ml solvent contains 160 mg docesaxel.  the other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 ) and citric acid anhydrously . what doesdocetaxel accord looks like and contents of the pack don ' t contain any animal products . the concentrate is a clear pale yellow to brownish - yellow solution . it is supplied in glass vials . each carton contains : - a single - use vial with a low 
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . your doctor has prescribed this medicine because you are impulsive ( hyperactive ) and you are not currently taking this medicine . you have a condition called ' attention deficit hyperactivity disorder ' ( adhd ). you have adhd that is not controlled well enough with your current stimulant medication . if current medication does not reduce adhd symptoms , your doctor may prescribe the medicine together with a treatment programme called psychological therapy , educational therapy and social therapy . it is used to treat 38 children and adolescents who are a child with adhd who are not able to tolerate the effects of adhd on their own .
do not take intuniv - if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have low or high blood pressure . you have heart problems . this medicine can increase your risk of heart problems you have ever fainted recently because of thoughts or feelings of suicide you have any other psychiatric conditions you have or have had withdrawal symptoms you have increased heart rate or you have high bloodpressure . if any of these apply to you , tell your doctor before using this medicine you are unsure . these problems may occur with older people . children and adolescents do not give this medicine to children or adolescents under the age of 6 years . it is not known whether this medicine is safe and effective in this age group . other people
your treatment should be initiated by a doctor who is experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your treatment will start at a low dose and will usually be gradually increased over the first 1 month of treatment . the starting dose is 0 . 05 mg per kg of bodyweight . you will then gradually increase your dose depending on how well the medicine works for you and your child ' s weight is adjusted for you by your doctor . starting treatment in children and adolescents your doctor will work out the right dose for you based on your weight . this dose is usually given every 1 month for up to 7 months . intuniv can be taken with or without food . swallow the tablets whole with water . do not chew , crush or split the tablets
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell while you are taking your medicine , stop taking it and talk to a doctor straight away . serious side effects some patients have had side effects before , including feeling drowsy and feeling dizzy ( hypotension ). slow heart beat ( bradycardia ) feeling faint , loss of conciousness ( syncope ), a serious withdrawal side effect . high blood pressure , which can cause symptoms such as headaches , feeling confused , nervousness , agitation , and tremors ( hypertensive encephalopathy ). the following side effects have also been reported : very common side effects ( may affect more than 1 in 10 people ): diarrhoea , being sick ( vomiting ), stomach pain ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister pack after " exp ". this medicine does not require any special temperature storage conditions . store in the original package in order to protect from light and moisture . the tablets should be taken immediately after opening .
what intuniv contains 1 - the active substance is guanfacine hydrochloride . 1 mg / ml solution for injection : each vial contains : one vial ( containing 1 g / 2 g debossed with " g "), one sachet ( " containing 0 . 5 mg "), a single dose ( " injection "), two vials ( " methacrylic acid - ethyl acrylate copolymer "), lactose monohydrate , povidone , crospovidone type a , microcrystalline cellulose . not all pack sizes may be marketed .
ecalta contains the active substance anidulafungin . it is used to treat adults ( aged 1 to 18 years ) with a type of fungal infection that affects the blood or other internal organs ( called invasive candidiasis ). the infection is caused by fungal cells called candida , which are resistant to echinocandins . these medicines help to prevent serious fungal infections caused by the fungal cell walls to crumble . eCALta is used when some of these cells have incomplete or defective cell walls , making them fragile and unable to grow .
do not use ecalta : - if you are allergic to anidulafungin , other echinocandins ( such as caspofungin acid ) or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before you are given this medicine , and while you are being treated , you may need to have a check - up of your liver function . tell your doctor if any of these apply to you . liver problems may occur during your treatment with anaesthetics . your doctor may decide to interrupt your treatment , interrupt , or stop your treatment while being treated with echelta and you may experience an allergic reaction , such as itching , wheezing or blotchy skin . an infusionrelated reaction may develop as a rash 
the treatment will be started by a doctor who has been trained in the use of ecalta . the recommended dose is 200 mg ( 100 mg ) given once a week . use in children and adolescents ( aged 1 month to 18 years ) the dose may be increased or decreased by 3 . 0 mg ( 200 mg in the form of 1 . 5 ml ) or lowered to 100 mg by administering the dose based on the patient ' s weight . your doctor will decide the right dose for you . you will be given the first infusion ( a drip into a vein ) in the vein ( intravenously ) over a period of one to two hours . it may take between 200 mg and 100 mg doses . depending on the dose prescribed for you and your weight , your doctor may slow down your infusion or stop your treatment temporarily or permanently 
like all medicines , this medicine can cause side effects , although not everybody gets them . some of these side effects may be serious and may include life - threatening allergic reactions such as difficulty breathing , wheezing or an existing rash . stop using ecalta and tell your doctor straight away if you notice any of the following serious side effects such as convulsion ( seizure ) or flushing . rash ( pruritis ), itching , hot flush , hives , sudden contraction of the muscles . these may be signs of coughing , difficulty of breathing other side effects include : very common side effects ( may affect more than 1 in 10 people ): dizziness , headache , diarrhoea , nausea , vomiting , abdominal pain , constipation , loss of appetite , weight loss ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special storage conditions . the reconstituted solution may be stored for up to 24 hours in a refrigerator ( 2 - 8 ). the infusion solution can be stored at room temperature ( up to 25 ) for 48 hours , or under refrigeration ( 20 - 25 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of anhydrous fungin ( as mesilate ). the other ingredients are mannitol ( e421 ), polysorbate 80 , tartaric acid , sodium hydroxide , and hydrochloric acid . the solvent is water for injections , which should be used within 30 minutes if not used right away ( see section 2 ). what you need to know before you have been given a box containing 1 ml of concentrate for solution for infusion . it is important that you keep this medicine out of the sight and reach of children . your doctor or nurse will show you how to store the powder .
adynovi contains the active substance rurioctocog alfa pegol and is a pegylated human coagulation factor viii . how does a person ' s body make enough of the necessary number of cells of the blood to form clots and stop bleedings ? in patients with haemophilia a it is missing or not working properly if they do not have factor vii at the start of treatment , or if someone else has taken some of your blood to make it harder for them to do so . your doctor has prescribed the medicine for you in order to help prevent bleeding in patients of all age groups ( including children and adolescents ) and for the treatment of bleeding in adults and adolescents ( 12 years of age and older ) with his / heralding condition ( also known as lack of factor  vii ).
do not use adynovi : - if you are allergic to rurioctocog alfa pegol , or any of the other ingredients of this medicine ( listed in section 6 of this leaflet ). if this applies to you , tell your doctor immediately and do not take the next dose until you are sure . warnings and precautions talk to your doctor , pharmacist or nurse before or during treatment if : you have ever had an anaphylactic reaction ( a severe , sudden allergic reaction ) to the medicine . if any of these apply to you ( or you are not sure ), talk to a doctor or pharmacist before using adenovi ( see section 4 ). allergic reactions such as rash 95 , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing 
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . your doctor will decide on the appropriate dose of adenovi based on your body weight and on your individual needs for treatment of bleeding . the doctor will calculate the dose you should receive and determine for how long you should be treated for . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . use in children and adolescents the doctor has determined the correct dose for the child and will determine the dose for each child . in children it is used in adolescents and children ( aged 2 years and above ) who are at an increased risk of bleeding and in adults the doctor may calculate your dose and will perform appropriate laboratory tests to make sure that you have adequate factor viii levels . for major surgery ( such as dental
like all medicines , this medicine can cause side effects , although not everybody gets them . if severe , sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . you must contact your doctor immediately if you have any of the following early symptoms of allergic reactions : - rash , hives , wheals , generalised itching - swelling of lips and tongue - difficulty in breathing - wheezing - tightness in the chest - general feeling of being unwell - dizziness - loss of consciousness . severe symptoms , including difficulty in breath or fainting , require prompt emergency treatment . patients who have received previous treatment with adynovi may experience a higher risk of severe or severe reaction , which may result in fainting and require prompt urgency treatment if they do not respond adequately to previous treatment 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . store and transport refrigerated ( 2 8 ). do not freeze . keep the vial in the refrigerator in order to protect from light . from a microbiological point of view , the powder vial may be stored at room temperature ( up to 30 ) for a single period not exceeding 3 months . if the product is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 hours at 2 - 8 , unless dilution has taken place in controlled and validated aseptic conditions . once the powder has been dissolved it should be used within 3 hours . use immediately the powder if it is discoloured or if
what adynovi contains - the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 , or 2000 iu ( international units ) ( corresponding to approximately 80% w / v ). the concentration in the solvent vial is 5 ml sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrate and tris ( hydroxymethyl ) aminomethane , polysorbate 80 and sterile solution for injection .
rekovelle contains the active substance follitropin delta , which is a fertilising hormone produced by recombinant technology without addition of any human - or animal - derived components in the manufacturing process . gonadotropins are involved in the development of female infertility in women undergoing assisted reproduction programmes ( in vitro fertilisation ( ivf ) or intracytoplasmic sperm injection ). these hormones stimulate the ovaries to produce many egg sacs .
do not use this medicine - if your fertility problems do not improve if you are allergic to follicle stimulating hormone ( fsh ) or any of the other ingredients of this medicine ( listed in section 6 ). - you have a tumour of the uterus ( ovaries ), breasts , pituitary gland or hypothalamus ( womb ), enlarged oaries , or cysts on your ops ( called polycystic ovarian disease ), bleeding from the vagina ( an early menopause ), or malformations of the sexual organs . warnings and precautions talk to your doctor , pharmacist or nurse before using rekovelle if : you are a woman of childbearing potential . you are at risk of pregnancy . there is a risk that fibroids of the unborn baby may develop
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will calculate the rekovelle dose for you during your first treatment cycle . you will be given anti - millerian hormone ( hcg ), a medicine that will stimulate your ovaries to respond to stimulation with gonadotropins . the dose you receive is based on your body weight . a blood sample taken in the last 12 months will be used to measure the duration of treatment . this will be calculated by your doctor and will be shown in the table below . how much you weigh and how often you will have treatment , the dose will depend on how well the body weight is responding to treatment and the amount of medicine you weigh . depending on the type of treatment you have , your doctor may tell you to increase or decrease your dose . usually ,
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects may occur due to the changes in hormones involved in infertility . this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms may include pain or discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain , and difficulty breathing . contact your doctor immediately if you experience any of these symptoms . a side effect is common ( may affect up to 1 in 10 people ). headache and nausea may also occur during treatment with rekovelle , which may be a sign of ovulation syndrome and may be life - threatening . in a small number of women , it is possible that you may experience a combination of symptoms such as pain and discomfort 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special storage conditions . rekovelle can be stored in a refrigerator ( 2 8 ) or at room temperature ( up to 25 ) for a single period of up to 3 months . from a microbiological point of view , if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 months below 25 and should be disposed of in accordance with local requirements for storage in the original package . the treatment any unused solution must be discarded by the user . no longer than once it has been dissolved in the water . medicines should not be thrown away . these measures will help protect the environment .
what rekovelle contains - the active substance is follitropin delta . each multidose cartridge contains 12 micrograms ( corresponding to 0 . 6 millilitres of solution ). each pen with 12 ml of solution contains 33 . 3 milligrams [ fld ] pfu / l . flld is produced by recombinant dna technology ]. the other ingredients are : phenol , polysorbate 20 , l- methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrate and concentrated phosphoric acid and sodium hydroxide . the solvent contains water for injections ( see section 2 under ' important information about some of the ingredients in this pack '): - one cartridge contains 3 pen injection needles .
the active substances of revinty ellipta are fluticasone furoate and vilanterol . two different active substances in one tablet are used : - in the treatment of asthma : one tablet of 12 mg / 184 mg , and one in the other : two tablets of 22 mg . each tablet is used for copd . if you have the impression that the effect of both of these active substances is too strong or too weak , talk to your doctor or pharmacist . the recommended dose of rev inty ita is 92 / 23 taken twice daily , either as a single tablet or as an add - on to the active ingredients . in addition to the two ingredients , the recommended total daily dose of 92/23 taken as two separate tablets . when used for chronic obstructive pulmonary disease ( copd and asthma ) in
do not use revinty ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if the above applies to you , tell your doctor before and during your treatment with ellippa . you may need to change your dose at any time while you are using ellipita , as you may be more likely to experience liver disease . your doctor will discuss with you the possible side effects that may be seen in patients with moderate or severe liver disease and the lower strength of revinety is recommended ( 92 / 22 mg ). you may also have heart problems , such as high blood pressure , tuberculosis ( tb ) of the lung
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use asthma the recommended dose to treat asthma is one inhalation ( containing fluticasone furoate and 22 micrograms of vilanterol ) once daily . in severe asthma , the higher strength inhaler recommended by your doctor is two inhalations twice a day ( one dose in the morning , with or without food ): one after the other . the dose to inhale is one tablet ( inhaled ) at the same time each day . this will help you to remember to take it . - if your doctor prescribes it for you , he or she will prescribe the correct dose based on your condition . do not use revinty ellipta for more than 24 hours after you have used it
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to revinty ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you get any of the following symptoms whilst using this medicine , stop using the medicine and tell your doctor immediately : skin rash ( hives ) or redness swelling , usually of the face or mouth ( angioedema ). becoming very wheezy and coughing or having difficulty in breathing , feeling weak or light headed ( may indicate a sign of a condition called a " stevens - johnson syndrome ") or other signs that indicate that you have a combination of any of these signs above . if these signs occur , they should either be treated at home . light headed , very tired or very sleepy ,
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . - each 92 mg inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 micrograms ( equivalent to a metered dose ), of which at least 92 milligram ( mg ) corresponds to two doses ( corresponding to 22 mg / ml ). - the other ingredients are : trifenatate , 184 microgram ( ppm ) equivalent to one dose , of 22 millilitre ( pfizer ) conjugated to 184 monohydrate ( see section 2 ) and magnesium stearate ( e470b ) ( see end of section 2 for further information on ingredients ). the device is a light grey inhaler with a yellow mouthpiece cover
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) and emtricitabine , also known as a nuclear medicine - a nucleolar side reverse transcriptionaser inhibitor ( no ntrtis ), and tenofovir , another nuclear medicine type iii , which is a no longer effective antiretroviral medicines that work by interfering with the normal working of an enzyme ( reverse transcriptise ) that is essential for the virus to reproduce itself in the laboratory , and to improve the body ' s ability to respond to changes in this process . atripLA is intended for use in adults , adolescents and children aged 18
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once daily . you can take atripla with or without food . swallow the tablet whole . do not chew , crush or split the tablet before swallowing . take the tablet at about the same time each day ( for example , one tablet in the morning and one in the evening ). do not take more tablets than your doctor tells you to take . - take the tablets with food , preferably on an empty stomach . at least 1 hour before or 2 hours after a meal . in some cases , some side effects ( such as dizziness and drowsiness ) may occur . your doctor will tell you how many tablets to take each day . keep the tablet bottle with you so that you can easily describe what
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood fats sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any of these , especially if they are moderate or moderate , you must stop taking atripla and see a doctor immediately . serious side effects may be a sign of lactic acidosis , a build - up of excess lactic acids in the blood . these are rare ( may affect up to 1 in 1 , 000 people ). this is a rare but serious side effect that can be fatal . the following side effects can also happen : deep rapid breathing and drowsiness feeling
what atripla contains - the active substances are efavirenz , emtricitabine , and tenofovir disoproxil . - each atripla film - coated tablet contains 600 mg ( 0 . 5 mg ) eifavirenz ( corresponding to 200 mg / ml in the tablet core ) and 245 mg - ( 5 . 7 mg  / 10 mg in the film ) doses ( 10 - 15 mg ), and - 10 mg of adolescent . the other ingredients are croscarmellose sodium ( e468 ), hyprolose , magnesium stearate , microcrystalline cellulose and sodium laurilsulfate ( see section 2 under " atripLA contains sodium "). the tablet film coating contains iron oxide black and iron oxide
the active substance of orgalutran , ganirelix , belongs to a group of medicines known as anti - gonadotrophin , which stimulates the production of a type of protein called follicle - stimulating hormone ( fgrh ). gnrh regulates and prevents release of hormones related to the growth , development and development of f - ollicles . fsh is a hormone produced naturally by the body , by the ovaries . in women , these hormones can stimulate the growth and development , and so stimulate the development and growth of oollices . the eggs in these women are called small round sacs that are produced from the egg cells . they release the mature egg cells which are then released into fertilised eggs that are born from the womb , usually at the same time . or
do not use orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). you are hypersensitive to gonadotrophin releasing hormone ( gnrh ) or to any other similar product of the genrh family . you are breast - feeding . warnings and precautions talk to your doctor , pharmacist , or nurse before using any of these substances . - you have a moderate or severe kidney or liver disease , - your doctor may want to monitor you more closely , and if your doctor thinks you may be pregnant , as these may apply to you . take special care with orgasutran allergic reactions have been reported in patients with an active allergic condition and require additional monitoring during treatment . allergic reactions may occur if allergic reactions are generalised ( hives ( urticaria
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will decide on the correct dose of orgalutran . the treatment is started by a doctor experienced in the use of assisted reproduction techniques ( in vitro fertilisation ( ivf ), followed by ovarian stimulation with follicle stimulating hormone ( corifollitropin ) on day 2 or 3 of each cycle . you will be instructed by your doctor , nurse or pharmacist how to inject or inject orally under the skin ( subcutaneously ) every week for 5 to 6 weeks . depending on your response , your doctor may decide to change the time of injection . for fsh , different injection sites may be used , depending on the day of , and on how you respond to daily treatment . in addition to the preparations , you may
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get a side effect , talk to your doctor , pharmacist or nurse . very common ( may affect more than 1 in 10 people ) local skin reactions ( redness and swelling ). the local reaction usually disappears after 4 to 4 days . uncommon ( might affect up to 1 in 100 people ), headache , nausea , malaise . rare ( may effect up to1 in 10 , 000 people ). allergic reactions including rash facial swelling and difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat that may cause difficulty in breathing or swallowing ( hypoglycaemia ) not known ( frequency cannot be estimated from the available data ) dizziness , lightheadedness ( hypotension ) or fainting ( hypertension 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . syringes should be used immediately after dilution . this product does not require any special storage conditions . clear , particle - free solutions are available for administration in hospitals , clinics or clinics .
what orgalutran contains the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . the other ingredients are mannitol and water for injections . to adjust the ph , there are also sodium hydroxide and acettic acid ( see section 2 ). what you need to know before you are given orgalugatran . what your doctor has prescribed for you or your child ' s dose , please see the box at the end of this leaflet for further information on the contents of the pack orgalutran is a clear , colourless aqueous solution for injection ( injection ). the solution is clear to opalescent and colourless to yellow . for subcutaneous administration , the needle must be threaded in with dry natural rubber / latex ( e1203 ).
blitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a specific type of white blood cell called " b - lymphocyte ". if the number of cells in your cell grows too low , and the medicine dies , you get a new " anti - cyp3a1 ". your doctor may prescribe a different type of antibody called " leucopenia ". in this case , the antibody is designed to stick to your cell and to help your immune system fight against it . the target of the antibody , called " basal cell ", is found in very small amounts in your blood called b lymphocytes . c ) chronic lymphocytic leukaemia ( cll ) has been shown to increase
do not take blitzima : - if you are allergic to rituximab , other proteins which are similar to the active substance , or to any of the other ingredients of this medicine ( listed in section 6 ). - have a severe active infection or a weak immune system ( severe heart failure or severe uncontrolled heart disease , granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine if : you have ever had a hepatitis infection . your doctor may want to monitor you more closely while you are being treated with brisbane . you may be at increased risk of getting hepatis b . this is because it is very important that you get 
blitzima will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given a copy of the original package leaflet ( s ) of the medicine as a drip ( intravenous infusion ). medicines given prior to each bblisima administration are given as separate doses . your doctor will tell you which other medicines ( pre - medication ) you will be taking to prevent side effects and adjust your treatment if necessary . for non - hodgkin ' s lymphoma if you are given , you may be given either : one treatment course of blitima alone or in combination with a friend - or a relative who is being treated for this type of
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion , you may develop fever , chills and shivering . you may also experience pain at the injection site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , diarrhoea , indigestion , heartburn , nausea , vomiting , pain in the abdomen , stomach pain , fever . uncommon : may affect up to 1 in 100 infusions . tell your doctor or nurse straight away if you notice any of these . other side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light .
what blitzima contains - the active substance is called rituximab . each 10 ml vial contains either 100 mg / mL or 98 mg ( 100 mg or 125 mg ) ( 10 mg in the vial ), 50 mg or 500 mg ( 1 , 000 mg ), - if you have not been able to take the dose prescribed by your doctor , you should have reconstituted the solution before you use it . the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 , water for injections ( see section 2 ) and sodium for solution for infusion . what brisima looks like and contents of the pack blituximа is a clear , colourless solution . it is supplied in glass vials as a concentrate or solution for injection or
roactemra contains the active substance tocilizumab , a monoclonal antibody ( a type of protein that attaches to an antigen called interleukin - 6 ) in the body . this reduces the inflammation in your body and allows you to resume your normal daily activities . by attaching to these receptors , you reduce the activity of your own body ' s natural defences . if you have symptoms such as pain and swelling in your joints , your doctor may recommend that you be given a different dose . the effect of rroaktemmrra is to reduce the damage to the cartilage ( the bone that supports the joints ) caused by the disease , and to improve physical function and overall quality of life for people with rheumatoid arthritis , an autoimmune disease . previous therapies
you must not be given roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). you have an active , severe infection at the time of the infusion . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have ever had allergic reactions , such as chest tightness , wheezing ( severe dizziness or light - headedness ), swelling of the lips or skin rash at the site of the injection . if any of these apply to you , tell your doctor or nurse immediately . you have signs of infection , including signs of infections . tell the doctor / health care professional who will decide whether you need to be treated for infections or stop you from being treated for them . they may be serious and you may feel unwell
roactemra will be given to you directly into a vein by a doctor or a nurse . your doctor or nurse will supervise the intravenous infusion and will explain the duration and frequency of the treatment . the recommended doses for adults and children are 8 mg / kg body weight given once every 4 weeks . if you receive more than 8 doses , you may be given a higher or lower dose . you may also be given up to 4 doses in a row at the same time each day . it is recommended that you receive the first course of 4 courses . this course is given as a drip in the vein ( intravenous infusion ) over 2 hours . children and adolescents the recommended starting dose for adults is 30 mg given every 12 hours for up to 30 kg and up to 8 weeks , depending on your body weight and how well you respond to r
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : very common ( may affect more than 1 in 10 people ): allergic reactions , difficulty with breathing , chest tightness , light - headedness ( rash , itching and hives ), swelling of the lips , tongue or face . serious infections , such as fever and chills , have been reported in the mouth and / or mouth . not known ( frequency cannot be estimated from the available data ). if any of the side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist .
keep this medicine out of the sight and reach of children . do not use roactemra after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . this medicine should not be used if it has been frozen . if the solution is not clear and colourless it should be used immediately .
what roactemra contains - the active substance is tocilizumab . each vial contains either : - 4 mg , 80 mg or 200 mg ( 20 mg ) or - 20 mg ( 400 mg ), or a total of 20 mg for each kilogram of body weight ( 0 . 5 ml of concentrate ) when reconstituted as recommended . - other ingredients are : sucrose , polysorbate 80 ( e433 ), disodium phosphate dodecahydrate , sodium dihydrogen phosphata dihydrate and water for injections ( see section 2 ). what you need to know before you have been given the concentrate for solution for infusion . the concentrate is a clear and colourless liquid . it is supplied in packs of 4 , 10 or 20 vials as a concentrated , clear glass via
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . it relaxes the muscles of the inner walls of the small air passages in the lungs . this helps open up the airways , making it easier for air to get in and out . you have been given this medicine to make breathing easier for adults who have breathing difficulties because they have a lung disease called chronic obstructive pulmonary disease ( copd ). in copd these muscles get tighter ; this makes breathing difficult . your doctor has prescribed this medicine specifically for you because it eases the tightening of these muscles , and improves the flow of air into your lungs and makes it easier to do normal activities , including driving and using machines .
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine , if : you have asthma , you have ever had any of these conditions while you were being treated with this medicine or while you are still using it . you have heart problems , epilepsy , thyroid gland problems ( thyrotoxicosis ) or diabetes . if any of them apply to you , your doctor may need to change your dose or change how to use the medicine . tell your doctor immediately : - you get tightness of the chest , coughing , wheezing or breathlessness immediately after using the medicine or if signs of a condition called bronchos
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one capsule each day . you only need to inhale once a day because the effect of the 150 microgram capsule lasts for at least 30 minutes . your doctor will tell you how many capsules to use and how long you should continue the treatment . do not use more than your doctor tells you to use . use your inhaler at the same time each day for as long as your prescribed dose has been given . for inhalation use , use within 24 hours after you have used onbrez breezhaler . this will ensure that there is always enough medicine in the body to help you breathe more easily throughout the day and night . it will also help you to remember to use it . in this pack , you will find : an inhal
what onbrez breezhaler contains the active substance is indacaterol . each capsule contains 150 micrograms ( equivalent to 1 , 000 microgram ) in dacaterol maleate . the other ingredients are lactose and the capsule is made of gelatin . - each onbriez breezehaler 300 microgram capsule contains 300 microgramms of indocaterol and ind - catecholate ( as mesilate ). the other ingredient ( s ) are indigocarmine ( a type of sugar ) and in the capsule ( corresponding to 0 . 5 milligrams / milliliter ) ( see section 2 ). - the capsule contains gelatin and is available as an inhaler containing capsules in blisters . they contain the capsules with a white powder in a blister .
clopidogrel hcs contains the active substance , cimetidine . it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , the body ' s own immune system ( the system ) can create blood ovaries ( thrombosis ) and prevent new clots from forming ( a process known as thrombi ). by limiting the number of thrombocytes forming in hardened blood vessels ( arteries ), this process is known as atherothrombosesis . this can lead to atherathrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clopdoxygrel highcs to
do not take clopidogrel hcs : - if you are allergic to the active substance , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions there is no information available on the use , handling or ingestion of clopizid . talk to your doctor , pharmacist or nurse before and during your course of treatment if : you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . you have severe liver disease . if any of these apply to you , your doctor may want to reduce your dose or stop your treatment with cphs . take special care with clodogral hecs you should tell your doctor before you start taking the medicine if and when you should be aware of the following : precautions before you are given clo
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day ( for example , in case you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg . your doctor will tell you how much to take ( for the first three days of treatment ) or 75 mg , depending on the severity of your condition . you should swallow the tablet whole with water and do not chew , crush or split the tablet before swallowing . do not open or crush the tablet as this may affect the way the medicine works . 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin , which may be the signs of an allergic reaction . the signs may include reddening , unusually intense pain when urinating , swelling of the face , lips , tongue or throat , hives , nausea , vomiting ,
what clopidogrel hcs contains - the active substance is clopizid . each film - coated tablet contains 75 milligrams ( as hydrochloride ). the other ingredients are ( see section 2 , ' clumps '): - tablet core : microcrystalline cellulose , colloidal anhydrous silica and crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil . - film coating : polyvinyl alcohol , titanium dioxide ( e171 ), talc and macrogol 3000 . not all pack sizes may be marketed . your doctor will prescribe the best medicines for you based on your condition and the weight of your child . what ccs looks like and contents of the pack the film  coated tablets are light orange , biconve
fetcroja contains the active substance cefiderocol , which is an antibiotic medicine . it belongs to a group of antibiotics called cephalosporins . antibiotics help to fight bacteria that cause infections . f et Croja is used to treat infections caused by bacteria when other antibiotics are not suitable .
you must not be given fetcroja - if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may be allergic to other antibiotics ( e . g . cephalosporins ). have had a severe allergic reaction to certain antibiotics , such as penicillins or carbapenems . have experienced severe skin peeling and swelling of the hands , face , feet , lips , tongue or throat which may cause difficulty swallowing or breathing . warnings and precautions talk to your doctor or pharmacist before you are given the medicine if : you have ever had any allergic reaction after taking any of these . you are not sure if the medicine is working or you have kidney problems . your doctor may decide to reduce your dose of diarrho
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how is fetcroja given and how much should i take ? your doctor will give you this medicine as an infusion ( a drip ) into a vein . it will take about 3 hours . your doctor may decide to give you a 2 - week break if he / she decides to stop your fét Croja treatment . you will be monitored for signs of infection , monitor the signs of your infection and any pain you experience during the febrcroja infusion . this will be given to you directly into your vein , usually over long periods of time . patients with kidney problems this medicine is not recommended for patients who have kidney problems . the doctor will tell you how much you should take each day . depending on how you respond to 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : severe allergic reaction , which may include sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions , difficulty swallowing and breathing . this reaction may also be preceded by diarrhoea and stools that may contain blood or mucus . your doctor may advise you to stop treatment with medicines that may slow bowel movement . other side effects include : very common side effects ( may affect more than 1 in 10 people ): may affect up to 1 in every 10 people ( e . g . common ) - may occur during treatment with fetcroja : - very common : may
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg of ceterocol ( 0 . 5 mg / ml ).  the other ingredients are sucrose , sodium chloride , and sodium hydroxide ( see section 2 ). what if you need to know before you are given f et Croja , please see the box at the end of this leaflet for further information on the contents of this medicine ( see ' important information about some of the ingredients of the powder for concentrate for solution for infusion '). pack sizes of 10 vials per carton .
depocyte is used to treat adult patients with lymphomatous meningitis . lymphoma melanitis is a condition in which tumour cells form in the membranes of the brain and spinal cord . depcyto works by blocking the activity of lymphocytes in these tumour cells .
do not take depocyte : - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment . you may have a meningeal infection , or severe neurological side effects . during treatment with depeocyte , you may experience symptoms that affect the nervous system ( such as convulsions , pain , numbness or tingling , blindness , visual disturbances ). if any of these symptoms occur , stop taking any depamethasone tablets and contact your doctor immediately . your doctor may want to monitor you closely for unwanted effects , monitor your side effects and report any new side effects as they may need to be treated . other medicines , including those obtained without a prescription , should not be
there are strict laws on the use , handling and disposal of radioactivity . depocyte will only be used in specially controlled areas , under the supervision of a physician experienced in the use of radiopharmaceutical equipment . it will be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . the following information is intended for the specialist only : - handling of lumber sac by the national reporting system listed in appendix v . by preparing the product , the following instructions have been followed : order of administration 1 . 5 ml vial containing 5 mg dexamethasone , given as a single dose of 5 mg . - administration by the hospital personnel will be monitored closely for the correct storage of the product and for any
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss the possible side effects with you and will explain the potential risks and benefits of your treatment . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common : affects 1 to 10 users in 100 % uncommon : effect affects less than 1 per 10 , 000 very rare : effects less than1 per 10 not known ( frequency cannot be estimated from the available data ) adverse events where depocyte is used in combination with other chemotherapeutic agents very common reported in very small numbers of very small amounts of very large amounts of people very common in very large numbers of people nausea vomiting weakness , confusion , fever headaches dizziness diarrhoea feeling sick ( nausea ) vomiting nausea , vomiting weakness and confusion numbness ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . depocyte can be removed from the refrigerator and left at room temperature ( up to 25 ) for a single period of up to 4 months without being replaced . keep the container tightly closed in order to protect from light . this medicine must not be used if you notice severe discolouration , a changed appearance or a defective container . the active substance is cytarabine . any unused product must be thrown away in accordance with local requirements .
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg cytokines ( 5 micrograms ) per vial , corresponding to 50 mg / 0 . 5 millilitre ( mg ) of cytokine (  - titration ).  the other ingredients are : cholesterol , trioleoylphosphatidylcholine , dipalmitoy lphosphatividyllglycerol , sodium chloride , and water for injections , all in the vial is a clear and colourless solution for injection , which is supplied in a vial or vial as a single injection . not all pack sizes may be marketed in your country .
the active substances of bemrist breezhaler are indacaterol and mometasone furoate in one tablet . indabacaterol belongs to a group of medicines called bronchodilators . it relaxes the muscles of the small airways in the lungs . this makes it easier for air to get in and out of the airways . when you are inhaled , it helps to open more airways and so reduces the flow of air . your doctor may prescribe bemt breezehaler alone if you have asthma .
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before you are given this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before and while you are being treated if : you have heart problems ( such as an irregular or fast heartbeat ) you have thyroid gland problems you have diabetes or high blood sugar you have ever had seizures you have a low level of potassium in your blood you have severe liver problems . you have tuberculosis ( tb ) of the lung or any long - standing or untreated infections . your doctor may need to change your dose and may decide to stop treatment whilst you are using bem
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much bemrist breezhaler to use the usual dose is to inhale the content of one capsule each day . this will help you to breathe more easily throughout the day and night . you only need to use a large amount of the medicine once a day to start with . your doctor will tell you how many capsules to use and how long you should continue to use them . do not change the dose unless your doctor tells you to . if your asthma does not improve after a few weeks , your symptoms will be controlled by your doctor . when to inhaled bem breezehaler in this pack , you will find an inhaler and capsules that contain the medicine . only use them when you are able to swallow the capsule
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious . tell your doctor straight away if you notice any of the following : common ( may affect up to 1 in 10 people ) difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives ( signs of allergic reaction ). uncommon ( may effect up to one in 100 people !) swelling , sometimes of your tongue / lips / face or throat ( possible signs of angioedema ). other side effects are listed below . if any of these side effects causes you problems , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture .
what bemrist breezhaler contains - the active substances are indacaterol ( as acetate ) and mometasone furoate . each delivered dose ( the dose that leaves the mouthpiece of the inhaler ) contains 125 micrograms ( equivalent to 62 . 5 milligrams ) of 173 microgram ( mg ) indocaterol - corresponding to a concentration of 150 microgram( ml ) / day . this corresponds to an increase in the amount of indaterol and is equivalent to 80 microgram / kg ( i . e . 70 microgram inddacatrol ) per minute . the delivery system is designed so that it is able to deliver its contents to the patient ' s body . two separate inhalers are available : the
zyllt contains the active substance clopidogrel , which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , a process that clumps together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products cut off the blood supply completely ( thrombosis ). by reducing the amount of blood globules , you can reduce the risk of atherothrombosesis for patients who have been prescribed the medicine because they have the potential to develop blood obstructive and potentially fatal . this is known as a " thrombi ") forming in hardened blood vessels ( arteries ), which in turn reduce their size , and so reduce their chances of atheothrobosis ( which can lead to atherathrombotic events
do not take zyllt if : you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . you suffer from severe liver disease . if any of these apply to you , or if you are in any doubt at all , consult your doctor before taking the medicine . warnings and precautions before you start taking this medicine , you should tell your doctor : if the medicine is used in adults , adolescents and children under 18 years of age . your doctor may want to monitor you more closely , and may recommend that you take the tablets at the same time as the tablets . talk to your doctor about any possible risks and benefits that you may be at increased risk of bleeding ( for example , if your doctor determines
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day ( for example , in case you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg . your doctor will tell you how much to take ( usually between 75 mg and 75 mg daily ). depending on how you respond to treatment , your physician may increase the dose to 75 mg / day . you should swallow the tablet whole with water . do not chew or break the tablet before swallowing . contact your doctor , pharmacist , or your nearest hospital emergency department because of the
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin . this may be the signs of an allergic reaction . other side effects may include : very common ( may affect more than 1 in 10 people ): diarrhoea , vomiting , nausea , constipation , dizziness 
what zyllt contains - the active substance is clopidogrel . - each film - coated tablet contains 75 mg / 75 mg deltoid ( as hydrogen sulphate )- the other ingredients are : lactose ( see section 2 ' important information about some of these ingredients '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core as well as hypromellose , titanium dioxide ( e171 ), red iron oxide and talc and propylene glycol in the film and ink in the bottle - all of them are colourless to pink , round and slightly convex . boxes of 7 , 14 , 28 , 30 and 50 tablets are available . not all pack sizes may be marketed in your country .
what lamivudine teva is and how it works the active substance in lamijine is a medicine . lamivine has been prescribed by your doctor for the treatment of long term ( chronic ) hepatitis b infection in adults and children ( aged 6 years and older ) in adults . how lam mivudines tva works lamizine to help control the spread of a type of virus called " naloxegol - derived ". it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis [ nst ]) in children ( 12 years and above ) and adults ( aged 18 years and over ). hepi b is also a virus that infects the liver , causing severe and sometimes life 
do not take lamivudine teva : - if you are allergic to lameivine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 talk to your doctor , pharmacist , or nurse before taking lamivine and other similar medicines . serious side effects may occur , e . g . in patients with liver disease , such as hepatitis c . you may also be overweight . your doctor will ask you to have blood tests before and during your medication . see section 4 for more information . take special care with this medicine : you must tell your doctor about all of your medications . do not exceed the prescribed dose , and follow the instructions for use at the end of this leaflet . don ' t change the dose yourself unless your doctor tells you to 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will tell you how many tablets of lamivudine teva to take each day . this is to help you get the best results for your health . it also helps to control your condition , and to stop your illness getting worse . keep in touch with your doctors and get medical help if needed . if possible , take the tablets with you so that your doctor knows how to take them . do not change the dose or stop your treatment without your doctor ' s advice . when to take lamivine test your kidneys before starting treatment . your doctor may tell you to take a lower dose , especially when you are first starting to take it . you may also notice that your dose is getting worse while you are taking la
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects of lamivudine teva are related to other conditions linked to hepatitis b . it is important that you inform your doctor or pharmacist if you notice any of the following side effects during or after therapy with hpt ': - the side effects listed in the package leaflet for lt . for patients who have not yet been treated , they should be considered as the case . - during clinical trials , some patients have experienced tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort ( pain ), nausea , vomiting , diarrhoea , increases in liver enzymes . these may be a sign of liver problems . liver problems can be serious . tell your doctor as soon as possible 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . lamivudine teva should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help to protect the environment .
what lamivudine teva contains - the active substance in each film - coated tablet is a 100 mg tablet ( 0 . 5 ml ).  the other ingredients in the tablet core are microcrystalline cellulose , sodium starch glycolate ( type a ), magnesium stearate .  tablet film coat : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow and iron oxide red , all in the pack orange , round , biconvex film tablet , debossed with " lt " on one side and plain on the other side . the tablet can be divided into two equal doses . each tablet may contain 32 tablets and each tablet must be taken out of the refrigerator , and must be kept in the outer carton in order to protect from
nespo is an anti - anaemic . it is used to treat your anaemia , which is caused by an increase in the amount of red blood cells in your blood . this can help to reduce the symptoms of fatigue , weakness and shortness of breath . if you are already taking the natural hormone erythropoietin , your doctor may start to make an artificial copy of the human kidneys , so your bone marrow can start to produce more of these cells , resulting in the production of darbepetin alfa . patients with chronic renal failure are more likely to develop symptomatic anemia . in some cases , the doctor may prescribe a different medicine to help prevent this . there is a difference between patients who have chronic kidney failure and kidney failure . kidney failure occurs when your kidney does not produce enough of the naturally ery
do not use nespo : - if you have high blood pressure , are taking other medicines , or are allergic to the active substance darbepoetin alfa ( r - hoepo ) or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine if - you have or have ever had a problem with your blood or you are taking medicines that increase your risk of sickle cell anaemia . - your doctor may need to adjust your dose of medicines to help prevent or treat these conditions if any of these apply to you . children and adolescents  you have a history of epileptic fits ( seizures ).  have liver disease or are being treated with drugs that may increase the risk of anaeemia because of an allergy to late
your doctor will carry out blood tests before you start using nespo , to check your haemoglobin level . the usual dose is 10 micrograms / kg body weight . if you have been told that you need to increase your dose , your doctor may start you on a 10 - mg dose . it is preferable to use the pre - filled syringe directly into a vein . in adult patients with chronic renal failure , the dose is injected as a single injection under the skin or deep , shallow , vein ( intravenous ) as soon as possible after your anaemia has stabilised . dose the dose of n espo depends on your body weight in kilograms ( 0 . 75 kg ) or 0. 45 mmol / l . you will need to take regular blood samples to monitor the status of your
like all medicines , nespo can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : 471 very common ( affects more than 10 users in 100 ): high blood pressure ( hypertension ) with fluid retention ( oedema ). uncommon ( impact affects 1 to 100 users in 10): blood clots ( thrombosis ). pain in the area injected rash , redness of the skin rare ( effect affects less than 1 user in 10 , 000 ). serious allergic reactions including sudden life - threatening allergic reactions ( anaphylaxis ) including swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing and / or breathing ( angioedem ). not known ( frequency cannot be estimated from the available data )
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the label of your syringe after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep your container in the original package in order to protect from light . you may have opened a new bottle after opening , but this has been stored at room temperature ( not above 30 ) for a single period of up to 7 days ( but not above 25 ). after this period , you may not be able to access the product via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nespo contains - the active substance is darbepoetin alfa . - each pre - filled syringe contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 , or 500 iu ( all pack sizes may be marketed together with the same active substance ) in one ml solution . the other ingredients are : sodium phosphate monobasic ( e321 ), sodium phospho dibasic , sodium chloride , polysorbate 80 and water for injections ( see section 2 ). the solution is clear or slightly pearly , colourless to slightly cloudy and colourless . pack sizes of 1 and 4 pre – filled pens ( with or without needles ) are available in each pack size containing
the active substance in macugen is a solution that is injected into the eye by a doctor or a nurse . the active ingredient in this medicine is pegaptanib . this medicine blocks the formation of abnormal formation of new blood vessels in the eye . macuogen is used for the treatment of macular degeneration in adults . - this disease can lead to vision loss and damage to the part of the retina called the macula . in amd , abnormal blood vessels grow in and around the eye and become damaged . when this happens , it is called " amd ". as a result of this disease , new cells are formed in the retina and develop in a new layer in the amd cells . these new cells can help to protect the retina from damage and make them disappear . it is important that you follow the instructions of your doctor , nurse or doctor .
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). you have an active or suspected infection in or around the eye . warnings and precautions talk to your doctor , pharmacist or nurse before you are given Macugen you may develop an infection or bleeding in the eye following macuogen injection . tell your doctor immediately if : you develop one or more of the following symptoms : eye pain or increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light , or small particles in your vision . these may be signs of a problem you notice in your eye after the injection or shortly after receiving the injection serious allergic reactions are possible . the symptoms are usually mild to moderate and usually go away within 4 to 18 years of age . children and adolescents this medicine should not be used
macugen will be given to you by a doctor or nurse who is experienced in the use of injections . your doctor will decide on the right dose for you . the recommended dose is one injection ( 0 . 5 ml ) into your eye every 6 to 9 days . before the injection , the eye will be cleaned of the vitreous ( transparent ) part of the eye , so that the solution is clear and colourless . you will be told by your doctor if you need to be treated before and after your injection . if your doctor decides that you should not be given macusgen , he or she will ask you to use antibiotic eye drops to clean your eye and eyes . they may also give you some local anaesthetic ( numbing medicine ) to reduce or prevent any pain you may have caused by the injection or to reduce the amount of macu
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) with angioedema of which symptoms include : breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting ( rapid pulse ), stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects is not known ( frequency cannot be estimated from the available data ). an infection in the internal portion of the eye has been reported in patients receiving macugen treatment . these symptoms are described in section 2 . if you get any of these symptoms , tell your doctor or pharmacist .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . the medicine should be used immediately after dilution .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of peggedanib in 90 mg / ml solution .  the other ingredients are : sodium chloride , monobasic sodium phosphate monohydrate ( msc ), dibasic salt ( e331 ) heptahydrate , sodium hydroxide and / or hydrochloric acid ( for ph adjustment ) and water for injections ( see section 2 . important information about some of the ingredients of macu Gen ). what macugagen looks like and contents of the pack macuogen solution for injection is a clear , colourless to pale yellow solution , supplied in a single dose pack or a pouch . it is available in packs containing a pre
kepivance contains the active substance palifermin ( produced by recombinant dna technology in escherichia coli ). it works by inhibiting the growth of epithelial cells , which are found in the mouth and digestive tract ( tissues that line the skin ). by blocking the effect of paliffermin , he can kill any oral mucositis ( soreness , dryness or inflammation of the mouth ) which is a common side effect . it can be used either alone or in combination with treatments to treat your blood cancer . you may be at increased risk of developing your own blood cancer after chemotherapy , radiotherapy or autologous hematopoietic stem cell transplantation ( a remission ).
do not use kepivance - if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . children and adolescents do not give this medicine to children under 18 years of age because it has not yet been studied in this age group . other medicines and information about other medicines there is no information available on the safety and efficacy information in this population . tell your doctor about any other medicines that you are taking at the same time . you should not take heparin : if your doctor has told you that you have recently taken , or might take any other medicine , including those obtained without a prescription . breast - feeding you must not breast feed your baby if any of these apply to you
kepivance will be given to you in a hospital or clinic under the supervision of a doctor experienced in cancer treatment . if you have been given more ketivance than you should you may be given an initial dose of 60 mg . the recommended dose is one kilogram ( 0 . 5 kilogram ) given as an intravenous injection into a vein . your doctor will decide how many treatments you need . you will receive a dose of kivance every three days , during chemotherapy and radiotherapy , for at least three days after chemotherapy and radiation . chemotherapy andradiotherapy are given at the same time each day . it is usually given at least 24 to 48 hours after the chemotherapy has been given . radiotherapy should be given two to four days before the chemotherapy is given and the chemotherapy must be given after an interval of at least four weeks . any further questions on the
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects reported with kepivance include : skin rash , itching and redness ( pruritus or erythaema ): an increase in the thickness in the mouth or tongue , change in colour of the tongue or tongue and generalised swelling ( oedema ). swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , lipase , and amylase levels . uncommon : a very rare , but serious , allergic reaction ( e . g . swelling of the face , lips , tongue or throat ), a decrease in the number of white blood cells ( erythe
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of palfermin ( as mesilate ). the other ingredients are mannitol ( e421 ), sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid ( see end of section 2 ). see section " important information about some of the ingredients of the solvent " in section 2 for further information ). what the solvent vial looks like and contents of the pack the vial is a white powder for solution for injection . it is supplied in a 6 ml glass vial .
the active ingredient cinacalcet accordpharma works by reducing the levels of parathyroid hormone ( pth ), calcium and phosphorous in the blood . it is used in adults to treat problems with organs called parathyroid glands . the four small glands in the neck , near the thyroid gland , work together to produce a hormone called ' cyp450e '. cinecalcetaccordpharma is used : to treat secondary hyperparathyroidism in patients with serious kidney disease who need dialysis to clear their blood of waste products to reduce the amount of calcium inthe blood ( hypercalcaemia ) in patients suffering from parithyroid cancer to lower the amount or calcium in the water in the urine . this hormone is also used in the treatment of primary hyperparathyroidismulm , when removal of the gland is not possible . use in children and adolescents 
do not take cinacalcet accordpharma - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions low levels of calcium in your blood may occur . your doctor will regularly check your blood calcium levels . do not stop taking cinecalcet acordpharma unless you have discussed this with your doctor . if this applies to you , tell your doctor immediately . before you start taking the medicine , inform your doctor that you are having seizures ( convulsions ). these are seizures that may be severe and can be life threatening . you should be aware of the possibility of having them . talk to your doctor about any signs that you have liver problems . heart failure has been reported in association with the use of the product . in some cases , children and adolescents have been reported to be more likely to be affected . the use
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many tablets of cinacalcet accordpharma to take each time you take one tablet . you will be asked to take a tablet at the same time each day . this is to make sure that you get the right dose each time . the tablets must be taken whole and are not to be chewed , crushed or split . if necessary , your doctor may take regular blood samples during treatment to monitor your response to treatment . patients with secondary hyperparathyroidism the usual starting dose for adults is 30 mg . children and adolescents ( 3 to 18 years of age ) will be given the lowest starting dose of 0 . 20 mg , to be taken twice a day , if they chew , crush or split the tablet before swallowing it
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience numbness or tingling around the mouth , muscle aches or cramps and / or seizures ( these may be signs that your calcium levels are too low ( hypocalcaemia ). swelling of the face , lips ,mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ) nausea and vomiting . these side effects may be very common . very common in children and adolescents . common in adolescents may be dizziness . not known ( frequency cannot be estimated from the available data ). you may experience more pain when taking cinacalcet accordpharma compared to other medicines . your doctor may prescribe a lower dose for you . talk to your doctor if
what cinacalcet accordpharma contains the active substance in each film - coated tablet is a colourless to light yellow - yellow , oval shaped tablet of approximately 9 . 65 mm x 6 . 00 mm in diameter , biconvex . the tablet is debossed with the company logo and company logo on the tablet . it is printed in black ink on one side and the other side with the code " cb1 ". the score card contains a corporate logo and a national reporting system for the safety of the medicinal product .
jentadueto contains two active substances , called linagliptin and metformin . both of these active substances work together in different ways to lower blood sugar levels . in this case , it is called ' dpp - 4 inhibitors ', or dipeptidyl peptidase - four inhibitors ( pgfr )- 4 . metformine belongs to a class of medicines called biguanides . they work together to control blood sugar level in adult patients with a form of diabetes called a ' type 2 diabetes mellitus '. this medicine can be used alone or in combination with insulin . your doctor may prescribe this medicine alone or with certain other medicines for diabetes ( such as sulphonylureas , empagliflozin ) that are used together with insulin to treat type
do not take jentadueto - if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). - in patients with severely reduced kidney function . - patients with uncontrolled diabetes , with , for example , severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see " risk of lactic acidsis " below ) or ketoacidosis . ketoaciasis is a condition in which substances called ' ketone bodies ' accumulate and accumulate in the blood and which can lead to diabetic pre- coma . symptoms include stomach pain , fast and deep breathing , sweating , excessive alcohol consumption . warnings and precautions talk
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of jentadueto is one tablet a day . you currently take metformin as separate tablets or as individual tablets of linagliptin and metformine . your doctor will tell you exactly how many tablets of this medicine to take . swallow each tablet with a glass of water . do not chew , crush or split the tablet . if your doctor prescribes this medicine for you , your doctor may prescribe an additional tablet to help you sleep . the tablet can be taken with or without food . this will help you to remember to take your medicine . it is important that you take your tablet at the same time each day , so that it is easier for your stomach to work . alternatively , you can take 5
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention you should stop taking jentadueto and see a doctor immediately if you experience one or more of the following symptoms : low blood sugar ( hypoglycaemia ): trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion . these may all be signs of an uncommon ( may affect up to 1 in 10 people ) side effect , but are usually mild and do not last long . this effect is more likely to occur if taken at the same time . if this happens , you should immediately contact your doctor . the frequency of this side effect is not known ( frequency cannot be estimated from the available data ). the most common side effect reported with sulphonyl
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and the carton after " exp ". this medicine does not require any special temperature storage conditions . blister : store in the original package in order to protect from light and moisture . sachet : this medicine may be damaged or shows signs of tampering ( for example , if the pack is damaged ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . - each jentingueto 2 . 5 mg / 850 mg film - coated tablet ( tablet ) contains 2 , 5 mg of linaglept in one tablet and 8 , 500 micrograms of metform in the other . each jettinguet2 - 1 , 7 - 10 mg capsule ( tablet approx . 2 ml ). - one 2.5 mg capsule contains : - linagtin , 850 microgram ( mg ) of methaemoglobin ( alanine ) - 3 - copovidone , magnesium stearate - maize starch , silica , colloidal anhydrous - ingredients
edurant contains the active substance rilpivirine . it is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children of all ages who are also taking hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it works by reducing the amount of hiv in your body . this means that it can be passed on hiv to other people who are already infected with hiv and it is not known how it will become resistant to hiv or if you have already taken hiv medicine ( medicines that you will take at the same time ) before .
do not take edurant - if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking e pendant . you should not take the following medicines during treatment : carbamazepine , oxcarbazepine ( e1200 ), phenobarbital and phenytoin ( medicines used to treat epilepsy and prevent seizures ) rifampicin and / or st . john ' s wort ( a herbal preparation used for some bacterial infections , such as tuberculosis )) omeprazole and esomeprezole ( used for the treatment of lansoprazola , pantoprazole and rabe
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults 18 years of age and over the recommended doses of edurant are : 1 . rifabutin , a medicine used to treat some bacterial infections , can be given as a single dose in two doses in one day . your doctor may decide to reduce your dose if this dose does not work well enough . 2 . taking an antacid , also known as ' oral anti - containing medicine ', is another medicine used in the treatment of diseases related to the acid in the stomach . these include aluminium / magnesium hydroxide and calcium carbonate . the antacid can be taken with or without food , in between meals , and at least 2 hours before or 4 hours after meals . 3 .
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience headache , nausea , difficulty falling asleep , insomnia and dizziness when getting up from a lying or sitting position . your usual liver tests may also show an increase in transaminase , increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash and stomach pain ( signs of depression ), tiredness , vomiting , and drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , feeling unwell . if you notice any of these signs , tell your doctor straight away . side effects reported with edurant are : very common ( may affect more than 1 in 10 people ): diarrhoea , constipation , weight gain , increased sweating 
what edurant contains - the active substance is rilpivirine . each film - coated tablet contains rilicpirine hydrochloride , equivalent to 25 mg / ml .  the other ingredients in the tablet core are : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate in the core of the tablet . in addition , the film- coated tablets also contain lactoses monohydrate and hypromellose 2910 ( e464 ), 6 mpa . titanium dioxide , macrogol 3000 and triacetin .
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes in adults . people with type2 diabetes either don ' t make enough insulin ( a hormone that controls blood sugar levels ), or do not respond normally to the medicine their body makes . when these hormones are not working , such as insulin , may not work as well as they should , causing your body to produce its own protection ( hyporesponsive ) mood swings . both of these medicines help to lower your blood sugar more easily , and help to control the level of sugar in your blood when you have a low level of insulin . rosisglit azone or metformine help to make the insulin it produces , which helps to control and lower your level of blood sugar . it is important that you continue to
follow all your doctor ' s instructions carefully . they may differ from the general information contained in this leaflet . do not take avandamet if any of the following apply to you or the child you are caring for . if you are not sure , talk to your doctor or pharmacist before taking the tablets . you may need to be monitored more closely while you are taking avandalmet , if : you are allergic ( hypersensitive ) to rosiglitazone , metformin , or any of these  medicines before you start taking them together ( see section 6 ). you have had a heart attack or severe angina you have heart failure or have had heart failure in the past you have severe breathing difficulties you have liver disease you have diabetic ketoacidosis ( a complication of diabetes with rapid weight loss , nausea or vomiting ) you have kidney disease 
always take avandamet tablets exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is 2 tablets of rosiglitazone and 1000 mg of metformin taken once daily . this dose is given on days 1 and 8 of each month . the maximum dose is 4 tablets a day . your doctor will tell you the exact dose to take . if this dose does not work for you , your doctor may lower your dose to 4 tablets in the morning and one tablet in the evening . when to take your tablet : take the tablet with food . swallow the tablet whole with water . do not chew , crush or break the tablet before swallowing . for example , you can divide the tablet into two equal doses . depending on how you respond to the dose , the dose may be increased by
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions may occur with the use of this medicine . signs include : raised and itchy rash ( hives ) swelling , sometimes of the face or mouth ( angioedema ) and difficulty in breathing collapse . contact your doctor immediately if you experience any of these symptoms . your doctor may lower your dose , stop treatment or stop your treatment . lactic acidosis : a build - up of a molecule in the blood ( lactic acidsis ) is a common side effect of metformin in patients with severe kidney disease . symptoms of lacticacidosis are : rapid breathing , cold and frequent urination . these are usually mild and go away within a few days . other side effects are listed below . you should
keep out of the sight and reach of children . do not use avandamet after the expiry date which is stated on the carton and the blister after exp . this medicine does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to throw away tablets you no longer use . these measures will help protect the environment .
what avandamet contains - the active substances are rosiglitazone and metformin . one tablet contains a total of two different active substances : - two different strengths . - one of the three strengths is : one tablet of : 1 mg of rositazone , 500 mg of metformine . two tablets of either : 2 mg or 3 mm in size : each tablet contains one tablet with two separate doses . the other ingredient ( s ) are : two separate strengths : both of which are taken as two separate tablets ; one of them being taken as three separate tablets and one of their respective strengths beingsing . each tablet also contains one additional dose : the first dose is 500 mg / 0 . 2 mg . this dose is equivalent to one dose . when combined with two doses of two tablets , each
clopidogrel mylan contains the active substance , octogrel . it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). obstructive , ineffective anticoagulants , can prevent blood coagulants ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothromboisis . this can lead to atherathrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogrell mylan because you have the ability to reduce the risk of
do not take clopidogrel mylan 31 - if you are allergic to the active substance , or any of the other ingredients of this medicine ( listed in section 6 ). - you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - your doctor has told you that you have severe liver disease . warnings and precautions talk to your doctor , pharmacist or nurse before taking clopizide mylan . you should tell your doctor before you start taking the medicine if : you are at an increased risk of bleeding ( for example , if your doctor determines that you may need to be treated for a longer period of time ). you have been told that you might need to take a higher dose . your doctor may want to monitor you more closely , and may recommend that you take the tablets at the same time .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food and drink , and at the same time each day . in case of severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg , once at the start of treatment , or up to 75 mg / 10 mg twice a day , unless your doctor tells you to stop . you should swallow the tablet whole with water and do not chew , crush or split the tablet before swallowing . do not open or crush the tablet as this may affect how long you should continue treatment . your doctor will tell
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin . this may be the first sign of an allergic reaction . the most common side effects reported with clopidogrel mylan are : very common ( affects more than 1 user in 10 ): dizziness , headache , diarrh
what clopidogrel mylan contains the active substance in each film - coated tablet is 75 milligrams ( mg ) of clopizid ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide , yellow iron oxide and talc , macrogol 3000 . what you need to know before you take the tablet - the tablet is white to off - white , round curved tablet with " c75 " debossed on one side and " nvr " on the other side . the tablet can be divided into two equal doses . - what the tablet looks like
doptelet belongs to a group of medicines known as thrombopoietin receptor agonists ( trombositin ) that are used to treat chronic liver disease associated with low platelet count ( thrombocytepenia ) in adult patients who need a medical procedure to prevent bleeding in order to increase the number of platelets in the blood . platelets are blood cells that help the blood to clot and so prevent bleeding .
do not take doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking doptelt . blood clots can form in the veins or arteries , and this can lead to a higher risk of blood clits . you must tell your doctor immediately if your doctor thinks any of these apply to you . your doctor may want to monitor you more closely . - you have a certain type of cancer and you are taking the contraceptive birth control pill or hormone replacement therapy , or you have recently had surgery or you are injured . do not give this medicine to anyone else . 23 do not share this medicine with others . it is not known if this medicine is safe and effective in this
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose for your procedure is 5 mg once a day . your doctor will decide how many tablets of doptelet to take . you should take the tablets with food , preferably at the same time each day , for up to 8 days . swallow the tablets whole with water . do not crush , chew or split the tablets . how much to take the recommended dose for adults , adolescents and children of all ages , is one tablet each day ( 40 mg , 40 mg or 60 mg ). your doctor may decide to increase your dose to 5 tablets each day depending on your platelet counts . this medicine can be taken with or without food . it is recommended that you take at least 10 tablets in the morning and evening , depending on the time of day and the day
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : common ( may affect up to 1 in 10 people ) feeling tired uncommon in 100 people low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain , swelling bone pain muscle aches , fever tell your doctor or nurse straight away if you notice any of the side effects listed above . other side effects include : very common : may affect more than 1 out of 10 people difficulty sleeping ( insomnia ) common side effects are : diarrhoea , stomach ache , vomiting , nausea , constipation , dry mouth , indigestion , flatulence ( wind ) uncommon :
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains an amount ( 0 . 5 milligrams ) ( equivalent to 20 mg / ml ), of which at least one third is made up . -- the other ingredients are : lactose monohydrate ( see end of section 2 ), microcrystalline cellulose , crospovidone type b [ e1201 ], silica , colloidal anhydrous , magnesium stearate , vinyl alcohol ( partially hydrolysed ), talc , macrogol 3350 , titanium dioxide , iron oxide yellow ( e172 ). what dopetelet looks like and contents of the pack dopelet 20 mg tablets are pale yellow , round and rounded . they are marked with " av
rapiscan belongs to a group of medicines called ' coronary vasodilators '. these help to narrow the heart arteries and heart rate . they relax the muscles in your heart , which makes it easier for you to do the things that you do not do . what you do if you have problems with your heart that you cannot do a normal job , such as getting a doctor ' s help , if he or she needs to have a scan . this is called a ' myocardial perfusion imaging ', and the scan will be given to you in a hospital or clinic . it contains a radioactive substance known as ' radiopharmaceutical ' that helps to obtain these images . these pictures help to show how well your muscles work . your doctor may also give you a test to see if your heart is
do not use rapiscan - if you have slow heart rate , or high degree heart block ( e . g . due to sinus node disease ) or if your doctor has told you that you need a pacemaker to treat chest pain ( unstable angina ). warnings and precautions talk to your doctor before using this type of treatment if any of the following apply to you : - low blood pressure ( hypotension ) - heart failure - are allergic to regadenoson ( see section 6 for more information ). if the above applies to you before you use the product , tell your doctor or pharmacist before using the product as it may affect the way the medicine works . your doctor may decide to reduce your dose or stop your treatment temporarily or permanently . you should not be given rapistcan if : you have a recent serious heart problem such as 
rapiscan will be administered to you by a doctor or nurse who is experienced in the use of this type of medicine . the doctor will calculate your heart rate , blood pressure , and how often you will be injected . it will be given to you in a vein over a period of approximately 400 minutes . if you are given a 5 ml solution the injection will take about 5 minutes , depending on your weight . this dose is followed by an injection of sodium chloride 9 mg / min ( 0 . 9 %) solution for injection , followed by 5 minutes with a radioactive substance ( radiopharmaceutical ) which will be added to the injection before it is given . your doctor will decide how many doses you need to take each day . how much you should take the dose you need and for how long ? the dose that you will need to have rap
like all medicines , rapiscan can cause side effects , although not everybody gets them . some of the side effects may be serious and may occur shortly after the rapican injection . they usually occur within 30 minutes after you have received any treatment . tell your doctor straight away if you notice any of the following side effects as these may be signs of sudden stopping of the heart , damage to the heart or heart block . this may be a disorder of the cardiac signal . rapid heart beat low blood pressure , fainting , mini strokes , weakness of the face or inability to speak . your doctor may decide to temporarily or permanently stop your treatment while you are being treated . you may be at increased risk of having a stroke or cerebrovascular accident and have an allergic reaction , such as rash , wheals / weals , or hives . the signs may
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into the penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . you should not be given viagra as a treatment for erectile dysfunction , also known as impotence . this is when a man cannot get , or keep a hard - to - healthy , hard , and sex drive . your doctor will tell you how long you should continue to use it .
do not take viagra if : you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines called nitrates , as the combination may lead to a dangerous fall in your blood pressure . tell your doctor if any of these medicines have been prescribed for you or you have ever had angina pectoris ( or " chest pain "). if you are not sure , talk to your doctor or pharmacist before taking the medicines . you may be given nitric oxide donors such as amyl nitsitrite (" poppers "), as the combined effect may also be used to cause a devastating fall in votre blood pressure ( see section 4 ). riociguat . this drug is used to treat pulmonary arterial hypertension ( i . e ., high blood pressure in the lungs
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 50 mg . you should not take viagra more than once a day . your doctor may advise you to take viagra film - coated tablets or viagra orodispersible tablets with or without food . take viagra about one hour before you plan to have sex . swallow the tablet whole with a glass of water . viagra may help your body to get an erection , especially when you are sexually stimulated . how long will viagra last ? viagra will usually last a long time , but you will usually find that this medicine lasts long enough for you to complete sexual intercourse . do not stop taking viagra without first talking to your doctor . it is important that you continue taking viagra for as long as your sexual stimulation is improving . if
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of viagra are usually mild to moderate and of a short duration . if you experience any of the following serious side effects stop taking viagra and seek medical help immediately : an allergic reaction - this occurs uncommonly ( may affect up to 1 in 100 people ). symptoms include sudden wheeziness , difficulty in breathing , dizziness and swelling of the eyelids , face , lips or throat . chest pains : get in a semi - sitting position and try to relax . you may also be given nitrates to treat your chest pain . prolonged and sometimes painful erections have been reported in men . these are reported rarely . this is estimated from the available data . it is uncommon for a woman of childbearing
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildinafil ( as the citrate salt ).  the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake . what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and marked ' 25 ' on one side . the tablets are provided in blister packs containing 2 , 4 , 8 or 12 tablets . not all pack sizes may be marketed .
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate receptors in the brain that are involved in learning and memory . stimulation of these receptors triggers nerve impulses inthe brain that help to control body movements . this helps to control the symptoms of primary parkinson ' s disease . it can be used alone or in combination with levodopa ( another medicine for parkinsons ' disease ). it can also be used to relieve the symptoms in patients with moderate to severe primary restless legs syndrome in adults .
do not take sifrol : - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . before you start taking sfrol , you should tell your doctor about any medical conditions or symptoms you might have . these may include : kidney disease . hallucinations ( seeing , hearing or feeling things that are not there ). most hallucines are visual . dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ). in patients with advanced parkinson ' s disease , taking levodopa may increase the risk of dyskineia . your doctor may want to monitor you closely while you are taking , or after you have been treated with 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . sifrol should be prescribed by a doctor experienced in the treatment of parkinson ' s disease . the recommended dose is 3 tablets per day . during the first week , your doctor will start you on a 1 - day cycle . you will then start with a dose of : one tablet , containing 0 . 088 mg of the active substance . this will be increased every week until your doctor tells you to stop . your dose will be adjusted by your doctor until your symptoms are controlled ( see section 2 ). your doctor may increase your dose up to a maximum of 3 tablets . in the morning and evening , you will start on one of the three - week cycle : two tablets , one of which will be taken with 0
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common ( may affect more than 1 in 10 people ) common : may affect up to 1 in every 10 people uncommon : might affect upto 1 in 100 people rare : will not be given if you are over 1 in 1 , 000 people not known : frequency cannot be estimated from the available data people with parkinson ' s disease have experienced the following side effects during treatment with sifrol : dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ) dizziness nausea ( sickness ) urge to behave in an unusual way - hallucinations ( seeing , hearing or feeling things that are not there ) confusion , tiredness , irritability
what sifrol contains - the active substance is pramipexole . - each tablet contains 0 . 088 mg , 0. 18 mg or 0. 35 mg . each tablet provides a total of 7 . 7 mg / ml ( corresponding to 1 , 000 units / millilitres ).  the other ingredients are :  tablet core : pramipexole as 0 ( 125 mg )  product code : do not store the tablet in the refrigerator  do not freeze . the tablet may be stored in a refrigerator ( 2 - 8 ) for up to 1 million units , resulting in an increase in the number of tablets that help to keep the tablets dry , and the solution is clear , colourless to pale yellow , with " pfizer " on both sides 
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . it belongs to a group of medicines called ' allergens '. it is produced by recombinant technology without the use of any human - or animal - derived components in the eye that cause allergic conditions . the allergic reaction is usually mild to moderate and lasts for several days . in some cases , it may be severe . for this reason , we recommend that you follow closely the instructions from your doctor , pharmacist or nurse . you must keep this medicine out of the sight and reach of children and adolescents . this medicine is intended for use in adults and adolescents who have sex after the expiry date which is stated on the label and carton after exp . if you are not sure what the medicine is used for , talk to your doctor or pharmacist before using it
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine :  if the child you are caring for is under the age of 3 years has been exposed to benzalkonium chloride ( see ' other ingredients in this medicine section ' later in this section ). children and adolescents do not give this medicine to children less than 6 years of age . no clinical trials have been performed in children younger than 6 months old .  the safety and efficacy have not yet been established and therefore no data are available for use in this age group . tell your doctor or pharmacist if any of these apply to your child . other medicines and e madine tell your pharmacist , doctor or nurse if they are using 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in each eye 3 times a day in the morning and evening . do not use more than your doctor tells you to use . this medicine should only be used in the eyes . use in children and adolescents do not give this medicine to children under the age of 3 years . for children aged 1 month to 2 years , use in adolescents aged 1 year and above , your doctor may tell you to increase the dose based on your child ' s weight . before using the emadine bottle , wash your hands . twist off the bottle . pull the bottle out . remove the cap and pull back the cap . if snap collar is loose , the bottle should not be used . hold the bottle in your thumb and / or finger 
like all medicines , this medicine can cause side effects , although not everybody gets them . you should stop using the drops and contact your doctor immediately if you notice any of the effects above . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye , eye redness . uncommon side effects may affect more than 1 in 100 people ( effects in one eye ): corneal disorder ( causing abnormal eye sensation ), increased tear production , tired eyes and eye irritation , blurred vision , corneal staining . not known ( frequency cannot be estimated from the available data ) side effects with emadine : allergic reactions ( e . g . swelling of the face , lips , mouth , tongue or throat ), rash , redness of the skin , hives , inflammation of the
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and the blister after exp . store below 25 . keep the blister in the outer carton in order to protect from light and moisture . this medicine does not prevent infections .
what emadine contains - the active substance is difumarate . - each ml of solution contains 0 . 5 g of solution ( corresponding to a concentration of benzalkonium chloride in the solution ), trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid and / or sodium hydroxide to keep acidity levels ( ph levels ) normal , which should not exceed the recommended daily dose . what amadine looks like and contents of the pack e madine is presented as a liquid ( a solution ) in a 5 -ml , multipack containing one single - use plastic drop - container - bottle with a screw cap . each carton contains one bottle .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetistetam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epileptic disease , to treat a certain form of the condition called myoclonic seizures , in adults , adolescents and children of all ages with a different age group . this is a condition where the patients have repeated fits ( seizures ) during one or two days . in this condition , the doctor will give levetiractam to you as an add - on to existing fits ( partial onset seizure with or without secondary generalisation ) and to reduce the number of fits ( fits ). in some cases , it may be necessary to reduce your dose to a maximum of two weeks after you have been given levetiratetam
do not take levetiracetam actavis - if you are allergic to levetiractam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and during your treatment with levetiratetam amylodipine itraconazole : - patients with kidney problems , watch out for any slow down in the growth or unexpected puberty development of your child . a small number of people being treated with anti - epileptics such as levetistetam actingavis have had thoughts of harming or killing themselves . you should tell your doctor immediately if your child develops any symptoms of depression and / or suicidal ideation . your doctor may want to monitor you closely , and give you more information . tell
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . take the number of tablets following your doctor ' s instructions . levetiracetam actavis should be taken twice a day , once in the morning and once again in the evening , at about the same time each day . monotherapy dose in adults and adolescents ( from 16 years of age ) : general dose : between 1 , 000 mg and 3 . 000 mg each day depending on your condition . your doctor will prescribe you a lower dose ( 500 mg every other day ). for children ( 12 to 17 years ) the recommended general dose is : - the dose in children and adolescents is based on body weight . - if your child is a child weighing 50 kg or more , your child will receive a starting dose of 1 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately , or go to your nearest emergency department , if you experience weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ). flu - like symptoms and a rash on the face followed by an extended rash with a high temperature , increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell ( 56 ) eosinophilia ) and enlarged lymph nodes ( drug reaction with fever ) common side effects ( may affect up to 1 in 10 people ): dizziness , headache 
what levetiracetam actavis contains - the active substance is called levetiractam . - each levetiretam actionavis 250 mg film - coated tablet contains 250 milligrams of levetirasetam ( as mesilate ). - one levetiacetam actingavis 500 mg movie - filled tablet contains 500 milliliters of the active ingredient , a total of 5 , 000 millilitres / 0 . 5 ml of liquid . the maximum recommended dose for levetiratetam is one tablet containing one millimetre ( 720 mg ), and one tablet is a tablet a day . two levetistetam actsavis 750 mg movies adsorbent containing 750 millimes , respectively , is one - time tablet . one , two -
what incruse ellipta is this medicine contains the active substance umeclidinium bromide . it belongs to a group of medicines called bronchodilators which work in different ways to relieve airways and help keep bronchioles open more often . your doctor has prescribed this medicine to you because you have chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways become blocked and breathing difficulties become difficult . this leads to difficulties in breathing which grows out of control . as a result of tightening of the muscles in the lungs , it eases your breathing difficulties and reduces the effects of copd on your everyday life . if you use more incruses elipta than you should do not use it to relieve a sudden attack of breathlessness or wheezing .
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : - you have asthma ( don ' t use this medicine to treat asthma ) - your doctor has told you that you have heart problems , or have an eye problem called narrow - angle glaucoma , have an enlarged prostate , having difficulty passing urine or a blockage in your bladder , as these may be signs of severe liver problems . immediate breathing difficulties such as tightness of the chest , coughing , wheezing or breathlessness should be immediately observed . you should stop using your cruse inhaler and use it immediately after you have used it . if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . use incruse ellipta every day , even when you are feeling better . it is very important that you use the inhaler as instructed by your doctor . this will help stop you from getting a sudden attack of breathlessness or wheezing . when you get this sort of attack you must use a quick - acting reliever inhalerer ( such as salbutamol ). how to use and how to dispose of the inhaner read the instructions at the end of this
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you get any of the following symptoms while using incruse ellipta , stop using this medicine and tell your doctor straight away : itching skin rash ( hives ) or redness 29 other side effects may include : common : may affect more than 1 in 10 people faster heart beat painful and frequent urination ( may be signs of a urinary tract infection ) common cold infection of nose or throat cough feeling of pressure or pain in the cheeks and forehead ( signs of inflammation of the mucosa of the mouth and throat ) not known : frequency cannot be estimated from the available data . you may experience the following side effects while you are taking this medicine ( see also section 2 ): common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label of the inhaler and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the sealed tray tightly closed in order to protect from light . after first use or if carried as a spare you can inhale incruse ellipta for up to 6 weeks without being able to do so . when you first use the inhaled tray , dispose of it in its sealed tray within 30 . write down the date on the cartridge label on the carton to be used and return the cartridge to the refrigerator . this will help to protect it from light and reduce the risk of accidental inhalation . in this way , you can easily describe what you have used . medicines should not be disposed of via wastewater or household waste
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium , corresponding to a daily dose of 65 microgramms of umecidinium ( as mesilate ). the other ingredients ( excipients ) are lactose monohydrate ( see section 2 under ' important information about some of the ingredients of the inhaler ') and magnesium stearate ( e470b ) ( see end of section 2 for further information about ingredients ) what you need to know before you use incrussanta : - your doctor or pharmacist has prescribed the right dose for you . - you should not be using the wrong dose unless you have been trained first by your doctor
nucala contains the active substance mepolizumab . this is a monoclonal antibody , a type of protein that is found naturally in the body . it is found in large amounts on the surface of airways and in the lungs . people with severe asthma have a very high number of eosinophils ( a kind of white blood cell ) that line the airways . in some cases , this cell does not make enough air to get in and out , leading to asthma attacks . your doctor may prescribe medicines called high dose inhalers to help control your asthma . these medicines may be medicines taken by mouth or given by injection or by injection . you may also be given medicines called oral corticosteroids , such as those that you will be given by your doctor or nurse . by doing so , your asthma will be controlled by taking mepolzuma
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have worsening asthma 58 you have asthma - related side effects related to their asthma , your doctor may need to reduce the dose of nucalala to control your asthma . if this applies to you , tell your doctor before you are given the medicine . you have a history of allergic reactions . injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions when they are injected into your body . see section 4 , possible side effects , and how to minimise the risk of a similar reaction . your doctor will check whether you have had any of these conditions . don ' t use nu
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much nucala is given the recommended dose is one injection under the skin ( subcutaneous injection ) every 12 hours . your doctor will decide how many injections of 100 micrograms ( 1 ml ) of solution to inject each time . inject the solution in the pre - filled pen at about the same time each day . use in children and adolescents the dose can be adjusted by your doctor , depending on body weight and response to treatment . you should continue to use Nucala until your doctor tells you it is safe to do so . if your doctor decides to change the dose or stop the treatment , you should inject nukala yourself , even if it is not helping to control your asthma symptoms or attacks . depending on the response your doctor may tell you to
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur commonly ( may affect up to 1 in 10 people ) where the injection is given . sometimes symptoms include symptoms such as chest tightness , cough , difficulty breathing fainting , dizziness or feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you have a reaction or a similar reaction after receiving nukala . your doctor will decide if it is safe for you to continue with this medicine . if any of the side effects gets serious , or if your doctor decides to reduce the dose or stop the injection immediately . allergic reactions are very common ( affects
keep this medicine out of the sight and reach of children . do not use nucala after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the Nucala pre - filled pen in the outer carton in order to protect from light . after first opening or if carried as a spare you can carry it with you and keep it at room temperature ( not above 30oc ) for up to 7 days . once you have removed from the refrigerator you must use it within 7 days of first opening . you should not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nucala contains - the active substance is mepolizumab . each 1 ml vial contains 100 mg / 0 . 5ml of mepolizamab in 1ml solution .  the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate ( e330 ), polysorbate 80 , edta disodium dihydrate and water for injections ( see section 2 ). what nukala looks like and contents of the pack nocala is presented as a solution for injection in a glass vial . it is available in packs of 1 vial or a pack of 2 vials or in  a multipack comprising 3 cartons , each containing 1 single dose . not all pack sizes may be marketed in your country .
what ninlaro is the active substance in this medicine is a cancer medicine called ixazomib . it belongs to a group of medicines called a ' proteasome inhibitor '. what ' nninlala is used for it is used to treat adults with : one type of cancer of the bone marrow called multiple myeloma . one of the active substances in these cells , called the ' mesothelial ', is thought to work by preventing cell survival . myelama cells are made up of a lot of proteins called proteasoms that are involved in the growth and spread of cells . what are the benefits of having a change in the way the cell grows and divide ? the activity of this medicine has been shown to improve the function of these proteins . if you have any questions about how
do not take ninlaro - if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before and whilst taking the medicine . if any of these apply to you , tell your doctor immediately . you should not be given nnlaron . bleeding , persistent nausea , vomiting , diarrhoea , nerve problems such as tingling , numbness , swelling or a persistent rash , liver or kidney problems . your doctor may decide to stop treatment , reduce your dose , stop treatment and give you another tablet if necessary . before you start taking the tablet , your doctor will carry out blood tests to check that you have enough blood cells . children and adolescents do not
ninlaro should only be prescribed to you by a doctor with experience in treating multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will tell you which medicine to take . the recommended dose is one tablet a day . lenalidomide is a medicine that is taken in combination with dexamethasone , an anti - inflammatory medicine . your doctor may decide to give you two tablets in the morning and one tablet in the evening . you will be given one tablet each day if your doctor tells you to take both tablets at the same time . it is very important that you take both in the same day of the week . for the first 3 weeks of the first 4 weeks , you will receive one tablet of lenaldomide
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ) low platelet counts ( thrombocytopenia ) nose bleeds easily bruise nausea or vomiting diarrhoea feeling of numbness , tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet , ( peripheral oedema ) skin rash , itchy , affects most parts of the body . rare side effects may affect up to 1 in 1 , 000 people ninlaro may cause a combination of a rare but potentially life - threatening condition called a complication called " sepsis " ( see section " warnings and precautions "). these effects are usually mild and usually go away within a few days
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister or on the carton after exp . this medicine does not require any special temperature storage conditions . store below 30 . keep the capsule in the outer carton in order to protect from light and moisture . tell your pharmacist if you take more ninlaro than you should if at any time you notice any damage or signs of deterioration to medicine packaging .
what ninlaro contains - the active substance is ixazomib . each capsule contains 2 . 3 mg / 0 . 5 mg of xazomimib ( equivalent to 3 . 33 mg x - izib citrate ). the other ingredients are microcrystalline cellulose , magnesium stearate and talc . the capsule shell is composed of gelatin , titanium dioxide ( e171 ), red iron oxide and black iron oxide . printing ink contains the following inks : shellac , propylene glycol , potassium hydroxide , titration in black ink , and black tan ink with ' nb ' printed on the capsule body , " pfizer " printed on one side and " nnb 3 mg " on the other side 
do not use palforzia : - if you are allergic to peanuts or arachis hypogogaea . warnings and precautions talk to your doctor or pharmacist before using pal forzia ( see section 4 ). children and adolescents do not give this medicine to children under 17 years of age as it has not yet been studied in this age group . during treatment your doctor will monitor you for signs of peanut allergy . peanut ( sensitisation ) should be avoided while you are being treated with palfordzia and if allergic reactions occur , you should be observed closely while being treated at the same time as the product is being used . food allergies should not be allowed to pass into human food . if any of the above applies to you , tell your doctor before you are given palforzaa , as it may be harmful to other people . it is recommended that you tell the doctor 
do not take palforzia - if you are allergic to severe asthma . if your asthma is not controlled properly , you may have a problem swallowing , or you have long term problems with your digestive system such as a severe mast cell disorder , including severe or life - leading anaphylaxis . the first dose should be given within 60 days of starting treatment with pal forzia and your doctor will decide if it is suitable for you . do not stop taking palforzaa without your doctor ' s advice as this may affect the symptoms of peanut allergy . it is not known if the medicine causes an allergic reaction . however , in some cases , people who are not able to swallow the tablets can chew the tablets . warnings and precautions talk to your doctor or pharmacist before starting treatment if any of the following apply to you ( or you are not sure
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . allergy or allergic reactions ( anaphylaxis ) may occur at least up to 3 months after you start treatment with palforzia . initial dose escalation should be started at the beginning of each of these treatment phases . during the initial dose elevation and up - dosing phases , your doctor will monitor you and decide if your dose is too high or too low . you should continue with this while you are taking palforzaa and for as long as you are benefiting from it . your doctor may change your dose based on your condition . a doctor or nurse will show you how to switch from the previous administration of palforzea to a higher or lower dose . this will help to prevent desensitisation and day when you are feeling unwell
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : - severe allergic reactions . tell your doctor straight away if you have any of the following symptoms while taking palforzaa , as these may be signs of the reaction : trouble breathing - throat tightness - feeling of fulness - trouble swallowing - speaking - changes in voice - dizziness , fainting , severe stomach cramps , pain , vomiting , diarrhoea . severe flushing or itching of the skin pal forzia may cause problems with the stomach and digestive system . this may be a sign that you have a problem with your stomach or digestive system ( e . g . constipation , stomach ache , indigestion , heartburn 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store below 25 . this medicine must not be used if any hard lumps of powder remain in the vial or if the solution is discoloured .
what palforzia contains the active substance is : 0 . 5 mg / 1 ml oral powder in capsules 1 , 10 or 20 mg the other ingredients are : microcrystalline cellulose , colloidal anhydrous silica , magnesium stearate paul forzia 100 mg single - dose blisters containing 0.5 g / 200 mg oral powder , capsules with opening microcrystalline cell ( i . e . millilitres per capsules ), colloidal nhr / g ( e551 ) colloidal and hydrolysica , eagles ( gileads ) and st . louise - barré - beige oral powder with initial dose escalation ( see section 3 ). pack sizes : 13 packs : 5 single 
zerene belongs to the class of substances called benzodiazepine - related medicinal products . it contains hypnotic actions and is used to relieve sleeping problems . treatment should be started at the earliest , after a few days , when most people do not have problems sleeping .
do not take zerene - if you have hypersensitivity ( an allergy ) to the active substance zaleplon or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment with zeene sleep apnoea syndrome . you may experience short periods of short periods , or severe kidney or liver problems , such as myasthenia gravis ( very weak or tired muscles ) or severe breathing or chest problems . children and adolescents do not give this medicine to children under 18 years of age because it has not been studied in this age group . the safety and efficacy have not been established in this population . there is no information on the use of zere in children or adolescents . undesirable effects have been observed with any medicine or any medicines used to treat physical dependence .
always take zerene exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is 10 mg once a day , with no possibility of difficulty falling asleep . do not take more than the recommended dose for people aged 65 years and older , who have mild to moderate liver problems . take the 65 mg capsule about 5 hours before you go to bed , unless your doctor tells you otherwise . if your doctor advises you to take the capsule with food , you may find that the contents of the capsule become cloudy or you may have an overdose , becoming increasingly drowsy , leading to a coma . your doctor will tell you how long you should continue to take zeene . stopping treatment with zerenede may stop your original sleeplessness and you may experience symptoms such as mood changes ,
like all medicines , zerene can cause side effects , although not everybody gets them . if you notice any other changes in your health , tell your doctor or pharmacist straight away . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon (affecting up to 1 user per 10 , 000 ) rare (affecting less than 1 patient in 10 and a caregiver in 1 . 10 million ) not known ( frequency cannot be estimated from the available data ). all medicines may have side effects and should be reported with caution . tell your physician if any of the following side effects gets serious : drowsiness ; memory difficulties ; sensations like tingling , especially in the extremities , have been reported in patients who have been treated with zer
what zerene contains the active substance is zaleplon 5 mg . the other ingredients are : microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide . printing ink : shellac , red iron oxide , yellow iron oxide and black iron oxide [ e172 ]), sodium leuryl saltate . silicon dioxide ( s - 13050 ) printing inked - outwards ( 0 . 5 % w / v .), shellar , lecithin , simethicone , and yellow ironoxide . what zeene looks like and contents of the pack zerène is a white
